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This experimental study was designed to assess the effects of different surgical repair
techniques on the process of flexor tendon healing. In particular it aimed to evaluate
the effects of incorporating a novel biocompatible, biodegradable 'wrap' into the
process of tendon repair. This inorganic polymer wrap, Controlled Release Glass,
(Giltech Limited, Ayr, Scotland, UK) was composed of a combination of sodium and
calcium cations with phosphate and oxide anions and degraded into simple ionic
substances normally found in tissue fluid. The hypothesis to be tested stated that 'the
addition of this potentially anti-adhesiogenic substance to the process of flexor
tendon repair would result in no difference in musculoskeletal function or tendon
characteristics after recovery'.
Tenotomy and primary repair of the ovine Flexor Digitorum Superficialis Pars
Superficialis slip was performed using a variety of different repair methods,
involving combinations of the following elements of repair; modified Kessler core
suture, circumferential epitenon suture, CRG wrap, triamcinolone paste. Eleven
experimental groups of twelve cases each were set-up and evaluated in two time
cohorts; six weeks and six months after surgery. A control group of twelve non-
operated cases was also assessed.
Outcome was measured using a combination of standard in vitro tests (tensile
strength, morphometry and percent composition) and in addition two in vivo
assessments (Laser Doppler Blood Flowmetry and dynamic testing of displacement,
velocity and acceleration).
Results of statistical analyses showed that for the experimental groups containing
CRG wrap, the proliferative vascular response to injury was diminished toward
'normal' range at six weeks, and within 'normal' range by six months after repair.
This occurred in the absence of any significant difference in superficial blood flow
beyond the site of repair or in the strength of these groups of repaired tendons.
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Also, at six weeks after operation these experimental groups showed a reduction in
fibrous tissue at the sites of tendon repair without any other significant differences in
morphological features of the healing tendons. The implications for clinical practice
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Identification codes & variables
Group PRIMARY PROCEDURE
AEarly = KC repair at 6 Weeks
BEarly = KCE repair 6 Weeks
CEarly = KCW repair 6 Weeks
DEarly = KCEW repair 6 Weeks
ALate = KC repair 6 Months
BLate = KCE repair 6 Months
CLate = KCW repair 6 Months
DLate = KCEW repair 6 Months
N = Normal
S = Dissection only
w = Wrap only
T = KCEW repair + Triamcinolone
Doppler
R/LF1 = Right / Left Flux 1 (proximal probe)
R/LF2 = Right / Left Flux 2 (distal probe)
R/LF1-2 = Right / Left Flux 1- Flux 2
L/RF1 = Left / Right Flux 1
L/RF2 = Left / Right Flux 2
L/RF1-2 = Left / Right Flux 1- Flux 2
In vivo tendon dynamics
DmR/L = maximum Displacement. Right / Left
tDmR/L = time to maximum Displacement, Right / Left
DhrR/L = Displacement at half relaxation. Right / Left
tDhrR/L = time to Displacement at half relaxation, Right / Left
tTTR/L = time for Total Twitch. Right / Left
VmR/L = maximum Velocity, Right / Left
tVmR/L = time to maximum Velocity, Right / Left
tOAccelR/L = time to zero Acceleration. Right / Left
Instron
R/LF = maximum Force, Right / Left







R/LFF =Right/Left Form Factor
RT = Right Tendon fibres
RS ==Right Suture material
RV =:Right blood Vessels
RO =:Right Other/fibrous substance




his project was designed to assess the effects of several different surgical
techniques, including the use of a new product - Controlled Release Glass
wrap (CRG, see Biodegradable Glass, page 37) in the process of flexor
tendon healing. The hypothesis set out to be tested stated that 'the addition of a
potentially anti-adhesiogenic agent to the process of tendon repair would result in
no difference in musculoskeletalfunction or tendon characteristics after recovery'.
General aim
The principle aim of this research was to use a large animal model (ovine) to ascertain
if, after division of a tendon (tenotomy) and primary repair, peritendinous adhesions
could be reduced by the incorporation of anti-adhesiogenic agents, with a consequent
improvement in motor function.
Definition of a tendon
A tendon may be defined as a cord of inelastic fibrous tissue connecting a muscle to
its point of insertion.
Functions of tendons
Tendons transmit the force generated by contraction of their respective muscle to
effect movement of the appropriate joint(s). They also store elastic strain energy.
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Historical Background
Hippocrates (469 - 399 BC) was author of the first recorded description of the
function of tendons, to move joints (Peri arthron 111:17). Several centuries later the
second century Greek physician and philosopher Claudius Galen (131-201 AD) of
Pergamum (Pearcy 2004) wrote about tendons though he described the white cords
of tendons as being those of nerves. In his doctrine, the Ars Parva, he warned of the
dangers inherent in injuring or even touching nerves (or tendons) cautioning that this
could result in pain, convulsions and even gangrene (Kleinert & Pickford 1997). Thus
Galen advocated the avoidance of tendon operation after division or injury. His
opinion heavily influenced physicians in Europe for many centuries and it was not
until the tenth century that the first operation to repair a divided tendon was believed
to have been performed. This was carried out by the Arabian surgeon, Avicenna, but
his valuable observations remained ignored for nearly 600 years (Kleinert,
Spokevicius, & Papas 1995). A new generation of physicians then began to re¬
examine Galen's theories and in 1752 Albreecht Von Haller published results of his
work on sensibility and irritability of various tissues, surmising that tendons had no
sensibility (Seiler & Fogle 2004). Backed by the French Academy of Science and
along with the emergence of other authors' publications (such as Syme's successful
primary tendon repair in England in 1850), the primary repair of a tendon
(tenorrhaphy) gradually began to become accepted as the treatment for division of
tendons (Kleinert, Spokevicius, & Papas 1995). From this time reports of different
methods of tendon repair began to emerge including the description of a locking
suture method by Kirchmayr, of which the Kessler (see Core Suture, page 33) and
Tsuge sutures are close variants and still in use today.
In 1918 Sterling Bunnell, founder of the speciality of hand surgery in the United
States of America published a pioneering paper (Newmeyer 2003). In his manuscript
he introduced the concept of 'no man's land'1 (see Zone Classification, page 23) and
1
so called since results ofprimary repair performed in this zone (within the flexor sheath) were
extremelypoor
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advocated tendon grafts in this zone rather than simply avoiding any attempt at
surgical repair. He also reinforced the concepts ofmeticulous surgical technique, the
importance of the pulley system (see Flexor sheaths, page 21), the need for careful
postoperative rehabilitation and early mobilization regimens. In 1944 he published his
first edition of Surgery of the Hand, a highly prominent text at the foundation of the
speciality of hand surgery. The 1940s and 1950s heralded the publication of many
papers from authors such as Mason, Boyes, Koch, Pulvertaft, Allan, and Verdan, in
which the authors described their own observations and techniques for dealing with
tendon injuries. Then in the late 1950s and in early 1960 respectively, Verdan (in
Swizerland) and Kleinert (in USA) published results of their first series of primary
repairs performed on cleanly divided tendons, contrary to the generally accepted
practice of tendon grafting. The presentations of these encouraging operative
outcomes led to further inspection by the members of the American Society for
Surgery of the Hand. The Society then gave its approval of this practice of
tenorrhaphy, which has since become the 'gold standard' treatment for severed
tendons. Since the 1960s a vast amount of literature has been published describing
different methods of suturing, types of suture material used, protocols for post¬
operative mobilization and in-depth studies of the anatomy, physiology and
biomechanics of normal and healing tendons, including many papers by distinguished
authors such as Gelberman, Manske, Lundborg.
However, despite this increase in knowledge and understanding of the mechanical and
physiological properties of tendons and improvements in suture technique the
treatment of flexor tendons lacerated within their digital sheaths remains one of the
most challenging problems in hand surgery today (Beredjiklian 2003;Leddy 1988).
The major clinical problem is that of the development of restrictive post-operative
adhesions (see Healing & Sequelae, page 26) and much research continues to address
the balance of the multitude of factors which influence the outcome of surgical
intervention and the natural healing process.
Many novel techniques have been explored to-date in an attempt to overcome this
problem of adhesions. However, none has become widely accepted into clinical
practice and as such the search for this 'Holy Grail' in hand surgery continues.
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Anatomy of tendons
Detailed anatomy of human tendons may be found in any comprehensive anatomy
textbook (e.g Gray's Anatomy) thus for the purposes of this thesis description will be
limited to a few basic principles and some salient points related to the tendon under
examination; the flexor digitorum superficialis (FDS).
Tendons are composed of a strictly ordered hierarchy of successively larger structural
units. The most basic element is that of a collagen fibril (Type I). The fibrils are
aggregated into bundles to create 'fibres' which in turn link together to form
subfascicles. The subfascicles are grouped together along with fibroblast cells and
enclosed in a covering known as endotenon, thus forming a tendon fascicle. These
fascicles are then bound together in an outer layer of epitenon which completes the
hierarchical structure of a tendon.
Figure 1: Structure of a tendon
Classification of tvne
A muscle and its respective tendon may be classified as either 'flexor' or 'extensor'
dependent upon the action of joint movement effected as a result of contraction;
flexors bend the joint whilst extensors straighten it.
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Flexor tendons of the human hand
The flexor tendons of the hand commence at their musculotendinous junctions in the
distal third of the forearm and are derived from the following muscles; flexor
digitorum superficialis (FDS), flexor digitorum profundus (FPD), flexor carpi
ulnaris, flexor carpi radialis, flexor pollicis longus and palmaris longus (though often
the latter muscle is absent). For the purpose of this study however, description of
anatomical course will be restricted to only that of the FDS and FDP tendons.
The FDS muscle is supplied by the median nerve and arises from two distinct
origins; a 'humeroulnar' head and a 'radial' head. The humeroulnar head arises from
the medial epicondyl of the humerus and the medial margin of the coronoid process
of the ulna. The radial head arises from the oblique line of the anterior surface of the
shaft of the radius. The FDS muscle divides into four tendons which ultimately insert
into the base of the middle phalanx of each of the four fingers of the hand.
Figure 2: Origin and insertions of human right FDS muscle
View of palmar aspect of right forearm. FDS muscle and tendons
shown in red.
The FDP muscle is supplied by both the ulnar and median nerves and arises from the
upper part of the anterior and medial surfaces of the shaft of the ulna along with the
adjoining part of the interosseous membrane. It divides into four tendons which are
ultimately inserted into the base of the distal phalanx of each of the four fingers of
the hand.
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Figure 3; Origin and insertions of human right FDP muscle
View of palmar aspect of right forearm. FDP muscle and tendons
shown in red.
From their commencement at the musculotendinous junctions the tendons are divided
into two groups. If dissecting from the volar aspect of the forearm, the superficialis
group is identified first, lying as a group of independent tendons. Deep to these lies
the conjoined tendon of the profundus group. Continuing distally, to the level where
the tendons traverse the wrist, the eight tendons of the FDS and FDP enter into a
large synovial sheath, the common flexor sheath (see Flexor sheaths, page 21). The
tendons continue to course distally within the common flexor sheath, through the
tight space of the carpal tunnel; formed by the flexor retinaculum overlying the carpal
bones of the hand. The FDS tendons maintain a consistent arrangement with the
tendons to the middle and ring finger lying palmar to those of index and little, with
FDP deep to these. They then fan out into the palm with the FDS tendons in the same
plane and FDP remaining deep. At the level of the proximal transverse crease of the
palm, the superficialis and profunda tendons to the index, middle and ring fingers
emerge for a short distance before entering into individual digital synovial sheaths.
The tendons to the little finger continue uninterrupted in an extension of the common
sheath.
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Figure 4: Flexor sheaths of the human right hand
The palmar aspect of the right hand is illustrated detailing the
normal anatomic configuration of flexor tendon synovial sheaths
(blue).
At the level of the proximal phalanges, each of the FDS tendons divides into two
slips, allowing the FDP to pass through, before reuniting for a short distance and then
dividing again, into radial and ulnar slips, upon insertion into the sides of the middle
phalanx of each finger. The FDP having passed between the FDS slips continues to
course distally inserting into the base of the distal phalanx of each finger.
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Figure 5; Anatomical course of FDS and FDP in the human finger
Tendon insertions in the human digit (EXT = extensor tendon)
Comparative anatomy of the ovine model
Clearly the greatest difference between the forelimb of the human and the sheep is
that in the sheep the Sanction of the forelimb is limited to that of weight-bearing
without any need to perform fine motor skills. As such the process of evolution has
resulted in the sheep having a hoof, composed of distal-phalanges, very large
metacarpal bones (approximately equal in size to its radius and ulna) rudimentary
carpal bones and a relatively short humeral bone, as illustrated below.





1 = distal phalanx
2 = middle phalanx
3 = proximal phalanx
4 = metacarpal bones III & IV
5 = carpal bones
6 = radius
7 = ulna (olecranon)
8 = humerus
9 = scapula
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The FDS of the sheep arises from two heads; the medial epicondyle of the humerus
(pars superficialis, PS) and a smaller head (pars profunda, PP) from the postero¬
lateral margin of the radius. The two tendon slips (FDS PS and FDS PP) unite just
proximal to the level of the carpal bones, to form the common FDS tendon. As in the
human case, this tendon inserts into the base of the middle phalanx.
Figure 7: FDS in the right forelimb of the sheep
The FDP arises from the lateral border of the ulna and inserts into the base of the
distal phalanx/hoof. Both muscles are also supplied by branches of the median nerve
and their tendons are collectively enclosed within a synovial sheath. The sizes of the
FDS and FDP tendons in the adult sheep are comparable to that of the human case
(see also Ovine Model, page 48).
Vascular suddIv of the human flexor tendons
The blood supply to the fingers runs infero-laterally to the course of the tendons. It is
derived from branches of both the radial (deep palmer arch) and ulnar (superficial
palmar arch) arteries which run distally along the lateral sides of the phalanges, as
digital arteries. Digital nerves accompany the digital arteries to supply the skin of the
Medial view, FDS muscle bellies shown in red. The tendon slips of
FDS PS (below) and FDS PP (above) are shown as single lines
continuing distally to insert into the middle phalanges
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palmer aspect of the fingers as well as the distal half of the dorsal aspect of each
finger. In general the ulnar nerve branches give rise to the digital nerves of one and a
half fingers on the ulnar side (little finger and ulnar half of the ring finger) whilst the
median nerve gives branches supplying the remaining fingers and thumb (thumb,
index, middle and radial half of the ring finger).
The intrasynovial part of a flexor tendon receives a dual nutritional supply; a
segmental, intrinsic supply originating from the paratenon, in common with that of all
types of tendon and an additional extrinsic supply provided by the synovial sheath (see
Flexor sheaths below). It has been shown that upon flexion and extension of the digit,
the synovial fluid from the sheath is forced into the interstices between tendon
fascicles and thus the tendon is nourished by the process of imbibition (Manske &
Lesker 1985). The importance of both of these nutritional systems, perfusion and
diffusion, have been demonstrated (Manske & Lesker 1982; Steinberg 1997), but
there remains much debate and interest regarding the balance of the two systems in
both normal and healing tendons (Jones et al. 2000).
Figure 8: Cross-sectional view of the human digit
In the centre of this cross-sectional view of the finger the FDS
tendon lies above the FDP. They are enclosed within the digital
synovial sheath and lie adjacent to the palmar aspect of the proximal
phalanx. The digital arteries are indicated in red, the digital nerves
in yellow.
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Flexor sheaths
Flexor sheaths may be thought of as essentially double-walled hollow tubes that are
sealed at both ends (Leddy 1988). However they are in fact highly specialized
structures that secrete a fluid, synovial fluid, between the layers of their walls. They
provide the tendons with a source of nutrition and an environment which facilitates
low friction gliding, essential for optimal digital function. The tendons appear to be
invaginated into the sheath which wraps around and suspends the tendon from a fold
of synovial membrane know as the mesotendon or vincula (Powers 2003). It is these
vinculae which transport nerves and blood vessels to the enclosed tendons.
Figure 9: Schematic illustration of a human digital flexor sheath
The digital sheaths also contain thickened fibrous areas know as annular (A) and
cruciate (C) pulleys (Leddy 1988). These are of fundamental importance as they are
responsible for retaining the position of the digital sheath and enclosed tendons (A)
whilst facilitating shortening (C) during the movement of flexion.
T = tendon
V = vincula
S = synovial sheath
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Figure 10: Fibrous pulleys of the human digital flexor sheath
The fibrous bands of the digital sheaths commence at the level of
articulation of the metacarpal and proximal phalangeal bones and
end at the base of the distal phalynx.
Overview of tendon injuries
Epidemiology
The hand is one of the most commonly injured parts of the body and hand injuries
have been reported to account for a quarter of all accidents (BSSH 2002) as well as
being the leading occupational injury treated in the United States' hospital emergency
departments (Sorock et al. 2001). Of these injuries, laceration of a flexor tendon is
one the most commonly sustained (Steinberg 1997), although the exact incidence is
unknown. Much research has been carried out, and is indeed continuing, to advance
our understanding of the biomechanics and physiological processes of tendon repair.
Despite recent advances, a great deal of debate still exists regarding the best methods
of repair of tendon injuries.
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Zone Classification
In order to assist classification of flexor tendon injuries and discussion of their
appropriate management, the flexor tendons were historically divided into 'zones'.
This was originally described by Verdan, C in 1960 (Helm 2003) but has since been
modified to produce a five zone classification as illustrated below (Leddy 1988).
Figure 11; Zone classification of flexor tendons of the hand
Diagnosis
Not all cases of tendon injury are straightforward to diagnose. However, in clear-cut
cases, examination reveals a lack ofmovement of the affect joint(s) distal to the level
of transection. Testing for function of the superficialis tendon is performed by asking
the patient to flex the affected finger whilst the examiner blocks movement of all other
fingers of that hand, keeping them in extension. This normally results in flexion of the
finger at the metacarpo-phalangeal joint and the proximal interphalangeal joints only.
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Figure 12: Clinical examination for function of FDS tendon
The hand on the left of the illustration is that of the patient in whom
the FDS tendon is being assessed. The hand shown on the right is
that of the examiner, which is shown isolating movement to only the
finger under examination (left middle finger) by inactivating the
profunda unit with passive extension of the remaining fingers.
To test function of the profundus tendon the patient is asked to move the affected
finger whilst the examiner blocks the proximal interphalangeal joint (see illustration
over page). This should result in movement of the tip of the finger provided the FDP
tendon is intact.
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Figure 13: Clinical examination for function of the FDP tendon
The finger being tested is shown in the middle of this illustration,
the examiners four fingers and thumb (represented by the dotted line
behind the joint) can be seen blocking flexion of the proximal
phalangeal joint.
These tests of function are also then repeated against resistance which is provided by
the examiners fingers.
Clearly these clinical tests rely on patient cooperation with the assessment, which may
not be possible especially in the case of young children, confusion, hysteria etc. It
should also be noted that in cases where incomplete transection has occurred
movement distal to the level of injury may still be possible, though it is often
associated with pain or discomfort. So in general, if there is doubt regarding tendon
transection (or associated neurovascular injury) exploration of the wound is advisable.
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Management
As with any injury a thorough examination should be accompanied by cleansing of any
associated wounds. Initially this may consist of cleansing with an antiseptic solution
such as Betadine® (a 10% povidone-iodine solution). A more thorough cleansing and
debridement will most likely require some form of anaesthetic, however this should
only be instilled once examination for any sensory loss has been performed. If the
wound requires further exploration it is usually best performed by an experienced
surgeon under the sterile conditions of theatre. A local, regional or general anaesthetic
may be required depending upon the site and extent of injury sustained and the
individual characteristics of the patient concerned.
Healing & Sequelae
In order to function efficiently, tendons are required to glide smoothly through very
confined spaces of their sheaths and to be mechanically very strong and inextensible.
To achieve this they are composed of dense bundles of collagen fibers with a
relatively sparse intrinsic blood supply. After injury, two distinct mechanisms of
healing have been demonstrated to be active (Beredjiklian 2003): an intrinsic pathway,
where the cells for the healing response come from within the tendon and epitenon
(Lundborg, Rank, & Heinau 1985; Manske et al. 1984) and an extrinsic pathway,
where the cells migrate from out-with the tendon (Potenza 1969). The extrinsic
pathway is activated early after the injury has occurred whereas the intrinsic
mechanism is delayed by several days. However, much debate still exists regarding the
balance and importance of these mechanisms. During the process of healing of
tendons three distinct phases have been identified; inflammatory, fibroblastic and
remodelling (Strickland 1999). The inflammatory phase occurs first in the healing
period, up to around one week after injury and involves the migration of extrinsic
inflammatory cells to the site of injury. The fibroblastic phase peaks around three
weeks after injury at a time when proliferation of fibroblasts predominates with the
laying down of collagen and revascularization of the tissue. The final phase,
remodelling, occurs from about eight weeks onwards and is when the newly formed,
irregularly placed, collagen fibers become organized along the axis of the tendon.
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Adhesions
During the process of healing in an injured tendon, 'adhesions' are seen to develop.
These can be defined as 'abnormal attachments between tissues or organs' and occur
as a natural part of the fibroblastic response to injury (Jaibaji 2000). Adhesions are
initially vascular structures which may provide the area of repair with essential
nutrients soon after trauma has occurred. With progression of the healing process
these adhesions are remodelled to greater or lesser degrees. However, all too
frequently the persistence of some adhesions is sufficient to limit the excursion of the
tendon upon contraction of its muscle and thus interfere with joint movement and
function. Such adhesions are often referred to as restrictive adhesions
There are a number of factors believed to promote the process of adhesion formation
(which one can attempt to minimize during the process of surgical repair). These tend
to stimulate the extrinsic pathway of healing and the most important ones are listed
below (Matthews, Richards 1976; Strickland 2000):
I. handling of tissues (minimal, gentle tissue handling is essential)
II. exposure of the inner surface of the repaired tendon (hence use of an epitenon
suture to fold in the edges, whilst also greatly increasing the strength of repair)
III. presence of any foreign substance on the surface of the tendon (an argument
against epitenon suture placement, or for promoting the development of
different types of epitenon suture)
IV. compromise of the intrinsic blood supply (e.g. due to excessive suture material
within the tendon; strangulation of the repair site),
V. immobilization (hence the introduction of many different regimens for
mobilization, along with the requirement to maximize suture strength of the
repair).
Over the years there have been a number of authors who believed that adhesions were
a necessary and vital part of the tendon healing process (Leddy 1988) whilst others,
such as Manske and Gelberman, believed (and have demonstrated with in vitro
studies) that tendons possess an intrinsic potential to heal and can do so in the
absence of adhesion formation (Manske et al. 1984). Thus the degree to which
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adhesions should potentially be modulated has been in question, let alone any
postulated methods ofhow this could be achieved.
However, it is now universally agreed that the persistence of restrictive adhesions is
one of the most frustrating and disabling sequelae of tendon injury in the hand,
especially in Zone II. Such adhesions are the basis for substantial morbidity and their
consequences necessitate further operative interventions as well as prolonged periods
of recuperation and hand therapy (Jaibaji 2000). They produce negative effects on
both the patient and surgeon, in addition to a notable economic impact on society and
as such generate much interest in the field of tendon research.
Clearly there exists a very fine balance between the stability and mobility of a repair;
the amount, type and method of suture placement to provide strength at the repair site
with minimal risk of interfering with the blood supply or bulk of the healed tendon and
thus its ultimate strength or requirement for smooth gliding motion. As such, finding a
'solution' to this problem of restrictive adhesion formation is a rather complex matter.
Mobilization
The post-operative management of repaired flexor tendons is of critical importance to
the outcome of surgical intervention. Immobilization of the repaired digit(s) was
historically the preferred method of post-operative care. In 1941 Mason described the
site of early tendon repair as a 'gelatinous exudate' and at that time it was believed
that the repair site was not capable of withstanding externally applied forces. Recent
studies have challenged this view and immobilization has since been found to be
associated with problems ofjoint stiffness and a decrease in Ultimate Tensile Strength
(UTS) in the first 5-9 days post-operatively (Boyer et al. 2001). A number of studies
have demonstrated that tendons actually respond in a positive manner to increased
levels of mechanical stress (Banes et al. 1995; Hannafin et al. 1995; Hannafin &
Arnoczky 1994; Harwood et al. 1999). Immediate mobilization of the flexor tendon
repair has now been demonstrated to reduce peritendinous adhesions and increase
tensile strength, DNA content, eventual excursion, and uptake of synovial fluid
(Bolitho 2001). Thus current practice has moved to the implementation of post¬
operative mobilization regimens. Clearly, patient cooperation and compliance with a
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rehabilitation protocol is essential if optimum function is to be regained whilst
maintaining a low rate of complications.
In the literature available to-date, much attention has been paid to the development of
specific protocols to optimize rehabilitation. However a great degree of diversity
exists between the different programmes proposed, as regards type of motion used
(active or passive), type of splint used (dynamic or static) and the timing of the
progressive steps through the mobilization protocol. Despite this, the aim remains
constant: to allow controlled gliding of the repaired tendon relative to the sheath and
surrounding tendons or tissues in order to minimize adhesion formation and to
maintain capsular movements of the joints, thus avoiding the development of digital
flexion contractures. Certain common principles have become considered as standard
for all postoperative rehabilitation protocols (Strickland 1999) these include:
1) position at rest for wrist and metacarpophalangeal joints; maintained in
flexion
2) position at rest for proximal and distal interphalangeal joints; maintained in
extension
3) frequent application of motion (active or passive) in a structured programme
of rehabilitation
All protocols are designed to guide the patient through progressively intensifying
exercises of the injured tendon. However, this progressive motion must be kept within
certain limits in order to avoid rupture of the repaired tendon whilst healing is taking
place. Current rehabilitation protocols use both passive and active mobilisation
regimens. The main argument for regimens that instigate passive motion before active
is simply that passive motion results in less force being transmitted across the repaired
tendon whilst it is believed to be most vulnerable to stresses of force. In a series of
studies using a canine model Gelberman and colleagues showed that passive
mobilization enhanced the healing process, resulting in fewer adhesions, a more rapid
return of tensile strength, better nutrition and minimal repair site deformation of the
tendons compared against immobilized repairs (Gelberman et al. 1982). Then a few
years later, Aoki et al and Hitchcock et al published results of their series of studies
on the effects of active mobilization on the tendon repair site (Aoki et al. 1997;
Hitchcock et al. 1987). These two authors demonstrated that the application of active
mobilization further enhanced the strength of repair and biological response to injury
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to the extent that the tendons were shown to maintain their tensile strength during the
early weeks of healing.
The risk with post-operative mobilization, however, is the complication of tendon
rupture. Immediately after operation the degree of risk involved is clearly dependent
upon the amount of force that can safely be applied across the freshly repaired tendon,
which in turn is dependent upon the suture method used for repair and the condition
of the injured tendon tissue. As discussed earlier, a fine balance exists between
increasing the strength of the suture, modifying the method used, and potentially
compromising the blood supply, nutrition or gliding characteristics of the healing
tendon. Thus the amount of force applied across the repair site to allow mobilization
of the tendon, without increasing the risk of rupture, must be carefully balanced.
At present the specific rehabilitation protocol used for each patient depends upon the
surgeon's choice of repair method and personal preference for one protocol over
another. However, irrespective of the method of rehabilitation chosen for any patient,
it is essential to instigate frequent follow-up in specialized multidisciplinary hand
clinics. The progress of each patient can be closely supervised, monitored and adapted
to their individual needs.
In this study post-operative mobilization was active and uncontrolled. No attempt was
made to immobilize the ovine limb after operation. This decision was backed by the
findings of Aoki et al who demonstrated that in the canine model the UTS did not
diminish in the first three weeks after operation if immediate active mobilization was
allowed (Aoki et al. 1997). Also the observations of the team at the Marshall Building
had an important role to play in this decision. Their experience of previous research
projects where splints or plaster of paris casts had been applied to ovine limbs was
that these efforts had proved futile, the splints being broken or eaten off almost
immediately. Thus it was decided that, so long as the repairs did not immediately
rupture, active mobilization was likely to prove beneficial rather than detrimental to
the healing tendon and at the same time be the most manageable form of post¬
operative care.




In the modern surgical setting non-operative treatment of tendon injuries is only rarely
an option. The reason for this is the poor functional outcome and frequent
complications which are likely to occur in the absence of surgical intervention. These
complications include stiffness, triggering, synovial sheath entrapment and late
rupture. Also there are often concomitant injuries of nerves, blood vessels, or bone,
which necessitate surgical exploration and treatment. However, if a tendon was only
partially ruptured - less than 60% of its cross-sectional area - then the decision not to
operate could be a feasible option (McCarthy et al. 1995b). In such a scenario
immediate active motion of the digit would be of critical importance in ensuring
optimal functional outcome.
Surgical Indications for Primary renair
Tenorrhaphy, or primary repair, refers to surgical end-to-end repair of a divided
tendon as soon as possible after injury. This can only be performed if the following
criteria are met:
I. Adequate facilities and skill are available
II. There is not excessive tissue loss
III. There are no associated fractures which cannot be immobilized
IV. There is no gross contamination of the wound
V. The divided tendon ends can be approximated
Should any of the above criteria not be met, a more appropriate alternative procedure
should be performed, such as delayed primary repair, tendon grafting etc.




As previously mentioned in this chapter, the principles of atraumatic tissue handling
were highlighted by Bunnell as early as 1918 and are of fundamental importance when
operating in the hand, especially within the confines of Zone II. Along with this,
meticulous haemostasis, use of a tourniquet and, most basic of all, carefully planned
positioning of the patient and ease of surgical access, should be routinely adhered to.
Aim - the ideal repair
Such a repair would allow for easy placement of suture, minimal tissue handling, a
neat repair site with minimal gap (see Tensile testing and Morphology, page 43)
between repaired ends and minimal bulk, yet with sufficient strength to allow early
mobilization and smooth gliding of the tendon. In practice though, these requirements
are not all easy to achieve!
The complexities involved in surmounting the problems inherent to achieving this aim
are testament to the fact that there remains great variation in the methods of repair
used in current practice despite the sheer number of publications of different suture
methods, materials, adjuncts and protocols for mobilization which have been tried and
researched to-date. However, despite this 'debate' on the optimal method of repair, a
number of basic principles have been agreed upon by most hand surgeons
(Beredjiklian 2003). These include the use of:
I. a core suture (two or more strands) with equal tension across all strands
II. an epitenon suture
III. wrist and metacarpophalangeal joints maintained in flexion at rest
IV. distal and proximal interphalangeal joints maintained in extension at rest
V. a post-operative mobilization program (passive or active)
VI. a multidisciplinary approach for review and appraisal of outcome
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4Gold Standard' repair
It is generally accepted that the 'gold standard' method of tendon repair involves the
placement of a core suture, such as the modified Kessler core suture (see Core Suture
below) and a running epitenon suture (see Epitenon suture, page 33) combined with
an early postoperative mobilization protocol (Strickland 1999). This is probably still
the most commonly used combination for flexor tendon repair (Helm 2003). In a
survey conducted by McCarthy and colleagues, 72% of 591 hand surgeons surveyed
in America used the modified Kessler core suture (McCarthy et al. 1995a). This
survey specifically investigated the repair technique used for partially lacerated flexor
tendons as opposed to completely divided tendons but it gives a good indication of
the high frequency of continued use of the modified Kessler core suture (albeit for a
different type of flexor tendon injury the management of which is more controversial
and will not be entered into within the scope of this research work).
Core Suture
Most hand surgeons prefer to place a grasping core suture using a synthetic braided
suture (Steinberg 1997). The core sutures in use today are mostly variants of the
technique originally described by Kirchmayr in 1917 (Kleinert & Pickford 1997). The
modified Kessler core, illustrated over the page, uses a single strand of suture with
one centrally placed knot whereas the original suture described by Kessler used two
sutures with two peripherally placed knots.
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Figure 14: Illustration of core suture techniques
Above: Original core suture described by Kessler, placed with two
strands of suture material and two peripheral knots.
Below: Modified Kessler core suture, placed with a single strand of
suture and only one, buried, central knot.
In recent years a number of authors have published their research showing that the
greater the number of strands that cross the repair site, the greater the strength of
repair (Angeles, Heminger, & Mass 2002; Labana et al. 2001; Smith & Evans 2001;
Wada et al. 2000; Wang, Xie, & Tang 2003) and some of these new methods are
gaining popularity in specialist hand centres. However, the use of such multiple-strand
core techniques must be balanced against the inherent increased risk of creating a
bulky repair and compromising the healing process by interfering with the tendons
intrinsic vascular supply owing to the amount of suture material being placed within
its core.
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Eoitenon suture
In addition to a core suture the majority of hand surgeons today place an additional
running epitenon suture around the circumference of the site of repair (Steinberg
1997). This serves to invaginate the ends of the tendon thus avoiding exposure of the
inner core of the tendon and stopping the area of repair from catching on the tendon
sheath (triggering), as well as exponentially increasing the strength of repair (Wade,
Muir, & Hutcheon 1986). Many techniques for this have been described, the simplest
being an over-and-over circumferential suture (as illustrated below) but other newer
methods such as the cross-stitch circumferential suture (SilfVerskiold & Andersson
1993) are also being used in clinical practice today.
Figure 15: Illustration of circumferential epitenon suture techniques
v
Above: Simple over-and-over circumferential suture (Strickland)
Below: cross-stitch circumferential suture (SilfVerskiold)
Novel techniques
Numerous different operative techniques (and programmes for postoperative
mobilization) have been devised and studied in an attempt to overcome the frustrating
complication of post operative restrictive adhesion formation and to improve
functional outcome after flexor tendon injury. From studies carried out to-date, a fine
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balance has been seen to exist between limiting the formation of adhesions and
interfering negatively with the healing process of the repaired tendon. Although
healing is a multifactorial process, maintenance of adequate perfusion to the lacerated
and repaired tendon remains the single most important factor in obtaining good
healing (Leddy 1988).
Historically, a number of blocking agents were used in an attempt to isolate the
repaired tendon from the surrounding tissues. These included the use of fascia,
peritoneum, tunica vaginalis, vena cava, cellophane, nylon, Teflon, polyethylene,
silastic sheaths, and gelatine tubes (Meislin et al. 1990). However, these were found
either to initiate foreign body reactions or to interfere with tendon nutrition and
healing and thus did not prove at all beneficial. More promising studies have included
the incorporation of various pharmacological or other agents around the site of repair.
These have included the use of NSAID's (Riley et al. 2001) 5-fluorouracil (Cerovac
et al. 2001; Khan et al. 2000) hyaluronic acid (Wiig & Abrahamsson 2000);
ADCON®-TN gel (Golash et al. 2003; Mentzel et al. 2000) human-derived fibrin
sealant (Jones et al. 2002). A number of membranes and diffusible barriers have also
been used; condroitin sulphate-coated polyhydroxymethyl methacrylate membrane
(Gudemez et al. 2002), Sterispon wrapping (Austin & Walker 1979) a mesh sleeve
(SilfVerskiold & Andersson 1993) expanded-polytetrafluoroethylene diffusible
membrane (Hanff& Hagberg 1998), hyaluronic acid membrane (Isik et al. 1999). To-
date, no single method has been entirely successful.
However, of most recent interest has been the development of biocompatible,
biodegradable materials which exhibit anti-adhesiogenic effects, such as polyvinyl
alcohol-hydrogel shielding (Kobayashi, Toguchida, & Oka 2001), Interceed (TC7) an
absorbable barrier (Meislin et al. 1990) and Seprafilm a bioresorbable membrane
(Menderes et al. 2004).
These materials, Adcon®-TN, interceed(t7) and Seprafilm are all American
products which have been reported by their respective authors as being successful in
reducing adhesion formation in the rabbit and rat model and advocated for use in
tenolysis procedures. However, concurrently in the UK the Research and
Development Company Giltech Limited (see Biodegradable Glass, below) produced
Chapter 1 - Introduction 36
Flexor Tendon Healing
an entirely different biodegradable product, an inorganic polymer - controlled release
glass (CRG) which was the product of interest to be evaluated in this research project.
Biodegradable Glass
Company Information
The Scottish Research and Development Company Giltech Limited was founded in
1984 to develop novel biomaterials for medical devices. It is based in Ayr (12 North
Harbour Estate, Ayr, KA8 8AA) and has an excellent record for the application of its
technologies in the medical field with successful products including the Arglaes® and
Sorbisan® wound dressing ranges. One of their newer controlled release products is
the innovative wrap substance - Controlled Release Glass (CRG) wrap.
CRG - product Information
This product has been established as being both biocompatible and biodegradable and
was originally produced for use in the laboratory of the Peripheral Nerve Research
Group in 1998 (Gilchrist et al. 1998). It was first manufactured in the form of rigid
tubes and was used for repairing nerves. These tubes were impermeable and acted as
reservoirs for e.g. growth factors. However since this time, further refinement of the
characteristics and processing of CRG have led to the additional production of a wrap
which has the appearance of a very fine sheet of lens or paper tissue. This has three
great advantages over the rigid tubes. The wraps are pliable, can be cut to any desired
size or shape and thirdly, since these sheets are made from matted strands of CRG
they have the great benefit of being permeable. The wraps are composed of a
combination ofmetal cations (Na+, Ca++) with phosphate and oxide anions and contain
no silicon, thus upon degradation they always form into simple ionic substances which
are all found normally in tissue fluid. Chemically therefore, this is an ideal substance
for implantation and its role in the prevention of adhesion formation is postulated to
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result from an early space-occupying effect followed by dissolution into what is
effectively extracellular fluid. The rate of solution can be altered by the manufacturers
simply by changing the proportions of the CRG constituents, thus tailoring
degradation to the requirements of any given situation.
The original rigid tubes were shown in an ovine model successfully to support nerve
regeneration and it was suggested that they may also have reduced adhesion
formation although this was not formally quantified as it was not an objective of the
study (Gilchrist et al. 1998).
The new fine polymer mesh wraps are seen to be pliable and easily fashioned to any
desired size or shape, permeable, degrade over a defined and modifiable time into
naturally occurring bodily substances and yet have a more robust structure than a gel.
Therefore it was postulated that the CRG wraps may be used with anti-adhesiogenic
effect in the surgical repair of tendons and the planning behind this research began.
Manufacture ofCRG wraps
The flexible, biodegradable wraps are made from one or more non-woven layers of
water soluble glass fibres. Upon dissolution (the rate of which is controlled by the
manufacturers by varying the composition of the glass) the glass fibres release ions
and ionic compounds which occur naturally in human tissue fluid, but which vary
dependent upon the compounds within the glass itself.
The water soluble glass can be manufactured in various forms, dependent upon the
constituents used and their relative proportions. However, each mixture of glass
consists of a 'former' (usually P2O5), non-toxic glass 'modifiers' (including metals,
lanthanoid oxides or carbonates and alkaline earth metals) and glass 'additives' (such
as boron containing compounds). Thus varying amounts of the following chemicals
were included into the glass mix used for this project: sodium oxide (Na20), silver
oxide (Ag20), zinc oxide (ZnO), calcium oxide (CaO), magnesium oxide (MgO),
phosphorus pentoxide (P2Os), iron oxide (Fe2C>3), boric oxide (B203).
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The exact chemicals and their relative proportions were carefully selected by the
manufacturing company to allow accurate tailoring of dissolution rate, which was
mainly determined by the ratio ofglass-former to glass-modifiers.
Once the appropriate glass forming composition had been decided upon it was mixed
and heated to a melting temperature of around 750-1050°C. This temperature was
then slowly lowered until the working temperature (approximately 200°C less than
the melting temperature) was achieved; this was the temperature at which fibre
formation could begin. The molten glass was poured into a brushing with several fine
holes drilled in a row along its base. These holes were initially sealed with a substance
which gradually melted over the period of time required for the glass to reach its
required working temperature.










Once the sealant had melted, the molten glass ran downward through the air forming
fine glass fibres, which landed and cooled on a drum that turned at high speed,
winding the fibres around it. These windings of fibres were then cut perpendicular to
their direction (longitudinally along the surface of the drum) and removed as a bundle
of fine glass fibres. The lengths of these fibres were uniform, equal to the
Chapter 1 - Introduction 39
Flexor Tendon Healing
circumference of the drum, and they were substantially aligned in the same direction.
The bundle of fibres was then laid flat on a clear surface and one of the non-cut edges
gently teased sideways away from the bundle. The fibres expanded to form a fine non-
woven web and this expansion was continued until the fibres of the web were well
separated. Several layers could then be overlapped to obtain the desired thickness of
glass wrap. To combine layers, the first layer was placed on a non-stick backing
material (siliconized sheeting) and a binding material was applied to the web. This
binding material was polycaprolactone dissolved in chloroform. The additional layer
ofweb was placed on top and a further piece of non-stick material applied before the
layers were sandwiched together and pressed flat. Once the chloroform had
evaporated the backing material was peeled off leaving behind a bound web of double
layers of glass fibres. The wrap material was then cut to size (though it could also
have been be rolled, or left in large sheets) packaged and sterilized. The sterilization
process was carried out using gamma radiation as this did not degrade the wrap. The
CRG wrap was then ready for experimental use.
Fteure 17: CRG wrap
Indicators of Outcome
The indicators of outcome chosen for this study were decided upon after extensive
review of the available literature. This comprehensive review was carried out during
the planning for the project and immediately revealed a problem inherent to the
comparison of results of different studies: that which arises from the variation in
choice of indice(s) for measuring outcome and in the methods used to gain results.
Thus the indices chosen for this work were selected to provide as detailed an analysis
as possible of different types of tendon repair, using a novel method of in-vivo
assessment along with several more traditional indices of outcome.
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Clearly, it is of fundamental importance to consider the original goal of any study in
order to be in a position to comment upon the appropriateness of the assessments
performed and conclusions drawn. In this respect the literature available to-date can
be superficially subdivided into two main groups: 1) studies assessing suture material
or technique and 2) those assessing the actual process of tendon healing or anatomy.
Many of the published studies have had the principal aim of assessing the
performance, especially strength, of new suture materials or techniques. These have
generally been performed on ex-vivo tissue harvested from cadavers (Angeles,
Heminger, & Mass 2002; Labana et al. 2001; Wade, Muir, & Hutcheon 1986; Zobitz
et al. 2001) or on ex-vivo animal tendons (see animal models, foot of page). The
tendons were either frozen for future use (Angeles, Heminger, & Mass 2002; Aslam
& Afoke 2000; Labana et al. 2001; Silfverskiold & Andersson 1993; Wada et al.
2000) or freshly divided and repaired. In these experiments the repaired tendons were
immediately tested for tensile strength and function. Therefore, these studies
concentrated only on the basic properties of suture material and technique, without
exploring the effects that the new substances or methods had on the process of tendon
healing. Thus although interesting tensile and other biomechanical profiles were
described, many questions remained unanswered regarding the effects of these new
methods/techniques on the process of tendon healing. Without further research into
these effects, the potential application of the new methods/techniques to clinical
practice may be precluded. Hence, this group of studies ought to be considered the
first step in a series, and have the purpose of answering the basic question 'does this
new suture material or technique work?' in terms of both ease of application and
immediate resultant strength.
After this, further steps should be taken, to explore the interactions of any new
material or technique in the context of tendon healing. The best approach for studying
these interactions during the healing process is through the use of animal models and
in vitro cellular studies. Such studies have generally involved the setting up of groups
of cases which were left to heal for various time intervals after operation before being
assessed. Animal models used have included the pig (Smith & Evans 2001; Wang,
Xie, & Tang 2003), dog (Pruitt et al. 1996; Wada et al. 2001; Zhao et al. 2001),
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sheep (Silfverskiold & Andersson 1993), fowl (Isik et al. 1999; Kobayashi,
Toguchida, & Oka 2001; Tanaka et al. 1995) and rabbit (Austin & Walker 1979;
Cerovac et al. 2001; Chow, Hooper, & Chan 1983; Gudemez et al. 2002; Hanff &
Hagberg 1998; Jones et al. 2002; Jones et al 2000; Khan et al. 2000; Meislin et al
1990; Menderes et al. 2004; Wiig & Abrahamsson 2000).
However, as mentioned above, the series of studies published to-date have performed
assessments on harvested tissue (in-vitro), as opposed to attempting any form of in
vivo assessments. A wide range of cleverly constructed measuring devices, clamping
mechanisms, pulley systems (with or without the inclusion of displacement or force
transducers) have also been used (Gudemez et al 2002; Isik et al. 1999; Kobayashi,
Toguchida, & Oka 2001), but again these assessments have been performed on ex-
vivo tissue (see ROM, page ).
In view of these observations, one of the aims of this project was to devise an animal
model for the assessment of flexor tendon function in vivo after surgical repair and a
pre-specified period of healing. At the same time, however, it was considered
fundamental to include a number of standard assessments of tendon function and
composition in order to provide as broad a picture as possible of the effects on healing
of the surgical interventions. This would also facilitate comparison of results with
those originating from other studies published to date. Three of the assessments
performed in this study - tensile testing, morphology and percent composition - were
chosen because they were considered to be important basic measures for assessing
outcome of tendon healing. Also two in vivo tests, doppler flux and the novel
dynamic assessments (see chapter 2, pages 74-94), were included for the first time to
advance the level ofunderstanding of tendon repair during the process ofhealing.
Blood Flow
Laser Doppler Blood Flowmetry (LDBF) is a minimally invasive method of assessing
superficial blood flow of tissues (see Laser Doppler Blood Flowmetrv. page 75). It
has previously been used to assess blood flow in the achilles tendon of the rat and
human (Astrom 2000; Astrom & Svensson 1991; Astrom & Westlin 1994). Aside
from these applications however it is a relatively underused tool in the scientific
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armamentarium available for the assessment of tendons and their process of healing.
Thus this informative means of assessing blood flow was chosen to be used as the first
basic indicator of outcome in this study.
Tensile testing and Morphology
These assessments can clearly only be performed on harvested tissue and not in vivo.
Review of the literature, however, revealed a degree of variation within the
methodology for these relatively basic indicators of outcome and also showed the
tissue specimens to originate from two broad groups; freshly harvested and repaired
tendons (cadaver/animal) or those from animal models, harvested after a spell of in
vivo healing. Thus fundamental differences in study design make it more difficult to
compare outcomes between studies.
Tensile testing
One indicator of outcome which has frequently been used, especially when comparing
different suture techniques, is that of ascertaining the tensile profile of a repaired
tendon. Tensile testing has generally been carried out using standard tensile test
machines (see Mechanical Assessment, page 95), with particular attention being given
to the ultimate tensile strength, UTS. Review of the literature revealed a number of
differences within the methodology for tensile testing which must be allowed for when
attempting any comparison between studies. These factors include the use of
cyclic/non-cyclic tension, the rate of cross-head speed and the method of clamping the
tissue sample to avoid slippage or shearing.
Some studies have also examined gap formation. This is an important concept because
the development of a gap between the two ends of the repaired tendon is the
precursor to eventual failure at the repair site. In the early 1980s Seradge and
colleagues (Seradge 1983) illustrated this in the clinical setting by marking repaired
tendons and then measuring the gap between the repaired ends. He showed that the
formation of a gap between the repaired ends of tendon predicted a poor final
outcome and the larger the gap, the worse the end result. Various other authors
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(SilfVerskiold, May, & Tornvall 1992) have set up studies to investigate whether gap
size correlates with clinical outcome, and some have attempted to define the size of
gap that may predict an acceptable outcome. Although there is still some debate in
this area, it may be concluded from the results of all these studies that the key to
achieving optimum results is to minimize any potential for gap formation. In this
study, however, it was decided to concentrate only on the tensile profile obtained
when the tendon was loaded to breaking strength, this value of UTS being of
fundamental clinical importance.
Morphology of tendons
The morphological assessments performed to-date have ranged from the very
simplistic (measuring the 'bulk' of repair by winding a thread around the
circumference of a dissected repaired tendon, six times, marking it and laying it out on
a ruler [Williams & Amis 1995]) to more sophisticated micro-calculations performed
on histological cross-sections of removed tissue (e.g. Gudemez et al. 2002; Meislin et
al. 1990; Tanaka et al. 1995; Wada et al 2001), and immunohistochemical studies
(e.g. Khan et al. 2000). Since one of the aims of this study was to maintain a high
level of scientific precision for all indices measured and observed, great care was
taken in processing the tissue samples to enable detailed histological examinations and
calculations to be performed (see Morphological Assessments, page 99).
Range of movement
As previously mentioned, a number of cleverly designed devices have been used by
various authors to obtain measurements of degrees of flexion or motion of a digit with
a repaired tendon enclosed. Although these have been carried out on harvested tissue,
the tendons have in most instances been left in their original sheath and pulley system
(Gudemez et al. 2002; Isik et al. 1999; Kobayashi, Toguchida, & Oka 2001).
However in one study 'friction' was measured by pulling freshly dissected and
repaired cadaver tendons through a pulley system (A2) created from the dissected
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digit of one of the cadaver hands. As stated by the author, the fact that the dissected
pulley was not of the same anatomical origin as that of the tendon under examination
had considerable implications on the usefulness of the test (one tendon stuck firmly
within the sheath) and on the results obtained (Williams & Amis 1995). However all
of the above-mentioned studies have aimed toward designing a model appropriate for
the assessment of movement or friction, and thus ultimately quantification of
adhesions.
In-vivo tendon dynamics
This new method of assessing the outcome of healing of repaired tendons was
developed in view of the perceived gap in the literature of in vivo indices of outcome.
Movement of a repaired tendon is clearly dependent upon the sum of two opposing
forces: 1) the force applied in an attempt to move the tendon (initiated by nerve
stimulation and muscular contraction) and 2) the resistance to gliding that must be
overcome in order to allow movement to take place. The former is clearly limited by
the breaking strength of suture material and method of repair used, whilst the latter is
affected by the bulk of repair, presence of adhesions and any other limitations
imposed by the anatomical surroundings of the individual healing tendon (eg as a
result of concomitant injuries sustained, such as underlying bony fracture). Hence, one
of the aims of this research project was to develop an in vivo model to assess tendon
dynamics within as close as possible their normal anatomical and physiological
environment, in order to expand upon the information gained through basic tensile
testing and morphological analyses.
The apparatus and methodology devised for this assessment (described in In vivo
dynamic assessment of tendons, page 81) allowed for detailed evaluation of the
displacement, velocity and acceleration of the FDS tendons which occurred upon
nerve stimulation. The specialized limb fixation apparatus (see Fixator Frame Bracket
page 76) was designed in close collaboration with a colleague from the University of
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Edinburgh department of Engineering, Mr Brendan Hawes. It was developed to
replace the original apparatus that had been used by previous researchers in the
PNRG, which had consisted of a simple pulley system and weights. In the original
experiments the cord for the pulley was attached to the distal end of the limb by
means of a Steinman pin driven through the hoofof the animal, the cord being looped
around the pin. Weights were then hung on the end of the cord to maintain the limb in
extension during muscular contraction, which was initiated by electrical stimulation of
the nerves of the brachial plexus. The proximal end of the limb was kept in position by
the opposing force of the operating table supports against the thorax of the animal.
The major limiting factor of this setup was the lack of any specific point of limb
fixation and therefore the potential for movement other than that being assessed, to
cause error within the observed values. This was not an area of great concern for the
previous studies, given that they had been assessing the characteristics of nerve repair
which generally showed more profound changes in end muscle function than was
expected to be seen after tendon injury and repair. The aim of the in vivo dynamic
assessments was to detect potentially very small differences in musculo-tendonous
function and thus modifications in the old apparatus were felt to be of critical
importance. The new apparatus was developed to provide a stable frame within which
the tendon and muscle of interest (FDS) could be reliably and repeatedly assessed
whilst the limb remained firmly fixed; a reference point of fixation close to the origin
of the FDS muscle was chosen. Initial studies were performed on ovine carcasses and
carefully dissected specimens of the forelimbs, before carrying out a pilot study.
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Objectives of research project
The objectives set out at the start of the project were as follows:
1. To establish a systematic programme of physiological and anatomical
assessment of tendon function which may be applied to the experimental
model
2. To use (1) to establish the properties of normal tendons at site(s) to be used in
the model
3. To assess, using (1) in comparison with data obtained in (2) the effects of
repairing a tendon using conventional methods e.g. modified Kessler suture
technique.
4. To repeat (3) to assess the value of additionally repairing the epitenon
5. To consider the anti-adhesiogenic effect of a CRG wrap in the model (3)
6. To consider the anti-adhesiogenic effect of a CGR wrap in the model (4)
Aims added within the first few months of commencing the study:
7. To consider the effects of dissection only in the otherwise normal model
8. To consider the effects of dissection and CRG wrap only in the otherwise
normal model
9. To consider the effects of addition of a second anti-adhesiogenic agent to the
model (6)
Full details of experimental groups are given in Chapter two Protocol, page 55.





The animal model chosen for this research study was the sheep (Ovis aries,order Ungulata) which has been used as a laboratory animal in medicalresearch since the later years of the 19th century. This choice of model was
based on a number of different factors. First, there is evidence in the literature to
suggest that the ovine model is very appropriate for the study of techniques or tissue
responses that one then wishes to attempt to relate to human subjects. This is because
there is a closer correlation between the bone and soft tissue composition of the
human body and sheep, than with other animal models commonly used in research
(Martini et al. 2001). Secondly, the size and anatomical setting of the organs and
tissues of the sheep make it a good model for extrapolation to the human case (Rand
2002). Of particular note, the flexor tendons in the forelimb of the adult sheep are
roughly comparable in size to those of the flexor tendons of the human hand. The
third consideration was the fact that the research group with which this project was
affiliated, The Peripheral Nerve Research Group, had previous, very successful,
experience working on the nerves in the forelimbs of sheep, with a large data-base of
physiological and neuromuscular information, though they had not studied tendons
before.
Ethical Approval
The proposed plan for this experimental research project was described in detail and
submitted to the Home Office for inspection. After review of its contents ethical
approval and a Project Licence were granted. The appropriate Home Office Animal
Handling Course was then successfully completed and a Personal Licence obtained
for this work.
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Choice of Flexor Tendon
As briefly mentioned in Chapter 1, page 19, the flexor digitorum superficialis (FDS)
tendon in the sheep is composed of two slips (see illustration below) enclosed in a
tendon sheath, alongside the FDP tendon. Upon opening the flexor sheath, the pars
superficialis is found to lie above the pars profunda, separated by only a very small
amount of thin connective tissue. In the human however, this tendon is composed of
a single slip only. Hence the choice of FDS tendon for this work was based primarily
on the fact that it allowed the study of a tendon injury which caused minimal
incapacity in the animal model whilst representing an equivalent injury of great
disability in the human. The superficialis slip of the FDS tendon of the right forelimb
was chosen to be divided and repaired.
Figure 18: Ovine flexor digitorum superficialis
pars superficialis
pars profunda
Illustration of ovine right foreleg dissection
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Research protocol
The protocol devised for this study is detailed below.
Group Size
The sample size of any research project is clearly critical to the potential relevance of
results gained, and conclusions drawn, at the end of the study. Home Office
regulations (Home Office (H.M.S.O) 1986) and Ethical Committees demand that
numbers of cases are kept to an absolute minimum and thus it is of fundamental
importance to be as accurate as possible when predicting the group size required for a
study.
During the planning of this research project, power calculations were performed
based on data from previous ovine nerve research carried out by the Peripheral Nerve
Research Group. One of these studies had involved peripheral nerve injuries in the
foreleg of several groups of animals. Part of the final assessment in this study included
measurement of the isometric myogram of the tetanically contracting flexor carpi
radialis muscle (which lies adjacent to the FDS muscle) in each repair group and for a
control group of normal animals. These measurements of tension were the closest
variable available, comparable to the variables that it was proposed to measure in this
new study. So values were obtained, with permission, and used to make an initial
prediction of required group size. The method for calculating sample sizes was
described by Kirkwood (Kirkwood 1991) as follows:
where:
gi - p2 is difference between means
<7i and o2, are the standard deviations
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v corresponds to the desired significance level (e.g. if significance
level is 5% v=1.96)
u corresponds to the desired power (e.g. if power = 90% u = 1.28)
N is the sample size of each group
The mean values for tension from the previous research were 25.12N (normal) and
14.47N (repaired and CNTF treated) with corresponding standard deviations of
2.79N and 2.91N respectively. These were inserted into the equation above and a
minimum group size ofN=5.63 given. Thus if a level of resolution equivalent to this
was required, groups of at least 6 animals would need to be used.
In theory therefore, group sizes of 6 animals were predicted as being adequate.
However, as the proposed measurement of in vivo tendon displacement had never
before been attempted by the group, or by any other researchers in the published
literature, it was decided to carry out a small pilot study before proceeding further.
This pilot study was carried out on three cases. Clearly this was not of sufficient size
for calculating any statistically significant results, but it was used to obtain example
values of the measurement, in millimetres, for the displacement that would be
observed during the FDS stimulation (see In vivo dynamic assessment of tendons.
page 81). This information was then used to re-check the predicted group size of
N=6, by performing power calculations on the observed displacement results using a
computer software program Statistica (Statsoft Inc., Tulsa, USA).
The first value chosen to study in these pilot cases was that of the ratio (right divided
by left) of the maximum displacement of the tendon obtained on muscular contraction
(see Understanding and Processing Picoscope Data, page 90) DmRJL. Values
obtained and the basic descriptive statistics are shown in the table overleaf:
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Pilot case No. DmR/L
1 0.142 Mean 0.142
2 0.227 SD 0.085
3 0.058
Inserting these values into the appropriate power analysis section of the Satistica
software program a sample size of six was predicted to reach a power of 0.900. This
is illustrated in the graph below:
Figure 19: Sample size calculation based on displacement results
1 Sample t-Test: Sample Size Calculation
One Mean, t-Test
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Hence this calculation suggested that a group size of six would be sufficient to yield
information of statistical significance attaining a power goal of 0.900. The graph
shown above also demonstrated that should an animal be lost from a group, for any
unforeseen reasons, a group size of 5 should still yield results with a reasonable power
goal ofup to 0.78.
The tendons from the same three pilot cases then underwent assessment of breaking
strength of both right and left FDS (see Mechanical Assessment, page 95). This was
one of the two assessments proposed to be undertaken on only half of each group, as
the tendon would be destroyed in the process and thus not suitable for proceeding to
undergo histological assessment. The same statistical procedure as above was
performed to calculate sample size. The results and informative power graph
produced are illustrated below:
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Figure 20: Sample size calculation based on tensile test results
1 Sample t-Test: Sample Size Calculation
One Mean, t-Test






Thus analysis of the values obtained from mechanical testing of the pilot case tendons
calculated that a group size of five would be sufficient to yield results with a statistical
power of 0.921.
In view of these findings it was decided to proceed with groups of six cases each for
the assessments of mechanical strength and histology (the tendons being destroyed
during the process of these assessments). However for all other assessments, which
would preceed the aforementioned tests, groups containing twelve cases would be
used.
Chapter 2 - Materials and Methods 54
Flexor Tendon Healing
Protocol
In total twelve groups, of twelve animals each, were studied.
Group 1 was the normal control group. Groups 2-8 were the different surgical
procedures being assessed.
The first five groups were chosen from the outset and a further three (groups 6, 7 &8)
were added at a later stage in the research period in order to attempt to examine in
greater detail some of the aspects of tendon healing. In the groups where tendon
injury was simulated, complete division of the tendon (tenotomy) was carried out by
performing a clean cut with a surgical blade.
Group Experiment
1 Normal Controls
2 Tenotomy + modified Kessler repair
3 Tenotomy + modified Kessler repair + repair of epitenon
4 Tenotomy + modified Kessler repair + CRG wrap
5 Tenotomy + modified Kessler repair + repair of epitenon +
CRG wrap
6 Dissection only (No tenotomy)
7 Dissection + CRG wrap (No tenotomy)
8 Tenotomy + modified Kessler repair + repair of epitenon +
CRG wrap + other anti-adhesiogenic agent
Two time-cohorts of experimental animals were studied. The first was used to assess
all surgical groups (2 - 8) six weeks after surgery. At this time most of the early
healing process would have occurred and investigation of early scar tissue could be
performed which later may be remodelled as healing progressed. In the human case
this would be the time when one would aim to remove any splints and increase
mobilization to within normal limits. The second time-cohort was used to assess an
additional set of groups 2, 3, 4 &5, six months after initial surgery. The purpose of
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this cohort was to investigate the more permanent scarring resulting from adhesion
formation. The normal controls were obviously examined without any time period,
thus in total twelve groups were studied.
Assessment
The objective of each of the different assessments was to determine specific
characteristics of the FDS tendons which were related to function.
Each case in every group underwent in vivo (physiological) observations followed by
harvesting of the tendon for in vitro (morphological or mechanical) analyses. These
tests were performed for both the operated right forelimb FDS and the non-operated
left forelimb FDS thus creating an individual control for each case, in order to
minimize within-group variation.
In vivo assessments
The purpose of these assessments was to ascertain information regarding the function
of the FDS tendons whilst they remained in their natural physiological environment,
'in situ'. Two different assessments were performed. The first, Laser Doppler Blood
Flowmetry (LDBF), was carried out to observe the superficial blood flow of the
tendons near the site of surgical repair (see Laser Doppler Blood Flowmetrv. page
75). The second was a novel technique which attempted to measure the displacement,
velocity and acceleration of the tendons upon contraction of the FDS muscle (see In
vivo dynamic assessment of tendons, page 81).
In vitro assessments
After the in vivo assessments had been performed, the FDS tendons were removed
from the animal and subjected to one of two additional tests (in vitro). One of these
was a mechanical test performed in order to determine the tensile properties of the
tendon (see Mechanical Assessment, page 95) whilst the other examined the
morphological characteristics (see Morphological Assessments, page 99).
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Animal Housing and Research Facilities
The research facilities used for this study were based at three different sites in
Edinburgh. The greater part of the experimental work was carried out at the Marshall
Building (see below) where all the operative procedures and in vivo assessments were
performed. The equipment required for tissue processing, along with stationery,
computer access and office accommodation was all provided by the Department of
Clinical Neurosciences at the Western General Hospital, under the directorship of
Professor Peter Sandercock. The tensile testing of the tendons took place in one of
the laboratories of the University Department of Engineering (see Mechanical
Assessment, page 95), access having been permitted by Professor Joseph McGeough
and Mr Jim Hutcheson. In addition to this, library resources were accessed at the
Royal College of Surgeons of Edinburgh, the Erskine Medical Library and the
Western General Hospital Library.
The Marshall Building
All of the experimental procedures were carried out at the Marshall Building; an
Edinburgh University part-owned research facility in Roslin. This unit was under the
directorship of Mr. Dennis Doogan and had a delightful staff team comprising six
members. All team members were highly experienced in the running of surgical
research projects as well as in the day to day care of the animals.
Animal selection and care
In accordance with Home Office regulations, the animals bought in from commercial
sources were housed in the keeping facilities of the building for at least one month
prior to any surgery. This enabled the animals to acclimatize to their new environment
and thus minimize any potential suffering or stress. However, approximately half of
the animals in this study were born and raised on site.
A variety of different breeds of sheep was used within this study including Booroola,
Blackface, Finn, and Dorset. The ages of the animals ranged between one and five
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years. Both the criteria of breed and age were randomly allocated between study
groups.
Each animal was thoroughly checked over by the Home Office Named Veterinarian
for the Marshall Building prior to being included in the study. This check was carried
out during the week before surgery and ensured that a strict level of good health was
attained from the outset.
Preoperative care
The day before planned surgery, each animal was transferred to a pre-operative pen
and food, but not water, was withheld for a period of at least twelve hours. From here
the animal was moved into a weighing machine, just prior to induction of anaesthesia,
to allow accurate calculation of the required anaesthetic dose based on the individual
animal's weight. The animal was then walked through into the anaesthetic room.
Anaesthesia
The appropriate intravenous induction dose of thiopentone sodium was calculated for
each animal according to dosage guidance instructions:
Dose (mg) = 20mg kg"1
Each animal was held calmly, whilst one side of its neck was shaved with electrical
clippers to allow clear visualization of the external jugular vein. The individualized
dose of thiopentone was then injected into the external jugular vein. Within a matter
of seconds the animal collapsed gently to the ground, lightly unconscious (thus
breathing spontaneously) allowing transfer onto the anaesthetic trolley. Placed in the
supine position, endotracheal intubation was performed, confirmed and secured in
place by tying with a tape. The animal was swiftly transferred through to the
operating room and the endotracheal tube attached to the ventilator. The anaesthetic
machine used for all cases was a Manley Pulmovent machine. Anaesthesia was
maintained with a 1:1 mixture of oxygen and nitrous oxide carrying vaporized
halothane, tailored to the requirements of each animal to ensure a sufficient level of
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unconsciousness and relief from pain (usually between 0.5 - 2% halothane and at a
flow rate of approximately 6 1 min"1).
Intra-operative care
Having established anaesthesia, each animal was connected to the following non¬
invasive monitoring devices to allow continuous assessment of its condition
throughout the operative period.
Electrocardiographic (ECG) monitoring
For each of the primary operative procedures, the front legs and one of the back legs
of the animal were clipped of hair over a small area, sufficient to allow attachment of
an ECG lead, which was then fixed in place with zinc oxide tape. For the secondary
operative (harvesting) procedure a slight modification in lead placement was made as
the animals were required to be placed in supine position rather than right lateral
position (see Secondary surgical procedures, page 69) and both forelimbs were
operated upon. As such, these cases required placement of the anterior limb leads
onto the lateral chest wall close to the axilla of each limb. This change of position
necessitated fixation of the leads by suturing to the skin. In all instances the leads
were connected to a Hellige ECG monitor (Servomed) and continuous monitoring
was performed until the animal had regained consciousness at the end of the
procedure.
Oxygen Saturation
A pulse oximeter probe was clipped gently to the animals tongue and continuous
monitoring of pulse rate and oxygen saturation was performed throughout the
operative period. The monitoring device used was a Microspan 3040 Oximeter (BCI -
Smiths Medical).
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Temperature
A fine thermometer probe was inserted into the oropharynx of each animal allowing
a continuous recording of basal temperature to be displayed on the appropriate screen
of the Hellige ECG monitor.
Post-operative care
At the end of each primary surgical procedure the animal was given an individualized
dose of an anti-inflammatory non-steroidal drug, flunixin meglumine (50mg per
25kg) and the first of three prophylactic doses of the antibiotic Streptopen (procaine
penicillin G and dihydrostreptomycin), Pitman-Moore Ltd, UK). The animal was
then allowed to recover from the anaesthetic in the operating theatre under continued
non-invasive monitoring. Once lightly conscious and breathing spontaneously the
animal was extubated, the monitoring devices were removed and it was then
transferred to an individual recovery pen in an area adjacent to theatre.
Figure 21: Ovine recovery pens
Each animal was kept here, under close observation, until fully recovered before
being moved to a larger more distant communal pen. The animals were reviewed
regularly throughout each day as they continued with their normal life.
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Surgical Procedures
All surgical procedures were performed by a single surgeon, the present author, and
were carried out in a strictly reproducible way.
The surgical procedures were of two distinct types. The primary procedure was to
enable the different experimental groups to be set up with the animal being allowed to
recover at the end. The secondary procedure was undertaken to assess the tendon at
the end of the appropriate healing time, initially in vivo but then to proceed to non-
recovery of the animal and harvesting of the tendon.
Primary Surgical Procedure
Preparation
The anaesthetized animal was positioned in the left lateral position. Padded side-
supports were attached to the operating table, against the belly and back of the
animal, in order to maintain this position without applying any undue pressure. The
left foreleg was gently tied back, hoof against the padded support of the belly, thus
providing a clear operating field for the right foreleg. An additional table support was
placed under the right foreleg and the limb was clipped of its wool.
Each primary surgical procedure was then carried out under strict aseptic technique.
The right foreleg was prepped with povidone-iodine solution (Adams Healthcare) and
a sterile bag tied around the hoof. Sterile drapes were placed over the operating table
and animal to isolate, and leave exposed, only the right foreleg.
Incision
An approximately five centimetre curvilinear incision was made in the longitudinal
axis of the postero-medial aspect of the right foreleg of the animal, running distally
from the point of the ulnar styloid process. This particular site was chosen so that at
the end of the procedure, once closed, the skin incision would not lie in contact with
the operative site of the tendon. The subcutaneous fascia was then divided to expose
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the FDS flexor tendon sheath. Throughout the surgical procedure, the operative field
was kept moist by occasional gentle irrigation with normal saline solution and
haemostasis was secured as necessary by the use ofbipolar diathermy.
Figure 22; Foreleg incision
A stay suture was placed loosely in the skin flap to hold it out of the way of the
operative site and the tendon sheath was incised longitudinally.
Figure 23: Incising the FDS tendon sheath
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The FDS pars superficialis slip was identified and traced to its junction with the FDS
pars profunda.
Figure 24: Identification of FDS tendon slips
Using surgical callipers a distance of 2.5cm was measured, in a proximal direction,
along the FDS pars superficialis slip from the point of tendon fusion. Here the FDS
PS slip was held gently but securely with an appropriately sized Meyer's neurotome.
For the first few cases a sterile 25 gauge (orange) needle was placed further
proximally in transverse direction through the tendon slip to act as an anchor and limit
any possible retraction after transection. However it was quickly discovered that
proximal end retraction was minimal and was able to be accounted for by limb
position alone, thus this step was discontinued.
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The tendon was then transected cleanly with a sterile blade at the 2.5cm point held
within the neurotome.
Figure 25; Tenotomy of the PS slip of the FDS tendon
Primary repair of the tendon was carried out according to group protocol.
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Methods of primary repair
In all cases a locking modified Kessler core suture (see Protocol, page 55) was placed
using 4/0 Ethibond (Ethicon Ltd. UK) a braided polyester coated suture with round
bodied needle.
Figure 26; Placement of core suture
Figure 27: Securing the core suture
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Groups 4 and 5 then had the addition of a continuous epitenon suture of 6/0 Ethibond
completely burying the knot and suture ends of the Kessler core.
Fieure 28: Placement of epitenon suture
Groups 3 (Kessler core only) and 5 (Kessler core + epitenon) then had the addition of
the CRG wrap. This was produced in sterile sheets from which a strip of
approximately 2cm width, 6cm length was cut and placed under the area of repair.
Fieure 29: Placement ofCRG wrap
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This was then folded around the repair site.
Figure 30: Folding the CRG wrap
Group 8 also had the addition of a very thin smearing of triamcinolone acetonide
paste (see Triamcinolone group, page162) which was applied to the inner aspect of
CRG wrap prior to being wrapped around the repair site. This can be seen on the
illustration presented above. The wrap was trimmed in length and secured in place by
addition of a few drops of CRG glue placed on the under-surface of the overlapping
edge ofwrap.
Figure 31: Securing the CRG wrap
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The cut edges of the FDS sheath were brought to lie in approximation with one
another over the site of repair. The stay suture was removed from the skin flap and
haemostasis re-checked. The skin incision was closed with continuous suture of
subcuticular 4/0 vicryl (polyglactin 910; synthetic absorbable sterile suture, Ethicon
Ltd. UK).
Figure 32: Skin closure
A dressing in the form of a spray (Opsite spray; Smith and Nephew, UK) was then
applied. This produced a transparent, quick-drying film that was elastic and water-
resistant but permeable to moisture vapour and air. Unlike traditional bandages, which
are commonly bitten offby animals, this dressing was well tolerated.
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Secondary surgical procedures
For these procedures full aseptic technique was not strictly adhered to owing to the
fact that the animal was not to recover. However this only eliminated the use of sterile
drapes and preparative povidone-iodine solutions and allowed minimal contact
between tendon and the equipment necessary for carrying out the assessments,
without the need for sterilization.
Preparation
The anaesthetized animal was placed on the operating table in the supine position and
all non-invasive monitoring applied. Padded side supports were attached to the table,
against either side of the chest wall of the animal, in order to support the animal
without applying any undue pressure. The animal was then gently rotated toward the
side of the foreleg which was to be assessed first. This foreleg was clipped of its wool
up to the level of the radio-ulnar joint with the humerus.
Incision
An approximately 3cm incision was made over the bony prominence of the olecranon
process of the proximal ulna on the posterior aspect of the foreleg. This point was
chosen as it was the area of bone closest to the origin of the FDS muscle. Using
'Synthes' orthopaedic equipment a 2.5 mm hole was drilled vertically downward
through the medial surface of the bony prominence and out from the lateral aspect.
This hole was then tapped using a 3mm hand tap tool and guide before insertion of a
60mm long surgical screw. The screw was driven through the bone until the two ends
were protruding approximately equal distances from each surface of the olecranon.
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Figure 33: Olecranon screw fixation of proximal limb
The limb and screw were then carefully manouvered into a specially designed metal
frame (see Fixator Frame Apparatus, page 76) which enabled fixation and thus
stabilization of the limb during the assessments of in situ blood flow and tendon
displacement (see In vivo Physiological Assessments, page 74).
Figure 34: Proximal limb fixation
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A second incision was then made close to the site of the primary intervention.
However this incision was placed further posteriorly than the original incision, directly
over the course of the FDS tendon. Gentle dissection was used to lift the skin flaps
and expose the tendon with minimal disturbance to the surrounding tissues. No
attempt was made to identify the edges of the flexor sheath, or dissect any of the
tissue overlying the FDS tendon. A stay suture was then applied loosely to the edges
of the skin flaps to hold them back and ensure good exposure of the surgical field.
Figure 35: Skin incision for secondary procedure
The Doppler blood flow assessment was then performed (see Laser Doppler Blood
Flowmetry. page 75).
Once these data had been collected and the apparatus removed, further dissection of
the FDS tendon was performed. The conjoint part of the FDS tendon was traced
distally and transected over the carpal bones, close to its point of insertion. This free
distal end was then tied tightly with a length of inextensible 1/0 linen (Ethicon Ltd.
UK) and a short loop was made at its distal tip in order to attach it to the appropriate
apparatus to allow assessment of its displacement, upon muscle contraction (see In
vivo dynamic assessment of tendons, page 81).
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Figure 36: Fixation of distal FDS tendon to transducer
Once this second in vivo assessment had been carried out the tendon was dissected
proximally. Great care was taken to follow the tissue planes and thus dissect out the
tendon along with any/all other adherent tissues.
Figure 37: FDS tendon dissection for harvesting
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The tendon was transected proximally at the level of junction with its muscle fibers
and stored appropriately according to protocol; the tendons in half of each group
were cleanly cut, with a fresh blade, into short sections and immediately stored in
10% formalin solution, prior to processing for morphological analysis. The tendons
comprising the remaining half were wrapped, in their entirety, in swabs soaked with
Hartman's physiological salt solution ready for fresh mechanical testing later the same
day.
All these procedures were then performed on the contra-lateral foreleg of each
animal.
End of Secondary surgical procedure
After the assessments and harvesting of both FDS foreleg tendons and whilst the
animal was still under anaesthesia a lethal dose of sodium pentobarbitone (Euthetal®;
Rhone Merieux, Ireland) was administered by intrajugular injection. This was carried
out in accordance with Home Office protocol, vital signs continued to be observed
until they had ceased and the animal was pronounced dead.
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Tendon Assessment
The aims of the various different assessments performed on the FDS tendons were to
determine characteristics relating to function and morphology of the healing tendons.
All aspects of the processing and analysis of the tendons were carried out by a single
operator, the present author, and were performed in a strictly reproducible manner.
Facilities
The assessment and processing of the tendons took place at three different locations.
The first analyses were carried out at the Marshall Building and included the two
physiological tests performed during the secondary surgical procedure. Then, after
harvesting of the tendons and in accordance with the project protocol, the tendons
stored in formalin solution were taken to the laboratories of the Western General
Hospital of Edinburgh, Department of Neurophysiology where tissue processing
required for morphological analysis was carried out. The other half of each group of
tendons was taken fresh from harvesting, wrapped in saline soaked swabs, to the
Edinburgh University Department of Mechanical Engineering, King's Buildings,
where the mechanical testing was performed.
In vivo Physiological Assessments
Two of the assessments performed on the FDS tendons were carried out with the
animal under general anaesthesia. These in vivo assessments were Laser Doppler
Blood Flowmetry (see next page) and measurement of the displacement, velocity and
acceleration of FDS tendon excursion (see In vivo dynamic assessment of tendons.
page 81).
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Laser Doppler Blood Flowmetry
The purpose of this assessment was to quantify the superficial blood flow in the FDS
tendons at sites both proximal and distal to the region of operative repair. Laser
Doppler Blood Flowmetry (LDBF) provides a minimally-invasive, real-time
measurement of superficial, local tissue blood flow. This was the first assessment to
be performed at the time of harvesting because it was of critical importance that the
FDS tendons and surrounding tissues were minimally disrupted, so that the course of
superficial blood supply remained intact.
Apparatus andPrinciples
The apparatus used consisted of a commercially available MBF3/D Laser Doppler
Blood Flow monitor manufactured by Moor instruments limited (Axminster) and a
specially designed frame (see Fixator Frame Apparatus, page 76) which was attached
to the operating table. This frame allowed fixation of the limb being studied, by the
olecranon process of the ulna proximally and stabilization of the hoof distally, thus
minimizing movement and risk of producing artifact on the recorded blood flow trace.
Laser Doppler Apparatus
The MBF3/D monitor consisted of a laser unit with the option of one or two probes
and an LCD screen.
Figure 38: Laser Doppler Flowmetry Apparatus
1ASER BLOOD FLOW MONITOR MBfiD
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This monitor used laser radiation generated by a semiconductor laser diode which
operated at a wavelength of 780 nm to 820 nm and a maximum possible power of
1.5mW. With the probes attached to the laser housing block the laser light was
coupled into the optic fibers and transmitted within the fiber to the tissue being
examined. The probe's aperture was only 7mm diameter and emitted a diverging
beam of light with an angular spread of thirty degrees. This technique depended on
the Doppler principle whereby the incident light was reflected back off the moving red
blood cells in the superficial blood vessels, causing the light to undergo a Doppler
frequency shift (broadening) which related to the speed of movement of the cells
(Wright & Davies 1995). This backscattered light was then passed onto a photo-
detector within the MBF3/D. The signal was amplified and processed by both an
analogue and then digital processor and calculations displayed on the LCD screen
regarding the perfusion data. Three different variables were obtained; concentration,
speed and flux. However this study concentrated on the assessment of flux which is
defined as the product of average speed and concentration of the moving red blood
cells in the tissue sample volume. This arbitrary unit of flux is the most relevant and
most widely used of these flowmetry measurements.
Fixator Frame Apparatus
The additional metal frame used for this study was designed and constructed in
collaboration with colleagues in the Edinburgh University Department ofMechanical
Engineering under the directorship ofProfessor McGeough. One of his postgraduate
students, Mr. Brendan Hawes, devoted time and expertise to reviewing the old pulley
and weights system of limb stabilization previously used in work carried out by the
Peripheral Nerve Research Group and devising a more robust and appropriate system
for this study.
The purpose of this frame was to hold the forelimb in a stable position whilst
assessments ofblood flow and displacement were being performed on the FDS tendon
and thus minimize any artifact or erroneous results which may have derived from
simultaneous movement of the limb.
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Figure 39: Fixator frame apparatus
The frame consisted of a long straight rigid metal support bar which attached to the
operating table using one of the standard table vices. Various other attachments could
then be fitted onto this fixed support bar in order to hold the limb and appropriate
pieces of apparatus in place. The most important of these was a bracket attached
proximally on the support bar into which the olecranon screw was fitted.
Figure 40: Proximal limb fixator bracket
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The hoof or distal end of tendon was then attached to the distal end of the bar
dependent upon the assessment being carried out. When measuring blood flow the
hoof was gently taped to the distal end of the support bar, but when measuring
displacement the transected end of FDS tendon was tied to the displacement
transducer which was in turn fixed securely to the support bar by means of a clamp.
This then provided a fixed datum which incorporated the FDS muscle, its tendon slips
and attachment into a stationary inertial frame of reference along the axis of the
support bar.
Figure 41:Fixation of distal end of FDS tendon
Calibration
Regular calibration of the doppler probes was performed in order to minimize any
change that occurred in the probes over time. This was performed by placing each
probe, in turn, into a tube of standard reference solution provided by the
manufacturers. This solution used the brownian motion of polystyrene microspheres
in water to produce the reference signals.
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It was also important to ensure that test conditions were optimal and constant for
each case in order to standardize measurements and eliminate other factors that might
have influenced the blood flow. The operating and room lights were switched off to
minimize ambient light. The body position of the animal was secured by appropriate
cushioned table supports and the temperature monitored and maintained throughout.
Both the forelimb being assessed and the doppler probes were fixed to the rigid metal
support bar to minimize movement artefact.
Setup
With the animal under general anaesthesia the forelimb to be assessed was fixed at the
proximal end by means of a screw placed through the olecranon process of the ulna
and fixed into the bracket on the support arm. The hoofwas then gently taped to the
distal end of an additional support bar and the two doppler probes, mounted into
sophisticated micro-manipulators which were capable of x-y-z axis adjustment with
micrometer precision. These in turn were screwed into brackets which were mounted
and fixed securely to the rigid metal support bar.
Figure 42: Laser Doppler Flowmetrv set up
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The probes were positioned over the tendon repair site, approximately 3 cm apart
with the first probe placed on the surface of the tendon proximal to the site of repair
and the second probe placed distally.
Figure 43: Laser Doppler probe placement
Having already checked the calibration and correct placement of the probes, the
graphic display was set to run at a sampling rate of 40 Hz and a time constant of 0.5
seconds per division. Conditions for performing the assessment were re-checked,
optimized and the laser beams turned on. The machine was allowed to run
undisturbed for two periods, each of five minutes. The data displayed on the LCD
screen were simultaneously recorded onto a laptop computer by means of the
computer software provided by the manufacturer. The data were then stored in
appropriately named files for later analysis.
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In vivo dynamic assessment of tendons
The purpose of this novel method of assessment was to enable measurement of the
displacement, velocity and acceleration of the FDS tendon upon contraction of its
muscle. The theory behind this was that, if it was possibile to measure and display the
displacement, velocity and acceleration of the tendon, it might then be possible to
identify changes (caused by overcoming ffictional forces imposed by the presence of
adhesions) from the normal pattern of movement that could be attributable to the
presence ofvarying numbers of adhesions.
Apparatus andprinciples
The apparatus used for this assessment was the commercially available Pico ADC 216
(see below), a displacement transducer, the metal fixator frame (see Fixator Frame
Apparatus, page 76) with special bracket for the transducer and a nerve stimulator.
Personal Computer 'Oscilloscope'
The Pico ADC 216 and its oscilloscope emulating software were produced by Pico
Technology Limited (www.picotech.com).
Figure 44: Pico ADC 216
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The Pico ADC 216 emulated a high resolution, high precision oscilloscope and was
used to convert the output voltage of the displacement transducer (see below) from a
16 bit analogue to digital signal over the period of time taken for the FDS muscle
contraction. Connected via a parallel port cable, these data were stored and displayed
on the computer screen oscilloscope.
Figure 45: Computer 4oscilloscope' fPicof
Displacement transducer
A Linear Potentiometric Displacement Transducer (LPDT), Sakae 15FLP30A,
manufactured by Sakae Tsushin Kogyo Limited was chosen for this study.
Figure 46: Sakae LPDT
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Table 1: Sakae LPDT specifications
Model Number 15FLP30A
Resistance Value lOkQ
Total Resistance Tolerance ±10%
Independent Linearity Tolerance ±1.0%
Resolution Essentially Infinite
Output Smoothness Below 0.1% against input voltage




Insulation Resistance Over 1000MD at 1,000 V.D.C
Dielectric Strength 1 minute at 1,000 V.A.C.
Internal Spring Restoring Force Approx. 300gf (3N)
Stopper Strength Approx. 2kgf (20N)
Resistance Temperature Coefficient ±400p.p.m/°C
Weight Approx. 30g
In order to accommodate attachment of the tendon to this transducer the shaft was
slightly modified by the addition of a small metal plate containing two holes through
which the linen tie, attached to the end of the tendon, could be secured. In so doing
the shaft required to be permanently displaced by a further 13mm, making this the
new point of zero displacement. The LPDT was then recalibrated (see Calibration
page 88).
Figure 47: LPDT bracket attachment
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The LPDT was attached to a 10V power supply (Thurlby DC power supply) and
connected to the tendon and Picoscope so that it acted as a variable potential






/ is the electrical stroke (30mm from the LPDT specifications)
Vin the input voltage
d the displacement
Vout the output voltage
The output voltage was related to the input voltage by the linear relationship
Vout ~ Vin—~
I
When the load resistance (RL), resistance of the Picoscope channel, was taken into
consideration, the equation became
Vou, = Vn —
lRL+d(l-d)
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However, the load resistance only significantly affected output voltage at small
values owing to the fact that current was drawn from the circuit. As the load
resistance tended toward infinity the effect became negligible as less and less current
was drawn from the circuit. The load resistance for this study was the impedance of
the input channel of the Pico ADC 216, which was 1 MO and thus was taken as
being essentially infinite. Therefore the first equation above could be rearranged to




This value was later converted into mm (see Calibration, page 88).
In the present experiment the objective was to measure the displacement of the
tendon not the force of its contraction. In order to do this accurately the transducer
chosen was required to have the lowest possible internal resistance, such that this
could be regarded as negligible and thus not diminish the length of excursion that
was observed upon isotonic contraction of the FDS muscle. This work must not be
confused with the large body of previous research which has used force transducers
to measure isometric tension; the way in which force transducers operate is to
balance internal resistance against the force applied by the muscle (allowing only
internal spring displacement to occur) and as such force transducers are required to
have high internal resistance.
Fixator Frame Bracket
A lockable sliding bracket was made to attach to the support bar of the fixator frame
apparatus. This bracket was designed to hold the LPDT using a micro adjustment
system which enabled the LPDT to be precisely positioned and aligned distal to the
FDS tendon, continuing along its natural course, prior to being secured into position
along the support arm (see figures 41 and 47, pages 78 and 83 respectively). The
proximal limb bracket of the support bar apparatus was used as previously described
(see Secondary surgical procedures, page 69).
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Nerve Stimulator Apparatus
This consisted of a mains-powered signal generator (Digitimer, model DS7) which
was used to supply a pulse of current via connecting cables to nerve stimulator leads
which were in turn attached to the limb of the animal. The signal generator was set to
produce a single square wave pulse of current, of 200ps duration. The current and
voltage could be set independently; a constant current of 30-50 mA was used which
resulted in a range of -5V to 5V. The signal generator was triggered manually to
deliver a single pulse of current sufficient to cause supramaximal stimulation of the
FDS muscle thus causing it to contract isotonically (shortening in length) as if
stimulated naturally by its own supplying nerve. The signal generator also had an
output channel which used transitor-transistor logic (TTL) to allow connection to the
Pico ADC unit (via input channel A) which was then triggered on the rising edge of
the input voltage. During the contraction of the FDS muscle belly, the distal FDS
tendons were displaced proximally pulling on the LPDT and resulting in a
measurable displacement and velocity displayed and recorded on the Picoscope.
Figure 48: Nerve stimulator — displacement circuit
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At the start of the study direct nerve stimulation was used by means of dissecting
clear the proximal part of the brachial plexus of nerves high up in the forelimb of the
animal. The end of the stimulator cable was attached to a tiny clamp into which the
median nerve (a branch ofwhich supplied the FDS muscle) was placed as illustrated
below.
Figure 49: Direct nerve stimulation ofmedian nerve
The median nerve of the ovine forelimb has been dissected clear of
its surround tissue, high up in the axilla and carefully placed inside
the connector end of the direct nerve stimulator cable.
However these early cases were also repeated using transcutaneous nerve stimulation.
This simply involved use of two small saline soaked pads, one positive the other
negative, placed a few centimeters from each other in a small blue plastic case
connected to the end of the stimulator cable. The pad was placed on the shaved area
of skin overlying the region of the median nerve trunk which branched to supply the
FDS muscle (as previously determined by postmortem forelimb dissection) and
therefore did not necessitate any tissue dissection. The two different methods of
nerve stimulation resulted in excitation of muscle contraction with equivalent output
results, hence the remainder of cases underwent transcutaneous nerve stimulation
only.
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Figure 50: Application of transcutaneous nerve stimulator pad
The blue plastic casing of the cutaneous nerve stimulator pad can
be seen lying over the region of the median nerve branch to the
FDS muscle. Secured in place by means of a velcro strap it
contained the saline soaked conducting pads (inferiorly).
Calibration
In order to ensure that the initial tension of the tendon and muscle unit was always
consistent the LPDT body was moved in a distal direction using the micro adjustment
mechanism,, extracting the shaft from the body until the Picoscope meter read, close to
4 Volts. This corresponded to a certain displacement and load on the internal spring
and therefore a resultant restoring force which provided initial tension consistent with
Hooke's Law:
F=kd
Where F is the force exerted by the spring on the tendon resulting in tension, k is the
spring constant (a measure of the spring's stiffness) and d is the displacement of its
free end from the position of the spring in the relaxed state, the distance the shaft has
been extracted from the body of the LPDT.
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The output voltage signal obtained from the transducer varied in a linear relationship
with the displacement of the transducer shaft and was calibrated so that the output
voltage could be converted to a displacement value ofmillimetres by use of a simple
formula. A calibration graph for this transducer was constructed, using an input
voltage of 10V and with the Picoscope in DC mode. The y axis was the output
voltages (V) recorded and these were plotted against the x axis of the measured
length ofLPDT shaft displacement in millimetres (mm).
Figure 51: LPDT calibration curve
Linear Potentiometric Displacement Transducer 15FLP30A Calibration at 10V
Displacement (mm)
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A 'best-fit' line was applied to the calibration graph from which the required
conversion formula was then derived.
output(V) - c





The constant, c was the offset potential recorded on the oscilloscope after fine
adjustment of the transducer-tendon unit. It was always maintained close to 4V and
was automatically recorded as the first datum point of each output trace.
Understanding andprocessing Picoscope Data
The output signal from the LPDT could be processed and displayed by the Picoscope
in either DC or AC mode. Set to DC mode the oscilloscope display essentially
provided a graph of displacement versus time (blue line in graph below). In AC mode
dV
it displayed the rate of change of DC voltage . Since the output voltage had
dt
already been shown to have a relationship directly proportional to displacement (x),
dx
the AC mode effectively gave the instantaneous velocity—. As such, in the AC mode
dt
the oscilloscope display provided a graph of velocity versus time (red line in graph
below).
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The blue line displays displacement and the red line velocity,
of the FDS tendon upon nerve stimulation.
Obviously it was also possible to derive mathematically velocity from the
displacement values by differentiation, or vice versa by integration. When both the
channels were used simultaneously (as in the illustration above) the process of
'chopping channels' meant that fewer data points were collected from each channel.
Thus the accuracy of each graph (and subsequently fitted curve) was diminished. So
for this study it was decided to set the Picoscope to display the LPDT voltage output
in DC mode only, thus providing a graph of displacement against time at maximum
sensitivity and the velocity data were derived mathematically, as were the acceleration
data.
The raw output data were stored in appropriately named files and later exported to a
software program, Datafit (Oakdale Engineering) for analysis. The reason for
exporting the data was threefold. The raw data recorded by Picoscope was a large
series of data points but included a fair amount ofbackground noise so by calculating
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the best fitting curve it was possible to determine specific points, such as maxima and
minima, more accurately. Also having fitted a curve to the data points it was then
possible to obtain the equation of the curve, differentiate this and plot the resultant
velocity curve, differentiate once again and plot the acceleration curve. Since both the
displacement and velocity graphs shared the same time-axis they could also be
overlaid and plotted using two separate vertical axes thus aiding interpretation. This
was performed by further exporting the data into a software program Statistica
(Statsoft Inc., Tulsa, USA).
Fteure 53: Superimposition of displacement and velocity curves
Once the graphs had been produced values were obtained for the following list of
variables:
Maximum displacement (Dm) on supramaximal nerve stimulation producing isotonic
twitch.
Time to achieve maximum displacement (tDm)
Displacement at the point of half relaxation (Dhr)
Time to half relaxation (tDhr) after isotonic twitch.
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Total twitch time (T,)
Maximum velocity (Vmax)
Time to maximum velocity {Vmccc)
Time to zero velocity (Vzt)
Time to zero acceleration (tOAccel)
Setup
After the assessment of laser doppler blood flow had been completed the animal was
kept under anaesthesia, in the same position, with its foreleg fixed proximally to the
support bar. The tape was removed to release the hoof and the tendon was dissected
distally, divided from its insertion and secured to the LPDT by a short length of 1/0
linen, Ethicon Ltd. UK.
Figure 54: Fixation of distal end FDS to LPDT
The LPDT mounted in its bracket was carefully and precisely aligned at the distal end
of the FDS tendon following its natural course and secured in position on the support
bar.
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Figure 55: Aligning the FDS tendon and transducer
The transcutaneous nerve stimulator cable was placed on the shaved area of skin on
the proximal limb and held in place by means of a Velcro strap. The Picoscope was
switched on. The LPDT was adjusted to obtain a Picoscope meter reading of close to
4 Volts and the stimulator triggered to release a single pulse of current large enough
to evoke FDS muscular contraction. The data were stored and the process repeated
with increased current being delivered through the stimulator in order to ensure that
supramaximal stimulation of the muscle had occurred.
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In vitro Assessments
These were performed after the FDS tendons had been harvested and each of the two
tests was carried out on only half of every group of cases; six cases per group were
tested for mechanical strength whilst the remaining six were processed for histological
examination.
Mechanical Assessment
As per protocol, half of the cases in each group underwent mechanical testing.
Immediately after harvesting they were wrapped in swabs soaked in Hartman's
physiological salt solution and sealed in individual, case-labelled, plastic packets. At
the end of each day of harvesting, the fresh tendons were taken to the University
Department of Mechanical Engineering at King's Buildings where access had been
granted to use the Instron mechanical testing machine. Each repaired tendon and its
contra-lateral normal tendon were placed in turn into the machine and a tensile test
conducted.
Tensile testingprinciples
A tensile test is probably the most fundamental mechanical test that can be carried out
on a material and demonstrates how it reacts to forces being applied in tension. The
test results are displayed on a graph to produce a curve illustrating the tensile profile
of the material being assessed. Although much information can be gained from these
graphs, for the purposes of this study particular attention was paid to point of tendon
failure. This is the point of particular interest in any tensile profile and is referred to as
the 'ultimate tensile strength' (UTS) of the material being tested. It is the maximum
load that the specimen sustained during the test. Obviously the UTS is of great
functional importance when evaluating methods of tendon repair and it is indeed one
of the measurements frequently referred to in published literature when debating the
efficacy ofmethods of repair.
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Instron Machine
The tensile test machine used for this study was the Instron 4500 model manufactured
by Instron Corporation, UK. This consisted of a sample testing unit, computerized
controls and a graphic display unit.
Figure 56: Instron tensile testing machine 14500)
When the Instron machine was switched on an appropriate tensile test regimen
required to be selected from the computer menu bar. For this study a regimen of
continuous incremental loading was chosen with a crosshead speed of 20mm min"1
and time base of 10 points per second. The output display was selected to plot force
(automatically displayed in kilograms of force, kgf) against displacement (mm). The
calibration of the machine was checked before the tendon to be tested was inserted
into the vice heads of the testing unit (see Instron vice modification, over page). It
was important to keep the time of air exposure of the tendon to a minimum so that its
characteristics were not affected by drying out. Therefore the tendon was only
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removed from its saline swabs once the machine was ready for testing and the
process of placing the tendon into the vice heads was performed as efficiently as
possible. Once the tendon was in place the vice heads were carefully distracted until a
force of 0.5kgfwas observed; then the test was commenced.
Instron vice modification
Prior to commencing the study much time was spent in collaboration with colleagues
of the Department of Engineering, designing appropriate vice clamps to hold the
tendon ends securely during testing. This posed a difficult problem which had not
been discussed in detail in the literature where tensile testing of tendons had been
performed. The main problem was that of slippage of the tendon ends within the
Instron vice heads. If the clamps were closed very tightly around the tendon ends then
deformity and tearing at the edge of the clamp head resulted. Several different
methods were considered and tried but in the end the best solution was found to be
the addition of two specially designed metal T-pieces which had a hole cut in their
stems.
Figure 57; T-piece insertions for Instron vice heads
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A decent length of the tendon end was placed through the hole thus creating a u-
bend. Fine sandpaper was positioned on either side of this end to keep it in place and
the T-piece was carefully slotted into the manufacturer's vice heads which were then
closed. This was repeated for the opposite end and the tensile test then performed.
Figure 58: Securing the FDS tendon in the Instron vice heads
Using this method of fixation, the tendons were observed to thin out upon distraction
but they did not slip. This was checked at the end of each test by observing the shape
of tendon after being removed from the vice. As illustrated below, the portion of the
tendon that was in the hole of the T-piece remained intact despite thinning of the
distracted portion. It was also noted that even when the tendon ruptured close to one
of its ends there was always a small portion of tendon free from the clamp head thus
eliminating tearing by the vice edge as the mechanism of failure.
Figure 59; FDS after rupture and removal from Instron machine
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DataManipulation
The data obtained were saved in appropriately named ASCII files and later exported
to an Excel Spreadsheet (Microsoft). Illustrative graphs were produced such as the
one below and the units of force could also then be converted easily from kgf to
newtons by multiplying each data point by 9.80665.











As per protocol, the FDS tendons from half of each group of cases underwent
morphological analysis. These tendons were stored individually in 10% formalin
solution immediately after harvesting. This was performed in order to preserve and
harden the tissue samples whilst causing minimal distortion of their physical features,
chemical characteristics or staining properties. The samples were then taken to the
Neurophysiology laboratories at the WGH where they were processed in preparation
for analysis.
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Wax Embedding
The first step in the process of preparing the samples for sectioning was to
impregnate them with wax and embed them into wax blocks which could be securely
held for cutting sections. The tissue impregnation with wax was performed using a
Tissue-Tek VIP wax processor.
Figure 61: Wax impregnation machine (Tissue-Tek VIP)
This process was carried out in batches, the stored tendon segments being removed
from their formalin solution at this time. Each tendon section was checked for size
and trimmed as necessary to ensure a good fit with correct orientation within the
plastic embedding cassettes. To create cross sectional slides of the tendons the
samples required to be orientated with the cut edges against the floor and roof of the
cassette, the tendon fibers running perpendicularly. The cassettes were then clearly
labelled with a lead pencil in order that the labelling would survive exposure to the
processing liquids and solvents.
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The plastic cases containing specimens were loaded into a specimen rack and placed
into the VIP machine, the lid securely closed and an appropriate embedding program
commenced. The program chosen for this study was program option 4 which bathed
the samples in solutions of alcohol of increasing purity, then xylene and finally
molten wax (see appendix 1). The alcohol served to dehydrate the tissue samples.
The xylene acted as a link between the other two solutions as it was completely
miscible with both, and the molten wax impregnated the tissues preparing them for
the final stage of embedding into wax blocks. This program was left to run overnight,
the entire cycle taking approximately eighteen hours to complete.
The final stage of the embedding process required the use of an embedding centre,
the one used was also manufactured by Tissue-Tek.
Figure 62: Wax embedding centre
Each specimen was removed from its cassette and placed in a stainless steel cassette
mould. Careful attention was once again paid to the orientation of the sample to
ensure that the cut section would yield cross sectional views of the tendon. The base
of the plastic cassette was then separated from its lid before being placed on top of
the tissue sample. Molten wax was poured on top to fill up the steel cassette mould.
This was then placed to cool on a cooling tray which was kept at a temperature of
minus four degrees. Once the wax had set, the embedded sample was removed from
the steel cassette ready for sectioning.
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Microtome sectioning
In order to prepare appropriately fine slivers of tendon tissue for mounting onto
microscope slides, a rotary microtome (Shandon AS 325) was used.
Figure 63: Microtome
This was simply a specialized knife with a mechanism for advancing the wax
specimen block standard distances across it. The wax embedded sample blocks were
mounted onto the vice of the microtome and a fresh blade was inserted at the
beginning of each cutting session. Disposable blades were used and were frequently
moved to a clean contact surface, or changed as the processing continued, to ensure
clean slicing of the samples. This was especially important for the samples which
contained suture material, although all samples were fairly hard and quickly blunted
the blade. Unsurprisingly, a sharp blade was the key to achieving the best sections.
The thickness gauge was positioned to cut slivers of just seven microns and a water-
bath was filled and heated ready to receive the slivers after sectioning. This was an
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important step as the cut sections were fragile and wafer thin, with occasional
wrinkles which were smoothed out on contact with the warm water.
Slide mounting
The slides used for this study were commercially available Superfrost® Plus 1mm
thick microscope slides (BDH Laboratory supplies, UK) which had been
electrostatically charged for improved binding. The cut sections of specimen were
carefully floated out of the water bath onto microscope slides before being allowed to
air-dry. Since the cut sections were so thin, it was possible to cut multiple sections
from each tissue sample. Two or three sections were therefore mounted on each slide
and at least two slides were made per sample. The slides were then labelled in pencil.
Histological staining techniques
Before any staining could be commenced the embedding process had to be reversed
to get the paraffin wax out of the tissue in order to allow the water soluble dyes to
penetrate the sections. The slides were therefore run through a series of xylenes to
alcohol to water to rehydrate them (see appendix 2).
General Principles
The purpose of histological staining is to make various tissue, cellular components
and extrinsic matter more evident. The principle behind any histological staining
technique is that the dyes, either natural or synthetic, are taken up by different cell and
tissue components in a selective or preferential manner. The mechanisms involved are
of two types, chemical or physical. In the chemical dye reactions, union between the
dye and stained substance occurs by means of chemical bonds such as salt linkages
and hydrogen bonds. These are dependent upon the acid-base characteristics of the
tissues and as such staining results in fairly predictable colour patterns. The second
type of staining mechanism is a physical reaction, that of absorption of the dyes. The
dye may be absorbed on the surface of the structure, or precipitated within the
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structure dependent upon what is favoured by the surrounding environmental factors,
such as pH, temperature etc (Stainsfile 1998).
Thus staining techniques make use of a variety of dyes that have been chosen for their
ability to stain different cellular components of tissues. Two different staining
techniques were chosen for this study, haematoxylin and eosin (H&E) and Gomori's
trichrome.
Haematoxylin and Eosin Stain
H&E is a very general histological stain and probably the most widely used of all stain
varieties. It is composed of haematoxylin-metal complexes which act as a basic dye
(positively charged), combined with eosin which acts as an acid dye (negatively
charged). The dyes undergo chemical reactions with tissue substances, forming
cellular bonds. Any substance that links with the haematoxylin dye is coloured a shade
of purple, and said to be basophilic. That which links with the eosin dye is coloured a
pink shade and said to be acidophilic (or eosinophilic). Thus nucleic acids in the
cytoplasm and nuclei are stained blue, purple or black and the more basic proteins of
the cytoplasm and extracellular tissue (collagen) are stained pink.
A complete set of slides was stained with H&E following the method described in
appendix 3. This procedure was performed with care in a fume cupboard and the
slides then completed by placement of a coverslip (see Applying coverslip, over page).
Figure 64: Histological staining apparatus
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Gomori's Trichrome Stain
This is a variant of a group of techniques described as 'trichrome' staining. Trichrome
literally means 'three coloured' but this class is in fact used to describe staining
methods which use two or more acid dyes of contrasting colours (Stainsfile 1999).
These dyes selectively colour different basic tissue structures and are most commonly
used to demonstrate the presence of collagen. There are two main variants in this
group of techniques; those which use a multi-step approach and those using a single
step method. The one step methods combine all dyes and reagents into a single
solution whereas the multi-step approaches apply the dyes sequentially. Compared
with the Masson's multi-step approach, the Gomori's one step method had been
shown to be simpler to conduct, less time-consuming, more cost effective and yet
indistinguishable in end result, except for the colour of the collagen which stained blue
rather than green (Tobias 1995). Thus the Gomori trichrome stain was used for this
study. A complete set of slides was stained with Gomori's trichrome stain following
the method described in appendix 4. This was performed with care in a fume
cupboard and the slides then completed by placement of a coverslip.
Applying the coverslip
To complete the process of slide preparation a thin piece of glass was placed over the
stained section on the slide. This served to protect the tissue from being scratched,
provide better optical quality for viewing under the microscope and to preserve the
tissue section. However, before this could be carried out the stained slide had to go
through the reverse process of that performed in preparation for staining, to remove
the excess water. It was therefore passed through a series of alcohols and xylenes to
dehydrate it (see appendix 5). Then a coverslip was gently laid in place over a couple
of drops of fixative glue. The glue used for this study was a thermoplastic substance,
Meltmount™ 1.539 (Cargille Meltmount, New Jersey, USA). The number
corresponded to the refractive index of the glue, which was optically similar to the
classical fixative Canada Balsam (made from the resin of the balsam fir tree ofNorth
America; Abies balsamea) and most importantly, to the refractive index of the glass
slides and cover slips.
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Slide scanning
In order to perform the morphometric analysis of the prepared tissue sections it was
necessary to upload specific images to the Analytical Imaging Station computer
program (see AIS Morphometric Analysis below). A number of different methods
could be used to perform this task. For work previously carried out by the Peripheral
Nerve Research Group a specially adapted microscope had been used. This was
computer assisted and took photographic images directly from the viewfinder of the
microscope which were then stored as usable .tiff files. This was clearly suitable for
the degree of magnification required for examining individual nerve fibers, but even
under the lowest power of magnification it gave too small an image field to be of
constructive use when attempting to calculate quantitative data of the entire cross
section of a repaired tendon. The notion of importing several image sections and then
uniting them before carrying out the analysis was considered but carried too great a
risk of error from overlap of indistinct margins of the images (this function was not
available in the version of AIS software used). So instead the slides were scanned
using a commercially available scanner by Hewlett Packard (PrecisionScan Pro). Each
slide was scanned using a resize function of 600%, thus ensuring optimal detail of the
image obtained. However, it should be noted at this point that the analyses being
performed were only to allow calculation of the circumference, maximum/minimum
diameters, area etc and thus the image did not require to be of great cellular
definition. The scanned images were stored and uploaded as .jpg (joint photographic
experts group) files.
AISMorphometric Analysis
For these morphometric assessments a commercially available computer software
program, Analytical Imaging Station (Version 3.0, Revision 1.1; Imaging Research
Inc.) was used. This was essentially a sophisticated computer-assisted tool for
obtaining quantitative data from an image. Upon opening the program, custom
settings could be selected to control for colour of the imported image (full colour was
chosen), and to select which measurements were to be calculated. The measurements
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of basic morphometry chosen to examine were as follows; area, perimeter, feret x,
feret y and form factor. The area was derived purely from the boundary (no account
being taken of any artifact within the tendon substance). The perimeter was computed
as the sum of distances between the midpoints of boundary vectors. Feret x and y
were the maximum diameter in the given axis, x or y respectively. The overall shape
of the tendon was calculated as the form factor:
Form Factor F =
P
Where: 71 = 3.142, a = cross-sectional area (pm2), p = perimeter (p)
This essentially indicated the roundness of the tendon using a range of values from 0
to 1, where 1 equated to a perfect circle. The more convoluted (and longer) the
perimeter, the less circular the target and thus the value of the form factor became
closer to zero. First an image was imported (as a jpg file) into the software program
and the calibration set. This was performed by measuring a known distance from the
image (the markings of a ruler placed below each slide at the time of scanning) which
was calculated by the program to give a reading in pixels. Thus for the scale used,
1mm equated to 47.2 pixels. Although each slide was scanned on exactly the same
scale, this calibration was checked regularly. Using the software tools provided, a
mouse was used to draw precisely around the outline of the tissue section on the
imported image and the appropriate areas selected to prompt calculation of the
desired parameters. The software program used digital image processing to extract
the selected data from the image. For example to calculate the tissue 'area' the
number of pixels inside the target outline borders were counted and a conversion
applied according to the calibration that had previously been set. These values were
calculated for each non-operated tendon as well as every repaired tendon of each
allocated case. The results were then able to be reviewed as independent values as
well as the more important ratio values of right divided by left, thus as previously
discussed, variation within groups was minimized.
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Calculation ofPercent composition
The purpose of this assessment was to quantify the percentage composition of the
various tissue components of all FDS tendons at their site of repair. The tissue
components studied were tendon fibre (T), suture (S), vascular (V) and 'other' (O).
An LW200 universal microscope (MinServ) with graticule eye piece was used. The
graticule was of the indexed-grid-square type which is most commonly used for
particle counting. It had a side length of 10mm and 100 subdivisions. A
magnification power of x 40 was used (objective lens x4, eyepiece xlO) and each
slide was initially positioned with the left hand margin of the graticule grid aligned to
just within the left hand margin of the tissue sample. A count of composition was
then made designating one of the aforementioned categories, T, S, V &O, to each
square of the grid. In this assessment the fibrotic 'other' tissue was differentiated
from the 'tendon' tissue as it stained a slightly lighter shade owing to its lack of
organization. It was almost exclusively found on and around the margins of the
tendons at the sites of repair. Where more than one type of tissue structure was
present within the square, the category allocated accounted for that occupying the
major part. This same process was repeated two more times aligning the margins to
the right side and also to the bottom of graticule and tissue section. The three values
were then added together and averaged to obtain the mean value used for later
statistical analysis. Since some of the values were 'zero', for example amount of
suture in non-operated tendons, and these values were analysed as absolute values,
not as ratios (see Percent composition, page 145).
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Experimental group and Case names
At the commencement of this research project it was decided to name each case
according to the surgical experimental group to which it had been randomly allocated.
However in order to keep the code names short (a limiting factor of fundamental
importance when using the statistical software program which had a finite number of
characters per variable and case) each experimental group was simply denoted by a
single letter as shown below:
A= KesslerCore
B = Kessler core and epitenon
C= Kessler Core and wrap
D = Kessler Core, epitenon and wrap
(N = Normal control group)
In order to distinguish the different time-cohorts, individual cases in the six month
groups were allocated sequential numbers (1 to 12) whilst those in the six week
groups were allocated sequential letters (A to N, the letter "I" was omitted owing to
the risk of confusion with the numeral 1).
E.g.
Al, A2 = Kessler Core, six month cases
AA, AB = Kessler Core, six week cases
Bl, B2 = Kessler core and epitenon, six month cases
BA, BB = Kessler core and epitenon, six week cases
Further to this, for ease of interpreting results of group comparisons, the six week
time-cohort groups were denoted 'early', whereas the six month time-cohort groups
were denoted 'late':
AEarly, BEarly... = groups assessed at six weeks after surgery
ALate, Blate... = groups assessed at six months after surgery
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Early in the course of conducting this project, three additional experimental groups
were proposed and permitted to be included in the project licence. These groups were
added in order to enhance the amount of information that could be gained from
carrying-out this research project and they were named as follows:
S = Dissection only
W = CRG wrap only
T = D group + triamcinolone
The dissection only group (S) underwent a primary surgical procedure which
involved simply dissecting down to the tendon and preparing it as if for tenotomy
without performing the tenotomy or proceeding further. The skin was then closed as
per protocol. The CRG wrap group (W) underwent similar preparation as described
above, again without tenotomy being performed, but this time a wrap of CRG was
placed around the intact tendon before the skin was closed. The final group to be
added were identical to group D (Kessler core and epitenon repair + CRG wrap) but
they had an additional anti-adhesiogenic substance added to the wrap; triamcinolone
(see Triamcinolone group, page 162). Each of these additional groups was assessed
at six weeks after operation.
A full list of the 'codes' used for case and variable identification during the recording
and analysis of data in this study can be found in appendix 6. An abbreviated list of
the more pertinent variables may be found on the laminated pull-out sheet at the back
of this volume.
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Statistical analysis
The method of statistical analysis used to evaluate the data acquired during this
research project was based on that which was developed by the Peripheral Nerve
Research Group, Department of Clinical Neurosciences, University of Edinburgh for
the appraisal of models of nerve injury and their surgical repair (Fullarton, Myles, &
Glasby 2002; Fullarton 1995; Fullarton et al. 2000; Fullarton & Glasby 1997; Glasby,
Fullarton, & Lawson 1997).
As previously mentioned in this chapter the data acquired from each assessment were
statistically appraised in two different formats. First as raw data values, for left and
right sides independently, then as the more important ratio of data (right divided by
left) thus minimizing within-group variation. It was feasible to perform these two
methods of analysis for all data except those of the morphological percent
composition of the tendons. These results could only be evaluated as absolute values
since some of the values were zero (e.g. amount of suture material in a non-operated
tendon).
Statistical analysis was carried out as detailed below and as summarized in the
flowchart of the statistical algorithm (over page).
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Figure 65: Flowchart for statistical analysis of data
The raw data were organized into a large spreadsheet using the computer programme
'Microsoft Excel'. The far left-hand column contained a list of identification numbers
of the individual experimental subjects. In a column immediately to the right of this
the independent variable 'Experiment' was placed as a list in which the surgical
subgroups, i.e. different surgical procedures, were designated. In subsequent columns
to the right, each dependent variable was recorded. Once the Excel spreadsheet was
complete, containing all of the morphological and physiological results, it was
imported into the statistics computer programme 'Statistica' (version 6.0' — Statsoft
Inc, 2300 East 14th Street, Tulsa, O.K. 71404, U.S.A.). This programme offered an
extensive range of statistical analyses and graph-plotting options.
Chapter 2 - Materials and Methods 112
Flexor Tendon Healing
Outliers
The data were then reviewed so that outlying data-points could be identified and
rejected. This was accomplished by plotting 'half-normal' probability plots in which
the selected variable was plotted in a scatter plot against the values 'expected from
the normal distribution with the same mean and variance' for each column of data.
Figure 66: Half-normal probability plot
Half-Normal P-Plot:R/LFF
Value
The half-normal probability plots were constructed in the same way as the standard
normal probability plot (see below), except that only the positive half of the normal
curve was considered. Consequently, only positive normal values were plotted on the
Y-axis. An ellipse was then drawn on each plot to represent the 95% confidence
intervals for the distribution. The points lying outside this ellipse were considered to
be outliers and were rejected from the study.
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After this process, the resulting spreadsheet was saved and termed 'weeded data'.
This became the fundamental spreadsheet upon which all the statistical analyses of
results were based.
Residuals
Residuals may be defined as the deviations of the observed values of the dependent
variable from the predicted values, given the current model (Statistica electronic
manual: www.statsofl.com). A residual must be differentiated from a statistical error
with which it is commonly confused. A measurement error (misnomer) is the amount
by which an observation differs from the expected value based on the whole
population from which the statistical unit was randomly chosen. The expected value is
the average for the entire population and is thus typically unobservable. On the other
hand a residual is an observable estimate of the unobservable error. To calculate a
residual the sample average is used to estimate the population average.
Having rejected the outliers from the spreadsheet, each of the columns of data was
used to determine the residuals of that variable and the residuals were then re-plotted
as normalprobability plots. This was performed in order to determine whether or not
the data fitted a normal distribution. It was better to use residuals rather than the data
themselves as occasionally the distribution of a set of data points is not normal when
the distribution of residuals is and it is this that matters. With this approach the need
to use the less sensitive non-parametric tests was minimized.
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Figure 67: Graph of data points for variable VmR/L
Data points Histogram: VmR/L
Shapiro-WilkW=.97041, p= .00954
Expected Normal
X <= Category Boundary
Plot of the data values obtained for the above variable, showing a
significant p value - non-parametric distribution of data




X <= Category Boundary
Plot of the residuals obtained for the same variable above, showing
a normal distribution of data
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The standard normal probability plot was constructed as follows. First, the residual
values for each variable were rank ordered. From these ranks, Z values (i.e.,
standardized values of the normal distribution) were computed based on the
assumption that the data came from a normal distribution. These Z values were
plotted on the y-axis in the plot. If the residual values of the variable under
consideration (plotted on the x-axis) were normally distributed, then all values would
fall onto a straight line in the plot. If the values were not normally distributed, they
would deviate from the line.

















0.2 0.4 0.6 0.8 1.0 1.2 1.4 1.6 1.8
Value
VmR/L
The blue circles represent the residual values for the variable
VmR/L. The red line represents the expected normal value for data
obtained from a population with normal distribution. The blue 'line'
created by the circles is essentially straight and thus these residual
values are likely to have a normal distribution; the fit of the curve is
tested below.
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The fit of the computed line to the scatter of the raw data was tested by the
programme using the Shapiro-Wilk W test.




X <= Category Boundary
The Shapiro-Wilk W test for this variable, VmR, showed the
residual values of the observed data to have came from the
same population as the computer generated 'expected' values,
and thus be normally distributed; p>0.05
If the W statistic, so produced was significant, then the hypothesis that the respective
distribution was normal had to be rejected. The Shapiro-Wilk W test was the preferred
test of normality because of its good power properties as compared to a wide range of
alternative tests (Shapiro, Wilk, & Chen, 1968). At this point the columns of
dependent variable data in the spreadsheet that were not normally distributed were
converted to a red fount for easy identification.
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Identifying differences
The next two stages in statistical testing were directed at identifying the presence of
differences (variants of the F test or non-parametric equivalent) and identifying where
those differences lay (variants of Student's t test or non-parametric equivalent).
Different algorithms had to be adopted for normally and non-parametrically
distributed data.
Parametric data
For normally distributed data, the F test was applied in the form of one way Anova.
The independent variable with its subgroups was the 'grouping' or 'factor' in the
Anova calculation and the dependent variables were the columns of weeded data.
From the Anova, 'p' values for statistical differences were identified.
Table 2: Analysis of variance
Variable
Analysis of Variance (Tendon Results - ratios on small groups)














R/LF 3.459913 7 0.494273 7.739856 58 0.133446 3.703926 0.002241
In order to find where differences lay it was necessary to performpost hoc tests which
compared the means of the independent groups of data. The theoretical basis for this
was Student's t test which compared the means of two independent samples. This test
asked the question: 'What is the probability that the two samples (represented by their
means) were drawn from the same population?'. Rather than actively testing for
'significant differences' it tests for probability of likeness. Anova therefore computed
the probability that the independent samples came from the same population,
disclosing multiple differences where present. If repeated t tests were to be performed
on a single cohort of data, there would be an increased likelihood of Type I error in
the analysis. Type I error is the acquisition of'false positives'. Thus when there were
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more than 2 subgroups within the independent variable, the more conservative Scheffe
test was used. This was a variant of the t test specifically designed for use in order to
reduce the probability of type 1 error in the situation of analysis of variance where
multiple groups were being considered.
Table 3: Scheffe test - Analysis of variance for multiple groups
Scheffe Test; Variable: R/LF
Marked differences are significant at p < 0.05
{1} {2} {3} W {5} {7} {8} {10} {11} {12}
EXP M=.98782 M=1.1590 M=1.1252 M= 26902 M=1.2193 M=1.1583 M=1.1578 M=1.0379 M=.33733 M= .34429 M=.40359 M=.31721
N {1} 0.954104 0.991758 0.000002 0.778399 0.980741 0.981165 1.000000 0.000006 0.000008 0.000074 0.000003
S {2} 0.954104 1.000000 0.000000 0.999998 1.000000 1.000000 0.997237 0.000000 0.000000 0.000000 0.000000
W {3} 0.991758 1.000000 0.000000 0.999837 1.000000 1.000000 0.999875 0.000000 0.000000 0.000000 0.000000
T {4} 0.000002 0.000000 0.000000 0.000000 0.000000 0.000000 0.000000 0.999994 0.999983 0.995403 1.000000
ALate {$ 0.778399 0.999998 0.999837 0.000000 0.999999 0.999999 0.950532 0.000000 0.000000 0.000000 0.000000
BLate {§ 0.980741 1.000000 1.000000 0.000000 0.999999 1.000000 0.999056 0.000000 0.000000 0.000002 0.000000
CLate {7} 0.981165 1.000000 1.000000 0.000000 0.999999 1.000000 0.999090 0.000000 0.000000 0.000002 0.000000
DLate {8} 1.000000 0.997237 0.999875 0.000000 0.950532 0.999056 0.999090 0.000001 0.000001 0.000011 0.000000
AEarly 0.000006 0.000000 0.000000 0.999994 0.000000 0.000000 0.000000 0.000001 1.000000 0.999992 1.000000
BEarly {10} 0.000008 0.000000 0000000 0.999983 0.000000 0.000000 0.0G0000 0.000001 1.000000 0.999998 1.000000
CEarly {11} 0.000074 0000000 0.000000 0.995403 0.000000 0.000002 0000002 0.000011 0.999992 0999998 0.999888
DEarly {12} 0.000003 0000000 0.000000 1.000000 0.000000 0.000000 0.000000 0000000 1.000000 1.000000 0.999888
Table showing results of Scheffe test for the ratio of data for the
variable of Force. The subgroups from the same distribution are
shown in black whilst those with significantly different distributions
are shown in red.
Non-parametric data
For data which were not parametrically (normally) distributed, statistical analysis
based upon the ranking of data had to be used. There is a variety of tests equivalent to
the more sensitive parametric tests used above but for this study the Kruskal-Wallis
test was chosen. This is a non-parametric alternative to one-way (between-groups)
Anova. It was used to compare two or more samples, and tested the null hypothesis
that the different samples in the comparison were drawn from the same distribution or
from distributions with the same median. Thus, the interpretation of the Kruskal-
Wallis test was similar to that of the parametric one-way ANOVA, except that it was
based on ranks rather than means.
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Table 4: Kruskal-Wallis AVOVA by ranks
Depend.:
tDmR/L Code Valid N
Sum of
Ranks
N 101 12 391.0
s 102 11 441.0
w 103 12 675.0
T 112 10 565.5
ALate 113 11 819.0
BLate 114 10 721.5
CLate 115 10 782.5
DLate 116 12 776.0
AEarly 117 6 542.5
BEarly 119 6 368.0
CEarly 120 12 765.5
DEarly 121 12 902.5
Kruskal-Wallis ANOVA by ranks; tDmR/L
Independent grouping variable = experiment
Kruskal-Wallis test H (11, N=124) =22.27731, p= 0223
The results of Kruskal-Wallis test for the ratio of data for variable
tDm (time to maximum displacement) revealed that there were
differences in distribution between subgroups (p<0.05).
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For testing where the differences lay the Mann-Whitney U test was used. This test
assumed that the variable under consideration had been measured on at least an
ordinal (rank order) scale. The interpretation of the test was essentially identical to the
interpretation of the result of a t-test for independent samples, except that the U test
was computed from rank sums rather than means. The U test is the most powerful (or
sensitive) nonparametric alternative to the t-test for independent samples; in some
instances it may offer even greater power to reject the null hypothesis than the t-test.
Therefore each variable shown by the Kruskal-Wallis test to have p<0.05 was
examined in detail by the Mann-Whitney U test; each experimental subgroup was
tested independently against all other subgroups within that variable, in order to
identify where differences lay.
Table 5: Mann-Whitney U test
variable
Mann-Whitney U Test (Tendon Results - ratios)
By variable EXP













R/LF1 111.0000 189.0000 33.00000 -2.25167 0.024344 -2.25167 0.024344 12 12 0.024184
tDmR/L 135.0000 141.0000 57.00000 -0.55391 0.579640 -0.55391 0.579640 12 11 0.607524
Table of results of Mann-Whitney U test, showing results of
comparison of the normal subgroup (N) with the dissection only
subgroup (S). Variable R/LF1 has a p value in red (p<0.05) and
therefore this test has revealed significant differences in distribution
between these two subgroups, N & S.
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The power of a statistical test is an extremely important concept and is defined as:
'The probability of rejecting a false statistical null hypothesis'. Calculation of
statistical power is of fundamental importance both in pre-determining the size of
samples before undertaking any experiments (see Group size page 50) and at the end
of analyzing results, in assessing the sensitivity of the analyses that were used. Failing
to reject a false null hypothesis (false negative) is referred to as Type II error and the
probability of detecting such an error is defined as:
p (Type II) = p
Hence the power of a test may be expressed as 1-p. The higher the value of the
power, the less likely a risk of type II error occurring and therefore the power of a
test should ideally be around 0.9.
The power calculations for this project were performed using the comprehensive
'Power Analysis' module of the software program 'Statistica'. The calculations made
for sample size have been described in full on page 50 (Group Size) whilst the power
calculations for each of the analyses used for each dependent variable may be found at
the end of the results section (Power Analysis, page 148).





One hundred and forty-four animals were included in this project, equallydistributed among 12 study groups (n=12). A total of six deaths occurred(see below), with two cases being replaced. Thus the final number of
cases available for analysis at the end of the study was one hundred and forty.
Deaths
There were 6 deaths, 4.2% of cases.
Four deaths (2.8%) were unrelated to surgery, as confirmed by post-mortem
examination. Two of these cases died early in the study period and were therefore
able to be replaced (5th case ofgroup ALate and 4th case ofgroup CLate).
Two further deaths (1.4%) occurred in the triamcinolone (T) group. These deaths
were related to surgery. The animals developed early wound infection, which rapidly
led to wound dehiscence (both at 9 days after primary surgery, see page 162). Thus,
in accordance with Home Office regulations and the project protocol, these animals
were painlessly killed by lethal injection of barbiturate.
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Figure 71: Wound dehiscence
Wound dehiscence at post-operative day 9 in the right forelimb of
the first case from the triamcinolone group. The divided ends of
the FDS tendon (arrows) protrude from the centre of the wound.
Complications
These are summarized in table 6, below.
Table 6: Complications
Group Seroma Infection Dehiscence Death Other
AEarly 0 0 0 0 0
BEarty 0 0 0 0 0
CEarly 1 0 0 0 0
Dearly 0 0 0 0 0
ALate 1 0 0 2 (1 replaced) 1 x scrotal hernia
BLate 1 0 0 2 (1 replaced) 1 x scrotal hernia
CLate 0 0 0 0 lx Crohn's disease
DLate 1 0 0 0 0
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Group Seroma Infection Dehiscence Death Other
N 0 0 0 0 0
S 0 0 0 0 0
w 0 0 0 0 0
T 12 6 2 2 0
The most common post-operative complication observed in this research project was
a wound seroma (n=16, 11.4%). In the cases undergoing tendon repair without
triamcinolone, the incidence of this complication was very low (n=4, 2.9%), the
seromas were small, resolved rapidly and spontaneously, and did not cause lameness
in any of the cases. However this was not so for the triamcinolone (T) repair group.
All cases in this group developed a wound seroma within a couple of days after
surgery. Six cases (50%) then developed wound infection and in two of these cases
(18%) the infection rapidly caused wound dehiscence, which required euthanasia of
the affected animals. The remaining ten cases responded well to antibiotic treatment
(Streptapen for one week) and daily changes of a pressure dressing.
Figure 72: wound seroma
Wound seroma at post-operative day 3 in a case from the
triamcinolone group.
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Figure 73: Pressure dressing
Pressure dressing as applied to the operated limb of each case in the
triamcinolone group, after development of seroma.
The data acquired from each of the assessments were statistically appraised as both
absolute values and, more importantly, 'ratio data' (in order to minimize within-group
variation - see Statistical analysis, page 111). All results presented in this chapter are
derived from analysis of the ratio data, except for the percent composition of the
tendons, which were evaluated as absolute values.
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Blood flow
The data resulting from this assessment of blood flow can be found in appendix 7.
All the abbreviations used for the recorded variables may be reviewed by referring to
the pull-out sheet at the end of this volume.
General observations
The typical appearance of intact and operated tendons, after the skin had been
incised, is shown in figures 74 - 76.
Figure 74: Intact FDS tendon prepared for the assessment of blood flow
This shows a non-operated left FDS tendon during the assessment
of blood flow. The surrounding connective tissue is very thin and
minimal in quantity.
Chapter 3 - Results 127
Flexor Tendon Healing
Figure 75: Right FDS tendon (six weeks) prepared for the assessment of blood
flow
This repaired FDS tendon is from the group BEarly. The site of
repair (inside rectangle) appears widened and covered with
thickened connective tissue.
Figure 76: Right FDS tendon (six months) prepared for the assessment of blood
flow
Repaired FDS tendon from the group (DLate). The site of repair
(inside rectangle) appears to be covered by a thin amount of
connective tissue with little evidence of any increase in superficial
vascularity.
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Three examples of typical flowmetry traces recorded during the assessment of blood
flow are shown below.
Figure 77; RBC flux in a non-operated FDS tendon
This trace shows the RBC flux obtained from a non-operated FDS
tendon. The blue line represents flux from the proximal probe and
the red line, the distal probe. In this case the probes record similar
levels of flux.
Figure 78: RBC flux in a core only repair assessed at six weeks
This trace shows RBC flux recorded from the repaired FDS of a
case from group AEarly. The proximal probe (blue line) registers
higher levels of flux than the distal probe (red line).
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Figure 79: RBC flux in a repaired FDS assessed at six months
■MB to cs ao D0fl5 (5 09:05:10 01 OS IS
This trace shows RBC flux recorded from the repaired FDS of a
case from the group DLate. Flux levels from both probes are
similar.
There were significant differences between groups for two of the variables,
characterizing blood flow, R/LF1 and R/LF1-F2, as detailed below.
R/LF1
This variable was the ratio of right (repaired) divided by left (non-operated) values for
proximal Doppler flux.
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Figure 80: Proximal doppler blood flow
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R/L proximal doppler flux
N versus:
S p = 0.024
W p = 0 024
T p< 0.001
AE p = 0.009
BE p <0.001
CE p = 0.003
DE p = 0.005
AL p < 0.001
BL p < 0.001
CLp = 0.176
DL p = 0.094
□ Median
N W AEarly CEarly A Late C Late [^] 25%-75%
S T BEarly DEarly B Late D Late Min-Max
At six weeks after tendon repair proximal flux values (just proximal to the site of
repair) were significantly elevated in all groups compared to the normal group.
However, comparison between these groups showed that the repairs performed
incorporating the CRG wrap (W, CEarly and DEarly) showed significantly less
pronounced elevation of flux levels, when compared to those repairs without CRG.
At six months after repair, the two groups incorporating the CGR wrap (CLate and
DLate) showed no difference in proximal flux levels when compared against the
normal control group. The remaining two groups, without wrap, showed significantly
elevated levels of flux compared to the normal group.
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R/LF1-F2
This variable was the ratio of the difference in flux values recorded, at the site of
repair (Fl) and after the site of repair (F2).








S p = 0.525
W p = 0.268
T p< 0.001
AEp = 0.031
BE p = 0.043
CEp = 0.166
DE p = 0.908
AL p < 0.001
BL p = 0.023
CL p = 0.086
DL p = 0.291
N W ALate CLate AEarly CEarly





At both six weeks and six months after surgery, significantly elevated (differential)
flux levels were seen for all the groups repaired without using the CRG wrap (AEarly,
BEarly, ALate, BLate) and for the group with triamcinolone (T), p<0.05.
At both six weeks and six months after surgery, all groups that incorporated CRG
wrap (CLate, DLate, CEarly, DEarly, W) and the dissection only group (S) showed
no difference in differential flux levels when compared to the normal control group.
No significant differences were found for the remaining variables recorded during the
assessment ofblood flow.
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Thus in this study, inclusion of CRG wrap at the time of tendon repair correlated with
either a less pronounced elevation of flux levels or no difference at all in flux levels
compared to the normal group.
IN-VIVO TENDON DYNAMICS
The data resulting from the assessments of displacement, velocity and acceleration can
be found in appendix 8.
The abbreviations used for the recorded variables may be reviewed by referring to the
pull-out sheet at the end of this volume.
General observations
A typical example of a graph obtained for the variable displacement is shown below.
Example graphs calculated for velocity and acceleration are also shown.













i ■ ... I .... I ¥>»T ■
Time (s)
This graph shows displacement (mm) on the y-axis against time (s)
on the x-axis, during FDS muscular contraction, for a non-operated
tendon, group N.
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Figure 83: Datafit plot of velocity
Time (s)
This velocity versus time curve was obtained by differentiating the
values recorded for displacement in the case illustrated above.
Figure 84: Datafit plot of acceleration
Time (s)
This acceleration curve was obtained by differentiating the values
obtained for the velocity curve (which in turn were obtained by
differentiating the data recorded from the original displacement of
the FDS tendon).
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Two variables characterizing the in vivo dynamic assessments showed significant
differences between experimental groups; tDmR/L (time to maximum displacement)
p=0.022 and tOAccelR/L (time to zero acceleration) p=0.017.
R/L tDm
This was the ratio of right divided by left values for the time taken by the tendons to
reach maximal displacement after transcutaneous nerve stimulation.
Figure 85: Time taken to achieve maximum displacement
R/L tDm
N versus:
S p = 0.582
W p = 0.121
T p = 0.061
AE p = 0 019
BE p = 0.055
CE p = 0.073
DE p = 0.002
AL p = 0.009
BLp = 0.008
CL p = 0.002
DLp = 0.019
AEarly CEarly A Late C Late




The significant differences between subgroups were as follows:
The normal control group showed a significantly shorter time to maximum
displacement from all Late groups (ALate, BLate, CLate, DLate) and two of the
Early groups (AEarly, DEarly).
The dissection only group (S) showed a significantly shorter time to maximum
displacement from ALate p=0.042, BLate p=0.035, CLate p=0.009 and AEarly
p-0.027.
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No differences were seen between groups with respect to either the time of
assessment, or the method of surgical repair performed.
No pattern of clinical relevance was discernable from these results.
R/L tOAccel
This variable was the time taken for the tendon to return to zero acceleration after
nerve stimulation.
Figure 86: Time taken to return to zero acceleration
R/L tOAccel
N versus:
S p = 0.133
W p = 0.998
T p = 0.429
AE p = 0.925
BE p = 0.925
CE p = 0.729
DE p = 0.065
AL p = 0.036
BL p = 0.057
CLp = 0.016




AEarly CEarly A Late C Late
T BEarly DEarty B Late D Late
Exp
The normal control group was significantly different from only the CLate group and
the dissection only group, S, from ALate (p=0.036). The wrap only group, W was
different from CLate (p=0.023). ALate group was different from BLate (p=0.005),
CLate (p=0.002), DEarly (p=0.007). BLate group different from AEarly (p=0.011).
CLate group different from DLate (p-0.027), AEarly (p=0.012), DEarly (p=0.025).
No clear pattern of clinical interest could be established from these findings.
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Tensile strength Assessment
The data set resulting from the tensile assessments can be found in appendix 9.
The abbreviations used for the recorded variables may be reviewed by referring to the
pull-out sheet at the end of this volume.
General observations
Below are photographic examples of the typical appearance of tendon rupture
observed on reaching maximum tensile strength at the conclusion of the tensile test.
Figure 87: FDS tendon rupture at UTS
Left: Repaired FDS tendon assessed at six weeks, failure occurring
at the site of repair.
Right: Repaired FDS tendon assessed at six months, rupture
occurring near the proximal end of the specimen.
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The six week tendon repair groups consistently failed at the site of repair when the
maximal tensile strength was reached.
Figure 88: Ultimate failure of FDS tendons at their sites of repair
FDS tendons from two cases examined at six weeks after repair.
The repaired tendons lie to the left of their respective control (non-
operated left FDS tendon). Both repaired tendons failed at their
site of repair on reaching ultimate tensile strength. The non-
operated controls failed at the proximal end of the FDS tendon
slip.
However, by six months after repair the tendons broke at the proximal end of the
specimen, the single tendon slip of FDS tendon, which was the thinnest part of the
repaired tendon.
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Figure 89: Appearance of FDS tendons after tensile testing
A repaired FDS tendon (below) is shown with its respective non-
operated control (above) after having been assessed for UTS, six
months after surgical repair. Both tendons ruptured near to the
proximal end of the specimens.
A typical example of the graphic output obtained during a tensile test is shown
below.
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Output graph from Instron 4500, obtained at the end of the tensile test for the
repaired FDS tendon from group DLate. Ultimate tensile strength reached was
29.46 kgf (288.90 N) at 12.35 mm of distraction.
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There were significant differences between groups for one of the variables recorded
from the tensile profile, R/LF p<0.001.
R/LF
This was the ratio of right divided by left breaking force values for the tendons placed
in the Instron tensile testing machine.






















N W AEarly CEarly A Late C Late
S T BEarly DEaHy B Late D Late
N versus:
S p = 0.954
W p = 0.992
T p < 0.001
AE p < 0.001
BE p < 0.001
CE p < 0.001
DEp <0.001
AL p = 0.778
BLp = 0.981
CLp = 0.981




There was a significant reduction in breaking strength between the normal control
group (N) and all the groups at six weeks which had been surgically divided and
repaired (T, AEarly, BEarly, CEarly, Dearly) each with p<0.001.
No significant differences were found between the normal control group and any of
the late repairs (ALate, BLate, CLate, DLate) or the dissection only (S) or wrap only
groups (W).
No significant differences in breaking strength were found between the subgroups for
method of repair when examined at either six weeks or six months after operation.
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Thus in this study, incorporation of CRG wrap at the time of tendon repair did not
interfere with the breaking strength of the healing tendons when examined at either six
weeks or six months after surgery.
Morphological Assessments
The data set resulting from these assessments can be found in appendices 10 (AIS
data) and 11 (percent composition data).
The abbreviations used for the recorded variables may be reviewed by referring to the
pull-out sheet at the end of this volume.
AIS calculations
General observations
Two typical examples of the outcome of sectioning and staining the tendons for
microscopic examination are shown below.
Figure 92: H&E stained FDS cross-section
Cross-sectional view through the repair site of a tendon from the
group AEarly (H&E xlO). The two strands of suture material
(arrows) are seen traversing the core (Kessler suture).
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Figure 93: Gomori stain of repaired FDS tendon
Multiple fibrous strands of core suture material (arrow) set amidst
bundles of collagen fibres in a repaired FDS tendon assessed six
weeks after surgery (Gomori stain x 40).
Figure 94: Gomori stained perimeter of FDS pars superficialis
This slide demonstrates the clarity of tissue discrimination using the
Gomori stain technique; the junction between the pars superficialis
tendon slip (blue) and a few muscular fibres (red) joining it to the
pars profunda slip underneath (xlOO).
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Two of the variables characterising tendon morphology showed significant differences
between groups and are detailed below.
R/LA
This was the right divided by left ratio values calculated for the area of the tendons
examined in cross-section.






















S p = 0.149
W p = 0.004
T p = 0.006
AE p = 0.006
BE p = 0.006
CE p = 0.004
DEp = 0.010
AL p = 0.006
BL p = 0.006
CL p = 0.006
DL p = 0.004
N W AEarly CEarly A Late C Late ° 5ie^ia" 0,
S T BEarly DEarly B Late D Late Mr. I.I Min-Max
EXP
All groups, except the dissection only group S, showed a significant increase in ratio
of tendon area after operation, when compared with the normal control group.
Comparison between subgroups of methods of repair showed only that ALate had
significantly smaller cross-sectional area than AEarly (p=0.028).
No differences were found between the different methods of operation performed,
apart from the dissection only group which showed a significantly less pronounced
increase in cross-sectional area than that observed from the other operative groups.
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No significant differences were found with regard to the time of examination of the
cases.
R/LXF
This was the right divided by left ratio values for X feret of each case examined
histologically.
The X feret is defined as the maximum distance of the horizontal axis of each
histological section and was calculated using the AIS software package (see A1S
Morphometric Analysis, page 106).
























N W AEarly CEarly A Late C Late
S T BEarly DEarly B Late D Late
N versus:
S p = 0.251
W p = 0.006
T p = 0.009
AE p = 0.006
BE p = 0.006
CE p = 0.006
DE p = 0.045
ALp = 0.014
BL p = 0.048
CL p = 0.028




All groups, except the dissection only group (S), showed a significant increase in X-
feret ratio when compared to the normal control group.
Therefore in this study, the groups which had CRG wrap added to the tendons at the
time of repair, did not show any difference in 'bulk' of repair from those without the
wrap.
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Percent composition
Analysis of the absolute values obtained from the right tendons were considered for
the variables characterizing tissue composition of the tendons (see Calculation of
Percent composition, page 108). These were compared against the control group of
(non-operated right) tendons.
There were significant differences between groups for two of the variables of
composition, RS p= 0.004 and RO p<0.001, as detailed below.
RS
This variable was the percent composition of suture material present in the
histological sections of the right tendons.


















N W AEarly CEarly A Late C Late
S T BEarly DEarly B Late D Late
EXP
N versus:
S p = 1.0
W p = 1.0
T p = 0.662
AE p = 0.004
BE p = 0.010
CE p = 0.002
DE p = 0.030
AL p = 0.663
BLp = 0.180
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Significant differences were found between the amount of suture material present in
the control group and all the early tendon repairs (AEarly, BEarly, CEarly, DEarly)
but not with the late repairs.
No significant differences were found between the subgroups ofmethod of repair at
either of the time periods.
RO
This variable was the percent composition, of 'other' tissue present on morphological
examination of the composition of the right tendons. This referred to the
fibrous/connective tissue present at the site of repair.













S p = 0.873
W p = 0.025
T p = 0.008
AE p = 0.004
BE p = 0.002
CE p =0.818
DE p = 0.394
AL p = 0.247
BLp = 0.132
CL p = 0.662
DL p = 0.394
□ Median
N W AEarly CEarly A Late C Late r—1250/ 750/
S T BEarly DEarly B Late D Late M Min-Max°
EXP
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When compared to the normal group, significant increases in fibrous tissue were seen
in the wrap only (W), triamcinolone (T), AEarly and BEarly groups.
At six weeks after repair comparison between groups showed that the two groups
without CRG wrap in the repair process (AEarly and BEarly) and the triamcinolone
group (T) had significantly increased amounts of fibrous tissue compared to the other
groups.
At six months after repair comparison between groups showed the two groups of
repairs without CRG (ALate and BLate) to have significantly increased amounts of
fibrous tissue when compared to DLate (p=0.036 and p=0.022 respectively).
Thus in this study, incorporation of CRG wrap at the time of repairing the tendons
was not found to alter significantly the amount of suture material remaining when
examined at six weeks or six months after operation. However, the repairs performed
with CRG wrap did result in a lesser percentage of fibrous tissue at the site of repair.
Power Analysis
Power studies were undertaken, as the final part of the analysis of results, to test the
sensitivity of the analyses used for each variable and thus the 'probability of rejecting
a false statistical null hypothesis' (see Group Size, page 50).
This process was performed for each dependent variable, using the 'power analysis'
module of the Statistica software program.
A descriptive statistics summary was created for each dependent variable in order to
obtain the values of the means for each group and the standard deviation of all
groups. These values were then used to complete the power analysis calculations. The
power and a graph of power against 'n' (pages 148-151), were then computed.
The results of the power analyses are summarized over the page:
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Table 7: Results of power analysis
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The variables shown in red represent those for which significant differences were
found between groups.
It can be seen from the table above that for every dependent variable (apart from
tDmR/L) that showed significant differences between its groups, the analyses
performed had very high power values. As such the probability of type II error was
minimal. The variable tDmR/L had a power value of only 0.707, however despite the
number of cases in this study statistically significant differences were found between
groups for this variable. Thus where a statistically significant result was found, the
group sizes predicted at the outset of this study have been demonstrated,
retrospectively, to have been of an appropriate size to detect reasonable departures
from the null hypothesis.
The power graphs for these variables are printed on the next couple of pages.
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In a few instances, however, where no statistically significant result was
detected the power value was observed to be low (see summary table 7,
page 148). The possibility of type II error was therefore much greater. An
example of this is the dependent variable DhrR/L which had a power of
only 0.4453 (N=12). The power analysis graph is shown below:
Figure 102; Power calculation graph for DhrR/L
10 15 20 25 30
Group Sample Size (N)
1-Way ANOVA: Power Calculation - DhrR/L
1-Way ANOVA (Fixed Effects)
Power vs. N
10 15 20 25 30
Group Sample Size (N)
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Thus retrospectively, it was shown that the sample size for this test was too small to
provide reliable answers to the questions it was investigating. Of particular
importance were the low values of power for the analyses performed on the variables
from the in vivo dynamic assessments, e.g. DmR/L and VmR/L with power values of
0.527 and 0.688 respectively. The implications of this are discussed in detail in
Discussion Chapter 4 (see In vivo tendon dynamics, page 159).




This project was designed to assess the effects of several different surgicaltechniques and a new product, CRG wrap, on the process of flexor tendonhealing. The hypothesis set out to be tested stated that 'the addition of a
potentially anti-adhesiogenic agent to the process of tendon repair would result in no
difference in musculoskeletal function or tendon characteristics after recovery'.
Blood flow
The first assessment to be performed was the in vivo assessment of superficial blood
flow by laser doppler flowmetry. This proved simple to perform, was reproducible
and the results were striking. When compared to the normal group, all operative
groups except for the two groups examined at six months that incorporated CRG
wrap (CLate and DLate), showed a significant increase in superficial blood flow over
the site of repair; this equated to elevated levels of proximal doppler flux being
recorded.
At six weeks after repair, although flux levels were elevated in all groups when
compared to the normal group, comparison between groups showed that the repairs
performed with CRG wrap (W, CEarly and DEarly) had significantly less pronounced
elevation of flux compared to the other six week repair groups (without the wrap).
No significant differences were found between these three surgical methods of repair
which incorporated the CRG wrap (W, CEarly, DEarly).
By six months after operation, the two groups which had incorporated CRG wrap at
the time of repair (CLate and DLate) showed no significant differences from the
normal group proximal flux levels, or from any of the other groups repaired with
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CRG wrap. Thus it appeared to be the inclusion of CRG wrap, as opposed to the
surgical method used, which accounted for this 'down regulation' of flux levels.
Another important finding was that no significant differences were detected for flux
levels measured at the second doppler probe, placed distal to the site of repair
(R/LF2). This implied that neither the type of surgical repair performed, nor the
addition of CRG wrap had interfered with superficial blood flow beyond the site of
repair. Thus the integrity of distal tissues had not been compromised by any of the
methods of repair used.
Therefore in this study, surgical intervention was seen to cause an elevation in flux
levels at the site of tendon repair, when compared with the normal group. This
increase in superficial blood flow was most likely due to an 'overgrowth' of
superficial blood vessels as part of the natural healing process. However, the
incorporation of CRG wrap into any of the surgical repair groups was seen to
diminish the healing response by decreasing this extrinsic vascular proliferation over
the site of repair. However, this did not interfere with the superficial blood flow
beyond the site of repair or with the strength of the repaired tendons (see below).
Tensile testing. Morphology and percent
composition
Tensile testing
When assessed at six weeks after repair all groups in which the tendon had been
surgically divided, then repaired (AEarly, BEarly, CEarly, DEarly), broke at an UTS
bearing a lesser load than their respective non-operated left side, and lesser load than
the normal group. However, by six months after repair all groups showed no
difference in UTS when compared to the normal group. Another interesting finding
was that at six months after repair, many of the operated tendons had an UTS greater
than their respective non-operated side (R/LF ratio value > 1). The results obtained
from these tensile assessments are of interest as absolute data values as well as in their
ratio form. This is because consideration of the absolute values allows the results to
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be interpreted in terms of newtons achieved at UTS. Hence, a summary graph of the
mean UTS and 95% confidence intervals is shown below.
Figure 103: UTS values for right and non-operated tendons
Plot of Means and Conf. Intervals (95.00%)
The all groups mean for repaired FDS UTS (T, A-DEarly, A-DLate) was 164.4N.
The mean UTS of the normal group right FDS tendons was 220.2N and that for the
left (non-operated) sides of all groups was 248.4N. When assessed at six weeks the
UTS means of the early repair groups were significantly lower than the normal control
group mean, as would be expected given that the assessments were carried out at an
early stage in the process of healing of the tendons. When assessed at six months after
operation, no significant differences from the UTS of the normal control group were
found. No differences were found between groups with respect to the method of
surgical repair performed, when examined at either six weeks or six months after
repair.
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In the human it is not known exactly how much force a repaired tendon must
withstand during the process of healing (Labana et al. 2001): clearly it is a dynamic
process which is affected by the individual circumstances of each case. However, in
1992 Schuind et al. performed investigations on patients undergoing surgery for
carpal tunnel syndrome, in which the forces occurring in the flexor tendons were
measured during various different movements of the wrist and digits. He and his
colleagues concluded that tendon forces reaching 8.9N occurred during passive
mobilization of the fingers and forces of up to 34.4 N occurred during unrestricted
active mobilization of the fingers (Schuind et al. 1992). Another reference figure
which has been calculated with respect to digital forces is that which is apparently
required to produce active tendon excursion in a repaired tendon of a traumatized
finger; 22 N (Strickland 1999). Obviously the results from this research are based on
an ovine model and thus the relevance of these findings to humans must be made with
caution. However, when examined at six weeks after repair, there was no evidence of
rupture at the repair site (other than in the triamcinolone group, see page 162), the
mean UTS of the repaired tendons (T, A-DEarly) was 88.6N and there were no
significant differences found between groups. This amount of force is well above the
range of forces described by Schuind et al and Strickland. Although it is not yet know
what range of force is involved in the ovine model during the process of healing, it is
reasonable to assume that forces between 8-34N could have been exerted. However
even if lesser magnitudes of force were involved in the ovine model during the period
of healing the results obtained in this study still allow useful information to be gained
and potentially extrapolated to the process of healing of human flexor tendons.
Thus it can be concluded that the addition of CGR wrap to either method of tendon
repair performed in this study did not impair the strength of healing tendons when
assessed at either six weeks or six months after surgical repair.
Bulk of repaired tendon
Results of the morphological assessments showed that after any surgical intervention
(other than dissection only, group S) examination of the site of repair revealed an
increase in bulk of the tendon (cross-sectional area [R/LA] and maximum horizontal
axis [R/LX Feret]). The only significant difference between groups was found
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between ALate and AEarly; Kessler core repairs at six weeks and six months
respectively, with the dimensions measured at the site of repair being significantly
greater when assessed at six weeks. Therefore it can be concluded that the
incorporation of CRG wrap into the process of tendon repair in this project, did not
significantly alter the bulk of the resultant repaired tendons. Thus the gliding
characteristics of the FDS within the confined space of its sheath should not be
restricted by the addition of CRG wrap, though clearly further work would be
required to confirm this.
Tissue composition of the tendons
When examined at six weeks after operation, the two groups of tendons which
incorporated the CRG wrap in the repair method (CEarly and DEarly) revealed less
fibrous and connective tissue at the site of repair, compared with the other groups.
These two groups, CEarly and DEarly, showed no difference from the normal group.
But when examined at six months after repair, all experimental groups showed no
difference from the normal group. Thus it may be postulated that, in this study,
addition of CRG wrap at the time of tendon repair resulted in a 'down-regulating'
effect on the early fibroblastic response during the process of healing. This occurred
without interfering with the amount of fibrous tissue present at the later stage of
healing (assessed at six months). It is of critical importance, however, that this finding
is considered in conjunction with the results of the tensile strength assessments.
Together these assessments demonstrate that the lesser percent of fibrous tissue
present at six weeks after tendon repair, was not associated with any loss of strength
of the tendons; no significant differences were found.
It was also revealed that more suture material was present at the earlier time of
examination, six weeks, than at the later stage of six months. With regard to method
of repair, comparison between groups showed no differences in amount of suture
material present. Importantly the presence of CRG wrap was not found to
significantly alter the amount of suture material remaining when the tendons were
examined at either six weeks or at six months after repair.
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In vivo tendon dynamics
Results of the displacement and velocity assessments did not reveal any discernable
pattern of differences between groups for any of the variables recorded. Despite all
care having been taken in the planning and development of this method for
assessment of the tendons, the power studies performed at the end of the analysis of
results (see Power Analysis, page 147) showed that the group size predicted at the
outset was too small to detect reliably differences for these two indices of outcome:
displacement and velocity. It must therefore be concluded that although these groups
appeared to have been drawn from the same population, the number of cases per
group was not sufficient to allow the null hypothesis to be accepted without risk of
type II error: accepting a false null hypothesis. Indeed undetected differences may
have been present but missed by too small a sample size.
There are two possible solutions that could be used to address this problem, one
retrospective the other prospective. Retrospectively the group sizes could have been
increased. However in the absence of supporting data from the pilot study this was
not known to be a future problem. In fact had there been evidence for this at the
outset of the project, ethical approval would have had to have been obtained for
larger group sizes and this may have proved problematic given the case numbers
desired by the power calculations (-25 cases). The second solution would be to
proceed with further research to address the best method of increasing the sensitivity
of these new assessments aiming to heighten the sensitivity of the apparatus to detect
greater differences between cases. This would best be achieved in collaboration, once
again, with colleagues from the Department of Engineering. Indeed if a different
animal model were found to demonstrate tendon excursion greater than the 3-5mm of
the ovine model FDS, and thus closer to human digital excursion, the apparatus in its
current form may indeed prove to be suitably sensitive for use.
The third indicator of outcome considered during the in vivo dynamic assessments
was the variable acceleration. The time taken to reach zero acceleration was used as
the principle variable for comparison between cases and groups. The aim was to
detect any prolongation of, or hindrance to, motion of the tendon which could
potentially be caused by the presence of and stretching or breaking down of
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adhesions. The power calculation for this variable had a high value, 0.906 but the
between group differences did not show any discernable pattern of clinical interest.
However, results from a few recordings of acceleration which extended beyond the
point of interest for this project (time to zero acceleration) showed interesting graph
patterns: the repaired tendons were generally seen to have an oscillating plateau phase
whilst their non-operated counterparts had a flatter plateau phase (see below).
Although this could be due to re-entry of the stimulus, these few results suggested
that the later plateau phase (not investigated in this study) may hold information
relevant to the assessment of adhesions and thus further studies are warranted to
concentrate on investigating this plateau phase too.
Figure 104: Acceleration graph of a non-operated FDS tendon
This acceleration curve from a non-operated FDS tendon shows a
rapid smooth deceleration phase followed by a fairly straight
plateau phase after having reached zero acceleration.
Figure 105: Acceleration graph of an FDS tendon assessed at six weeks
This acceleration curve from a repaired FDS tendon examined after
six weeks of healing (group A) shows a rapid smooth deceleration
phase to zero acceleration, followed by an oscillating plateau phase.
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CRG Wrap group
At the time of harvesting the tendons, gross inspection of the wrap-only group
revealed a most unexpected finding; five (41.6%) of the tendons had healed in such a
way as to have a large fibrous mound of tissue over the area of repair. This was out of
keeping with all other groups in which the wrap had been used.
Figure 106: Appearance ofW3, six weeks after primary surgery
A right FDS tendon (above), from group W had CRG wrap added
in the absence of any surgical insult to the tendon. Six weeks after
operation the site where the wrap was added is enlarged, with
respect to the remainder of the tendon its non-operated FDS
(below).
The remaining seven (58.3%) tendons had healed with very little evidence of any
increased bulk.
Figure 107; Appearance of W5, six weeks after primary surgery
This right FDS tendon (above), also from group W, had CRG wrap added
in the absence of any surgical/traumatic insult to the tendon. However,
six weeks after operation the site where the wrap was added appears only
very slightly enlarged with respect to the remainder of this tendon or to
its non-operated left FDS (below).
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This finding was also reflected in the results obtained for the percentage of 'other'
tissue present (see RO page, 146) and R/LA, R/LFX, R/LF, where resultant values
reflected the inclusion of some tendons with increased bulk. Interestingly there was
not much change in the range of superficial doppler flux levels, with the range of
values being greater than that for the dissection-only group, but in keeping with the
other groups of repairs that had been repaired incorporating the CRG wrap.
The conclusion drawn from this observation was that in the absence of any insult or
injury to the tendon itself, the healing process was not initiated in the same way as
after tendon injury. Instead a foreign body type reaction had occurred, creating
excessive bulk around the intact tendon. Clearly given the confines of flexor tendons
in zone II this finding was a very important cautionary discovery, albeit isolated to the
situation of non-traumatized flexor tendons.
Triamcinolone group
The right FDS tendons of the cases in this experimental group were repaired using the
full surgical repair technique, Kessler core and epitenon sutures plus the CRG wrap,
and the addition of an anti-inflamatory steroid agent, triamcinolone acetonide 0.1%
(Adcortyl in Orobase®, Squibb). This group of animals was added to the project after
becoming aware of the results of studies carried out by Mr J Yates and colleagues in
Sheffield using triamcinolone paste as an antiadhesiogenic adjunct during surgery to
the lingual nerve. It was postulated that the addition of this paste to the CRG wrap, at
the time of surgical repair of the tendon, may further enhance the already noted anti¬
adhesiogenic properties of the CRG wraps in this project. Previous work published by
Yuzawa in 1985 had also shown triamcinolone to have an adhesion-preventing action,
when applied to a scarred tendon and its gliding floor, but the effective dose of this
drug was shown to have very narrow limits (Yuzawa 1985). Thus, a preliminary step
was taken in this project to see if any encouraging results might be obtained.
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Unfortunately, this was not the case. The twelve repairs performed far worse than
imagined, resulting in the only two cases of wound dehiscence with tendon repair
rupture (nine days after surgery) and subsequent euthanasia of these two cases. The
remaining ten cases all developed early wound seromas, with 'stretching' of the repair
observed in six animals (66.6%) at the time of final harvesting. In these cases the
tendons were found to be intact but with a thin elongated fibrous section at the site of
repair with loose or irregular pieces of suture material visible on this elongated
surface. The assumption made was that these cases had undergone at least partial
rupture of the repair at some stage during the healing process.
Statistical analysis of results from tensile testing of these tendons showed that the
addition of this agent rendered them significantly weaker than their individual control
and all other groups of repair method (R/LF p<0.001). It was therefore concluded
that triamcinolone interfered with the healing process of the tendons. In fact, shortly
after the conclusion of the experiments for this project, Wong et al reported that the
addition of triamcinolone acetonide to cell cultures of human tenocytes led to
suppressed human tenocyte cellular activity and reduced collagen production (Wong
et al. 2004).
In conclusion, it was clear that the use of even a thin film of triamcinolone paste
proved inappropriate in this experimental setting of primary tendon repair. However,
it can be speculated that without injury to the tendon, e.g. in the setting of secondary
tenolysis procedures, the inhibitory effect on collagen production and subsequent
likely limitation of the fibrous reaction conferred by the triamcinolone-impregnated
wrap, could be harnessed for patients' benefit, to counter foreign-body type reactions.
Further research would be needed explore this possibility in appropriately designed
animal studies prior to considering its application to the clinical setting.
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Conclusions
The results of this research project showed the following important clinical findings
regarding the use ofCRG wrap for the repair of divided tendons, in the ovine model:
The proliferative vascular response to injury was found to be diminished toward
'normal' range at six weeks after repair and within 'normal' range by six months, in
all groups where repair had been performed with the addition of CRG wrap. This
effect was achieved without incurring any differences in superficial blood flow beyond
the site of repair and without any impairment to the strength of the healing tendons.
Also, when assessed at six weeks after repair, the groups which had been repaired
with the addition of CRG wrap showed a significant reduction in the amount fibrous
tissue present at the repair site. This occurred without any other differences in
morphological features of the healing tendons being evident at either of the times of
assessment. As such the hypothesis as set out to be tested, must be rejected.
The author concludes that the use of CRG wrap may prove beneficial in the treatment
of flexor tendon injuries, by limiting early adhesion formation during the time when
the site of repair is most vulnerable to the forces applied across it, especially in
instances where patient cooperation with rehabilitation is anticipated to be low.
Unfortunately in this study no patterns of significant difference were found in the
displacement, velocity or acceleration characteristics of the in vivo tendon
assessments. As such it has not yet been possible to correlate the diminished vascular
response with any quantification of presence or absence of adhesions, by this novel
technique. However, it remains likely that this reduction in superficial vascular
response minimizes the potential for adhesion formation between the healing tendon
and its surrounding structures. Thus further work remains to be carried out as a
follow on from this exciting study.
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It has indeed proved difficult to compare results of this work with studies available to-
date. This is partly owing to the variation in methods and indices of outcome used by
different studies (as previously discussed) but more importantly, because this work
was set up to establish a new large animal model for in vivo assessment of tendons,
thus by its very nature there are no previous studies with which to compare results.
Thus for the in vivo dynamic testing of tendons, no comparable studies are available.
The assessment of blood flow using LDBF after a period of healing, again found no
previous comparable data in the literature. The results ofmorphological investigations
ought to be interpreted in the context of the study in which they were performed since
they only truly relate to the exact methods chosen for a particular study,
complementing the other chosen indices of outcome. Hence comparison between
studies such as these is rarely beneficial. For the assessment of tensile strength,
consideration has been given to the findings of previous studies though it is
emphasized again that any comparison made between studies which use different
methodology, must be made with caution.
However, the author believes that through this research an important step has been
made with regard to the scientific methods used in the continuing quest relating to the
characteristics of tendons and their process of healing. By the introduction of this new
composite approach to the evaluation of tendons it is hoped that, despite the current
decline in incidence of large animal studies (a fact which the author acknowledges)
the techniques described herein may be developed further and modified as necessary
to contribute toward the continued development and enhancement of research into the
healing of injured tendons.
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Steps for removing wax from a section
'Dehydrating' or 'Taking towater'
No. Solution Time
1 Xylene 1 5 minutes
2 Xylene 11 5 minutes
3 Absolute Alcohol 5 minutes
4 96% Alcohol 5 minutes
5 70% Alcohol 5 minutes
6 Running tap water 5 minutes
After performing the above steps, the histological section is ready for commencing the




Haematoxylin and Eosin Stain
Summary
Mayer's hematoxylin is used because it eliminates the necessity for
differentiation and bluing of the section. It can be considered a progressive
stain which produces a stained section with clearly defined nuclei while the
background is completely colorless. The biggest objection to Mayer's
hematoxylin as used in the past, has been that stained slides often fade after 1
to 3 years. This problem can be eliminated, however, when the slides are
washed, after the hematoxylin, in running water for a minimum of 20 minutes.
This method gives consistent results even when more than one person stains
sections from the same block. Also, slides may be left in the hematoxylin for
hours with-out overstaining.
Fixation - Any well fixed tissue.
Technique




•Gram's or Lugol's Iodine
Staining Procedure
1. Remove paraffin and hydrate to water
2.Place slide rack in Mayer's hematoxylin for 15 minutes
3.Wash in running tap water for 20 minutes
4.Counterstain with eosin from 15 seconds to 2 minutes depending on the
age of the eosin, and the depth of the counterstain desired. For even
staining results dip slides several times before allowing them to set in
the eosin for the desired time
5.Dehydrate and clear in xylene (as per protocol in Appendix 5)
Results
Nuclei - blue - with some metachromasia




Gomori's One-Step Trichrome Stain
Purpose
To identify collagenous connective tissue fibers, or to differentiate between
collagen and smooth muscle fibers
Principle
In the one-step trichrome procedure, a plasma stain (chromotrope 2R) and a
connective tissue fiber stain (fast green FCF, light green, or aniline blue) are
combined in a solution of phosphotungstic acid to which glacial acetic acid has
been added. Phosphotungstic acid favors the red staining ofmuscle and
cytoplasm. The tungstate ion is specifically taken up by collagen, and the
connective tissue fiber stain is subsequently bound to this complex, coloring
the collagen green or blue, depending on the counterstain used.
Fixative
Any well-fixed tissue may be used.
Bouin's solution is used as a mordant to intensify the color reactions.
Equipment






Cut paraffin sections at 4 to 5 pm.





Picric acid, saturated aqueous solution .... 75.0 mL
Formaldehyde, 37% to 40% 25.0 mL
Glacial acetic acid 5.0 mL
Weigert's Iron Hematoxylin
working Solution = mix equal parts of solutions A and B.
Solution A
Hematoxylin 10.0 g
Alcohol, 95% 1,000.0 mL
Solution B
Distilled water 475.0 mL
Hydrochloric acid, concentrated 5.0 mL
Ferric chloride, 29% solution 20.0 mL
0.5% Acetic Acid Solution
Glacial acetic acid 0.5 mL
Distilled water 99.5 mL
Gomori's Trichrome Stain (Store this solution in the refrigerator)
Chromotrope 2R (Baker No. 5-F703) 0.6 g
Fast green FCF, light green or aniline blue 0.3 g
Phosphotungstic acid 0.8 g
Glacial acetic acid 1.0 mL




1 .Remove paraffin from sections and hydrate to distilled water.
2.Rinse well in distilled water.
3.Mordant sections in Bouin's solution for I hour at 56 °C.
4.Remove slides from the oven, allow to cool and wash in running water
until the yellow color disappears.
5.Rinse in distilled water.
6. Stain sections in Weigert's hematoxylin for 10 minutes.
7.Wash in running water for 10 minutes.
8.Stain sections for 15 to 20 minutes in Gomori's trichrome stain.
9.Differentiate for 2 minutes in 0.5% acetic acid.
10. Dehydrate, clear, and mount with synthetic resin.
Results
Nuclei black
Cytoplasm, keratin, muscle fibers red




Steps for dehydrating a section after staining
'Dehydrating* or 'Taking to Xylene'
The steps below should be performed after completion of the chosen staining schedule
No. Solution Method/Time
1 70% Alcohol Agitate rack, 4/6 seconds
2 96% Alcohol Agitate rack, 10/20 seconds
3 Absolute Alcohol Agitate, 30 seconds
4 Xylene I -
5 Xylene II -
Allow to air dry






Group & Case Identification
Group Primary Procedure Case Identification
AEarly = KC repair at 6 Weeks Letter (AA - AM)
BEarly = KCE repair 6 Weeks Letter (BA - BM)
CEarly = KCW repair 6 Weeks Letter (CA - CM)
DEarly = KCEW repair 6 Weeks Letter (DA - DM)
ALate = KC repair at 6 Months Number (A1 - A12)
BLate = KCE repair 6 Months Number (B1 -B12)
CLate = KCW repair 6 Months Number (CI -C12)
DLate = KCEW repair 6 Months Number (D1 -D12)
N = Normal (N1 -N12)
S = Dissection only (SI -S12)
w = Wrap only (W1-W12)
T = KCEW repair + Triamcinolone (T1 -T12)
Variables
Doppler
RFl = Right Flux 1 (flux units)1
RF2 = Right Flux 2
LF1 = Left Flux 1
LF2 = Left Flux 2
RFl-F2 = Right Flux 1 - Flux 2
LF1-F2 = Left Flux 1 - Flux 2
R/LF1 = Right / Left Flux 1
R/LF2 = Right / Left Flux 2
R/LF1-2 = Right / Left Flux 1 - Flux 2
L/RF1 = Left / Right Flux 1
L/RF2 = Left / Right Flux 2
L/RF1-2 = Left / Right Flux 1 - Flux 2
'Flux units are related to the product of average speed and concentration ofmoving red blood
cells in the tissue sample volume
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In vivo tendon dynamics
DmR = maximum Displacement, Right (mm)
tDmR = time to maximum Displacement, Right (s)
DmL = maximum Displacement, Left (mm)
tDmL = time to maximum Displacement, Left (s)
DhrR = Displacement at half relaxation, Right (mm)
tDhrR - time to Displacement at half relaxation, Right (s)
DhrL = Displacement at half relaxation, Left (mm)
tDhrL = time to Displacement at half relaxation, Left (s)
tTTR = time for Total Twitch, Right (s)
tTTL = time for Total Twitch, Left (s)
VmR = maximum Velocity, Right (mms"1)
tVmR = time to maximum Velocity, Right (s)
VmL = maximum Velocity, Left (mms"1)
tVmL = time to maximum Velocity, Left (s)
DmR-L = maximum Displacement, Right - Left (mm)
DmR/L = maximum Displacement, Right / Left (mm)
DmL-R = maximum Displacement, Left - Right (mm)
DmL/R = maximum Displacement, Left / Right (mm)
tDmR-L = time to maximum Displacement, Right — Left (s)
tDmR/L = time to maximum Displacement, Right / Left (s)
tDmL-R = time to maximum Displacement, Left - Right (s)
tDmL/R = time to maximum Displacement, Left / Right (s)
DhrR-L = Displacement at half relaxation, Right - Left (mm)
DhrR/L = Displacement at half relaxation, Right / Left (mm)
DhrL-R = Displacement at half relaxation, Left - Right (mm)
DhrL/R = Displacement at half relaxation, Left / Right (mm)
tDhrR-L = time to Displacement at half relaxation, Right -Left (s)
tDhrR/L = time to Displacement at half relaxation, Right / Left (s)
tDhrL-R = time to Displacement at half relaxation, Left - Right (s)
tDhrL/R = time to Displacement at half relaxation, Left / Right (s)
tTTR-L = time for Total Twitch, Right - Left (s)
tTTR/L = time for Total Twitch, Right / Left (s)
tTTL-R = time for Total Twitch, Left - Right (s)
tTTL/R = time for Total Twitch, Left / Right (s)
VmR-L = maximum Velocity, Right - Left (mms"1)
VmR/L = maximum Velocity, Right / Left (mms"1)
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VmL-R = maximum Velocity, Left - Right (mms"1)
ViiiL/R = maximum Velocity, Left / Right (mms"1)
tVmR-L = time to maximum Velocity, Right - Left (s)
tVmR/F = time to maximum Velocity, Right / Left (s)
tVmL-R = time to maximum Velocity, Left - Right (s)
tVmL/R = time to maximum Velocity, Left / Right (s)
tOAccel R = time to zero Acceleration, Right (s)
tOAccel L = time to zero Acceleration, Left (s)
tOAccel R/L = time to zero Acceleration, Right/Left (s)
Instron
RF = Right, maximum Force (N)
RD = Right, maximum Displacement (mm)
LF = Left, maximum Force (N)
LD = Left, maximum Displacement
R/LF = maximum Force, Right / Left (N)
R/LD = maximum Displacement, Right / Left (mm)
Histological
RA =Right Area (mm2)
LA =Left Area (mm2)
R/LA =Right/Left Area (mm2)
RP -Right Perimeter (mm)
LP =Left Perimeter (mm)
R/LP =Right/Left Perimeter (mm)
RL =Right Length (mm)
LL =Left Length (mm)
R/LL =Right/Left Length (mm)
RXF =Right XFeret2 (mm)
LXF =Left XFeret (mm)
R/LXF =Right/Left XFeret (mm)
2 Feret = the maximum distance of the X (horizontal) or Y (vertical) axis
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RYF =Right YFeret (mm)
LYF =Left YFeret (mm)
R/LYF =Right/Left YFeret (mm)
RFF =Right Form Factor3
LFF =Left Form Factor
R/LFF =Right/Left Form Factor
RT =Right Tendon fibres
LT =Left Tendon fibres
RV =Right blood Vessels
LV =Left blood Vessels
RS =Right Suture material
LS =Left Suture material
RO =Right Other/fibrous substance
LO =Left Other/fibrous substance
3 Form factor is a standard estimate of the circularity that relates perimeter length to area on a




Doppler Results - 6 Months (A)
Case Probe Mean Std Min Max Median
A1 r F1 102.7 50.5 57.8 321.4 79.2
F2 18.7 13.5 5.1 78.0 12.7
l F1 36.1 18.2 15.9 102.8 29.9
F2 32.2 20.9 10.9 125.5 24.3
A2 r F1 158.1 36.1 102.5 343.2 149.6
F2 46.2 36.1 15.7 215.7 30.5
l F1 50.1 22.9 30.4 170.1 41.2
F2 40.0 13.8 25.7 98.0 35.0
A3 R F1 56.0 25.8 28.0 155.7 45.9
F2 36.4 33.8 8.2 170.8 18.8
L F1 42.4 29.5 17.6 196.4 29.8
F2 39.7 21.5 20.0 130.8 30.9




A5 R F1 104.8 60.7 45.7 523.8 89.2
F2 71.6 42.5 24.8 249.1 57.5
L F1 52.2 28.0 23.4 176.9 41.0
F2 51.7 18.6 26.7 125.2 45.9
A6 R F1 212.6 99.8 102.0 719.8 186.3
F2 149.8 77.4 40.5 546.2 142.9
L F1 38.2 21.4 14.0 114.4 30.8
F2 26.4 17.7 8.2 111.5 20.2
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Doppler Results - 6 Months
Case Probe Mean Std Min Max Median
A7 R F1 123.2 25.6 85.4 228.8 114.1
F2 37.6 17.2 18.9 117.1 29.9
L F1 32.4 19.9 11.6 242.9 25.0
F2 31.8 20.0 9.5 193.0 24.3
A8 R F1 126.8 30.7 82.2 265.7 115.3
F2 37.9 17.2 18.3 123.4 30.1
L F1 33.2 16.4 16.2 107.1 27.6
F2 32.9 29.0 12.3 190.2 21.6
A9 R F1 85.0 26.1 50.8 186.3 74.8
F2 33.0 22.6 12.2 142.7 23.2
L F1 55.4 30.0 26.7 176.8 42.0
F2 47.8 21.7 23.6 136.5 38.4
A10 R F1 89.6 31.1 46.0 282.3 71.7
F2 26.6 19.2 11.4 103.7 21.1
L F1 24.3 12.1 8.7 91.7 20.7
F2 19.8 11.5 4.4 80.0 16.6
All R F1 54.6 56.6 11.7 503.1 32.6
F2 21.9 21.8 4.5 140.5 13.1
L F1 30.2 19.7 10.9 139.4 22.0
F2 31.4 19.8 12.0 135.9 23.9
A12 R F1 112.5 27.6 61.2 276.5 107.5
F2 38.1 15.7 13.6 124.3 33.8
L F1 43.6 19.1 23.0 154.9 36.7
F2 46.4 19.4 24.4 165.0 40.6
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DopplerResults - 6 Months (B)
Case Probe Mean Std Min Max Median
B1 R F1 169.1 53.3 83.7 287.3 163.8
F2 89.1 57.4 26.8 174.7 80.6
L F1 91.9 44.6 27.0 159.5 75.5
F2 89.3 25.8 36.1 166.5 84.7
B2 R F1 154.9 16.5 107.4 306.4 154.6
F2 38.5 30.3 12.1 295.4 26.9
L F1 58.0 23.9 20.0 162.5 52.3
F2 45.7 29.6 12.5 185.5 33.1
B3 R F1 147.4 37.2 78.9 313.8 135.7
F2 38.9 33.3 11.9 350.5 24.7
L F1 41.2 18.7 21.2 121.2 33.4
F2 26.2 20.4 7.8 116.2 16.9
B4 R F1 205.0 46.4 108.3 643.8 195.3
F2 49.7 29.1 24.3 265.2 37.2
L F1 48.6 21.1 22.8 180.8 43.1
F2 36.9 16.7 14.8 101.4 32.0
B5 R F1 80.9 29.7 37.3 264.8 74.3
F2 47.3 22.9 21.4 177.7 39.5
L F1 53.2 25.8 22.7 229.5 46.4
F2 35.2 23.4 11.0 165.3 26.7
B6 R F1 183.6 26.5 134.4 396.9 176.9
F2 42.2 26.1 14.3 165.5 32.0
L F1 58.5 28.9 22.3 171.3 47.8
F2 50.4 33.8 18.2 227.7 35.7
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DopplerResults - 6 Months
Case Probe Mean Std Min Max Median
B7 R F1 155.5 67.8 65.2 734.4 138.7
F2 62.3 49.0 16.3 487.4 45.2
L F1 77.4 55.9 19.2 332.8 54.2
F2 61.9 37.4 20.1 241.3 46.7
B8 R F1 142.2 40.4 67.5 387.1 138.2
F2 40.4 27.9 13.8 234.9 30.2
L F1 38.2 30.0 12.2 237.2 27.5
F2 34.3 26.2 10.0 183.2 24.3
B9 R F1 133.0 28.3 0.0 272.5 127.9
F2 34.6 21.2 0.0 146.1 26.0
L F1 48.2 34.6 14.9 222.3 32.2
F2 45.1 25.5 17.4 149.5 35.0
BIO R F1 118.5 39.3 42.3 296.9 111.4
F2 115.4 39.1 62.1 285.8 102.9
L F1 57.4 18.3 0.0 133.8 54.4
F2 56.7 27.1 0.0 324.4 52.5
Bll R F1 107.6 27.4 60.2 496.9 102.5
F2 45.2 27.1 17.8 267.6 33.7
L F1 32.8 12.7 15.2 98.0 28.8
F2 30.1 13.0 13.9 100.4 25.9
B12 R F1 117.7 25.6 78.0 368.6 111.0
F2 34.3 21.1 15.3 260.1 26.0
L F1 46.3 19.0 19.2 129.3 40.4
F2 43.0 24.0 17.4 159.2 33.5
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DopplerResults - 6 Months (C)
Case Probe Mean Std Min Max Median
CI R F1 33.6 14.8 17.0 71.0 28.5
F2 28.4 15.4 13.0 74.0 23.1
L F1 37.4 12.2 20.0 71.0 35.2
F2 3F2 9.3 19.0 61.0 30.3
C2 R F1 40.5 11.3 26.0 68.0 38.0
F2 31.2 10.9 14.0 55.0 29.0
L F1 32.8 6.3 24.0 51.0 31.0
F2 30.7 10.3 21.0 60.0 26.5
C3 R F1 47.2 11.1 28.0 78.0 46.0
F2 43.6 12.9 28.0 86.0 39.0
L F1 36.4 13.4 19.0 68.0 33.4
F2 31.1 10.9 17.0 61.0 28.0
C4 R F1 35.9 7.7 26.0 55.0 34.0
F2 28.1 11.5 16.0 50.0 22.0
L F1 35.5 9.2 20.0 52.0 37.0
F2 29.4 10.3 17.0 50.0 27.0




C6 R F1 34.7 4.7 25.0 44.0 33.5
F2 22.7 7.1 17.0 44.0 20.0
L F1 27.9 7.3 19.0 46.0 25.5
F2 23.8 12.5 10.0 49.0 20.0
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Doppler Results - 6 Months
Case Probe Mean Std Min Max Median
C7 R F1 78.2 48.6 24.8 401.5 55.9
F2 67.7 34.4 21.7 241.3 55.3
L F1 71.0 16.4 38.2 205.4 57.8
F2 50.6 12.5 29.1 129.1 46.9
C8 R F1 95.8 33.0 59.9 252.8 80.7
F2 92.0 36.0 54.3 241.3 75.1
L F1 88.2 28.6 44.2 227.9 78.1
F2 83.7 33.0 43.5 272.6 70.5
C9 R F1 108.1 40.9 60.0 345.4 94.6
F2 104.1 27.7 70.2 244.5 94.5
L F1 53.2 32.9 17,2 204.2 36.8
F2 51.4 29.6 18.1 194.9 36.5
CIO R F1 42.2 19.6 16.8 233.8 36.8
F2 32.0 14.7 11.7 160.3 27.2
L F1 26.8 12.2 10.1 87.0 22.4
F2 22.8 11.3 9.2 83.2 18.1
Cll R F1 50.7 25.5 23.9 157.5 39.7
F2 48.7 18.2 24.1 136.8 42.2
L F1 34.9 17.9 15.5 137.1 28.5
F2 27.0 11.8 12.5 106.7 23.2
C12 R F1 41.4 17.7 23.2 141.8 35.2
F2 32.4 12.8 10.2 147.0 19.6
L F1 23.7 12.9 10.2 147.0 19.6
F2 18.3 17.1 2.8 167.1 12.7
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DopplerResults - 6 Months (D)
Case Probe Mean Std Min Max Median
D1 R F1 48.4 9.8 29.0 71.0 48.0
F2 44.9 11.2 31.0 75.0 41.0
L F1 36.4 7.8 22.0 58.0 38.0
F2 29.8 7.5 20.0 50.0 28.5
D2 R F1 49.9 12.8 30.0 71.0 49.0
F2 48.6 10.4 28.0 78.0 48.0
L F1 51.3 24.0 29.2 98.7 45.9
F2 50.7 24.0 23.4 125.0 40.6
D3 R F1 45.9 10.6 32.0 79.0 43.0
F2 41.4 11.38 25.0 69.6 39.0
L F1 38.7 13.1 18.0 72.0 35.5
F2 36.3 11.6 20.0 67.0 33.0
D4 R F1 35.9 10.3 21.0 102.3 53.0
F2 34.7 13.1 19.0 76.0 31.7
L F1 28.1 6.11 19.3 42.0 27.5
F2 26.5 7.4 15.0 42.0 26.0
D5 R F1 52.2 19.2 21.0 102.3 53.0
F2 30.9 11.2 13.0 65.0 30.2
L F1 30.1 7.43 18.0 46.0 31.0
F2 27.0 7.39 18.0 50.0 26.0
D6 R F1 38.2 5.4 25.0 50.0 39.0
F2 32.4 6.2 24.0 49.0 30.5
L F1 35.6 5.5 23.0 45.0 35.0
F2 26.7 6.6 19.0 40.0 23.0
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Doppler Results - 6 Months
Case Probe Mean Std Min Max Median
D7 R F1 87.8 49.1 35.1 257.1 65.3
F2 69.9 31.1 32.5 176.7 54.8
L F1 86.8 44.4 32.6 246.5 66.3
F2 57.3 17.9 30.1 137.2 50.6
D8 R F1 118.3 41.4 68.2 709.3 106.4
F2 108.3 32.6 68.1 579.8 101.1
L F1 99.3 61.7 30.7 335.8 63.9
F2 77.8 39.1 35.7 231.8 57.8
D9 R F1 69.4 20.0 39.5 163.7 62.5
F2 61.1 25.9 27.1 172.6 52.0
L F1 50.6 8.0 42.4 69.1 48.0
F2 42.1 5.0 32.8 50.4 41.4
D10 R F1 92.5 12.2 72.0 138.4 89.9
F2 83.1 14.7 54.4 131.8 80.6
L F1 42.5 18.2 18.2 118.7 34.9
F2 41.4 12.3 22.7 101.3 37.5
Dll R F1 50.1 34.8 9.2 222.5 40.4
F2 33.6 27.7 5.8 194.2 20.5
L F1 30.3 12.0 11.7 82.6 26.4
F2 26.0 14.1 8.4 104.7 20.4
D12 R F1 50.9 14.8 27.0 117.5 46.2
F2 45.9 23.8 16.8 162.4 34.3
L F1 42.0 19.7 0.0 156.6 34.8
F2 33.3 14.4 0.0 110.8 28.9
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DopplerResults - 6 Weeks (A)
Case Probe Mean Std Min Max Median
AG R F1 147.3 81.6 40.0 565.8 134.1
F2 28.2 18.4 10.1 225.5 23.5
L F1 23.5 18.9 5.7 187.4 14.0
F2 22.2 14.5 8.1 140.4 18.3
AH R F1 90.1 19.6 47.3 173.9 85.3
F2 64.1 16.6 28.8 141.8 62.1
L F1 37.2 19.0 11.1 314.4 32.4
F2 34.5 18.4 12.1 218.8 29.8
AJ R F1 111.3 31.9 24.0 290.8 103.8
F2 50.9 38.6 20.2 275.7 24.7
L F1 67.0 39.8 23.9 278.7 49.4
F2 61.0 29.5 25.4 203.4 48.8
AK R F1 114.7 16.8 79.8 233.2 111.6
F2 28.2 12.6 36.3 42.7 37.1
L F1 23.6 15.6 6.3 129.8 19.0
F2 16.1 9.9 4.8 82.2 12.8
AL R F1 89.1 39.1 32.7 217.6 81.1
F2 57.9 19.5 25.2 150.9 53.2
L F1 35.9 28.2 11.6 266.9 24.0
F2 30.0 20.3 11.5 173.9 22.2
AM R F1 219.1 62.3 107.3 427.0 209.0
F2 25.1 13.1 7.1 121.1 21.5
L F1 28.2 19.6 11.5 199.6 22.3
F2 21.5 10.7 10.9 144.6 18.0
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Doppler Results - 6 Weeks (B)
Case Probe Mean Std Min Max Median
BG R F1 166.1 35.8 55.7 252.8 166.9
F2 54.2 25.4 23.2 257.9 47.2
L F1 45.7 24.0 16.4 253.6 37.3
F2 42.4 22.8 15.9 231.2 34.9
BH R F1 115.2 18.8 79.0 266.1 111.8
F2 34.9 25.0 12.9 199.2 25.4
L F1 29.9 23.0 8.3 298.0 21.6
F2 22.9 19.5 5.7 289.2 16.4
BJ R F1 187.2 17.7 144.6 424.1 185.2
F2 72.3 42.4 26.0 726.6 60.2
L F1 78.7 39.7 27.9 404.9 66.9
F2 77.2 36.2 18.9 370.6 68.5
BK R F1 178.5 34.6 101.0 442.5 174.8
F2 38.9 19.6 18.8 322.7 32.0
L F1 42.1 28.5 17.7 636.4 37.1
F2 40.4 37.9 15.6 796.8 31.4
BL R F1 214.8 40.8 145.0 808.4 202.5
F2 64.5 31.0 30.8 357.7 54.9
L F1 76.3 29.5 28.8 265.3 70.1
F2 69.7 29.7 28.5 326.2 61.7
BM R F1 126.6 15.8 84.9 210.5 125.1
F2 50.8 27.4 17.0 237.7 43.1
L F1 55.9 49.7 16.2 888.6 41.5
F2 52.6 40.8 21.4 882.0 41.7
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Doppler Results - 6 Weeks (C)
Case Probe Mean Std Min Max Median
CA R F1 29.4 23.4 4.6 130.0 17.1
F2 2F6 13.4 7.5 257.6 15.8
L F1 19.4 13.3 4.6 116.5 14.9
F2 18.7 11.7 6.3 88.2 14.5
CB R F1 63.6 19.5 32.0 132.9 56.3
F2 31.9 22.2 8.1 119.1 20.8
L F1 42.6 22.8 15.7 495.9 37.3
F2 31.6 19.2 9.9 423.2 27.1
CC R F1 58.4 16.2 26.4 116.9 57.8
F2 43.6 23.6 16.6 163.7 32.9
L F1 57.6 40.3 19.3 852.7 46.7
F2 47.2 30.6 14.8 342.6 35.7
CD R F1 42.5 14.2 20.1 140.3 37.9
F2 32.6 11.6 16.2 104.0 28.3
L F1 26.6 13.5 10.9 147.7 21.3
F2 19.7 10.8 7.5 86.2 15.5
CE R F1 49.7 13.4 24.1 118.5 46.2
F2 44.3 12.7 21.0 99.0 40.7
L F1 28.3 13.5 7.4 143.8 24.1
F2 26.9 14.7 8.3 182.0 21.1
CF R F1 52.4 15.2 27.4 146.7 48.0
F2 55.8 26.1 8.6 183.4 52.3
L F1 23.1 19.6 3.8 117.7 14.8
F2 19.0 15.6 1.9 101.9 12.5
11 Appendix 7 - Doppler Blood Flow Data
Flexor Tendon Healing
DopplerResults - 6 Weeks
Case Probe Mean Std Min Max Median
CG R F1 59.8 24.5 19.0 309.0 55.7
F2 57.4 30.0 14.8 281.4 49.2
L F1 29.7 13.5 23.8 126.1 47.0
F2 48.5 16.0 20.1 158.6 45.2
CH R F1 56.8 41.9 15.1 335.5 36.2
F2 55.2 23.2 18.8 203.4 48.9
L F1 47.4 18.3 20.9 122.5 41.2
F2 42.1 23.2 15.1 128.2 31.5
CJ R F1 51.6 30.0 17.5 201.6 38.0
F2 50.2 36.5 14.7 194.1 32.6
L F1 46.8 28.0 14.5 189.5 36.2
F2 45.6 30.4 13.8 188.0 32.6
CK R F1 53.9 36.7 17.2 539.0 39.4
F2 50.1 28.1 13.7 352.1 39.9
L F1 38.3 19.9 17.1 143.7 31.6
F2 33.1 17.2 15.6 141.2 27.3
CL R F1 48.6 37.5 9.8 341.7 31.2
F2 41.7 34.4 7.5 267.0 25.2
L F1 26.4 28.0 4.5 413.1 17.2
F2 22.2 20.6 3.4 190.9 14.4
CM R F1 64.2 25.8 33.4 213.7 54.3
F2 55.4 20.7 27.7 177.1 48.0
L F1 41.3 26.2 12.8 188.3 28.5
F2 36.2 19.0 13.0 160.3 26.7
12 Appendix 7 - Doppler Blood Flow Data
Flexor Tendon Healing
Poppler Results - 6 Weeks (D)
Case Probe Mean Std Min Max Median
DA R F1 64.9 50.6 17.1 349.9 42.8
F2 49.9 24.2 20.7 192.2 39.6
L F1 46.0 17.3 23.1 164.9 38.4
F2 4F0 61.5 5.2 879.2 22.8
DB R F1 49.2 30.9 13.5 203.4 34.7
F2 45.4 18.4 21.6 139.9 38.3
L F1 22.7 17.6 4.0 128.9 14.9
F2 2F6 11.4 7.7 79.0 17.8
DC R F1 50.9 27.1 13.8 209.1 42.7
F2 43.4 20.1 13.2 179.1 37.4
L F1 30.8 22.4 5.5 123.2 20.8
F2 2F4 18.4 5.7 100.4 12.2
DD R F1 41.0 24.4 13.2 165.6 31.8
F2 27.0 17.2 7.5 107.8 20.4
L F1 27.2 12.6 10.4 73.9 22.5
F2 26.5 20.4 3.9 101.5 16.5
DE R F1 38.4 22.1 12.4 144.1 29.6
F2 28.3 19.8 6.4 137.1 19.2
L F1 29.5 20.6 8.5 120.3 20.8
F2 20.2 17.7 5.6 95.5 11.6
DF R F1 56.1 37.3 15.7 217.5 38.9
F2 41.9 30.6 13.5 198.9 30.6
L F1 40.6 29.8 16.9 158.2 31.5
F2 39.4 24.2 14.7 145.9 26.9
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Flexor Tendon Healing
Doppler Results - 6 Weeks
Case Probe Mean Std Min Max Median
DG R F1 73.5 19.3 33.4 162.0 72.4
F2 63.9 24.7 29.4 200.1 55.0
L F1 66.4 26.6 31.7 267.7 56.2
F2 62.2 23.5 27.1 300.6 54.6
DH R F1 55.1 43.2 12.7 392.2 37.4
F2 49.7 38.8 12.4 470.6 34.5
L F1 47.4 48.9 10.2 850.4 30.5
F2 44.9 24.2 13.0 504.0 41.0
DJ R F1 51.9 23.0 23.2 213.8 44.9
F2 39.7 17.3 15.4 141.8 35.2
L F1 41.2 22.1 18.0 377.3 34.5
F2 38.1 33.8 11.6 630.1 28.3
DK R F1 65.5 48.9 20.5 462.0 54.8
F2 59.3 21.3 26.2 317.5 56.9
L F1 52.1 27.8 27.3 225.6 41.2
F2 47.5 19.8 28.0 151.2 39.7
DL R F1 59.3 85.4 6.0 644.3 27.6
F2 46.9 11.4 22.6 111.6 44.8
L F1 51.7 29.0 13.5 185.0 40.4
F2 39.4 20.7 15.8 143.0 32.0
DM R F1 45.6 14.4 25.4 127.6 40.5
F2 38.1 19.7 16.2 129.6 29.8
L F1 26.1 21.9 4.1 125.6 14.5
F2 23.8 11.4 9.7 68.6 18.5
14 Appendix 7 — Doppler Blood Flow Data
Flexor Tendon Healing
Poppler Results - 6 Weeks (N)
Case Probe Mean Std Min Max Median
N1 R F1 29.5 19.7 9.2 212.7 22.7
F2 26.9 16.9 9.6 187.4 21.2
L F1 24.7 13.6 8.4 194.3 20.4
F2 24.2 15.7 9.4 295.6 19.2
N2 R F1 46.1 21.5 16.2 183.3 38.2
F2 42.4 19.1 13.8 128.1 35.8
L F1 42.2 18.7 19.5 127.0 36.6
F2 40.2 22.8 14.3 163.2 32.4
N3 R F1 68.2 21.1 33.7 310.8 65.1
F2 59.2 27.5 18.6 409.8 55.0
L F1 61.2 26.1 23.1 441.0 59.2
F2 56.8 26.2 18.8 451.1 52.5
N4 R F1 61.4 28.8 20.2 228.6 51.2
F2 54.5 22.5 7.6 147.4 47.1
L F1 51.5 18.7 28.7 189.3 45.8
F2 48.4 27.9 17.2 366.3 40.9
N5 R F1 54.2 31.4 16.8 220.7 43.0
F2 39.2 17.9 16.0 170.1 33.5
L F1 51.8 49.7 13.1 379.3 35.3
F2 42.7 21.3 19.0 182.4 33.7
N6 R F1 78.4 110.6 23.5 919.2 53.8
F2 71.2 91.3 19.4 949.7 52.5
L F1 72.0 57.3 15.5 385.8 44.1
F2 70.9 53.1 26.3 593.3 50.2
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Flexor Tendon Healing
Doppler Results - 6 Weeks
Case Probe Mean Std Min Max Median
N7 R F1 56.1 23.0 29.7 251.5 46.5
F2 44.9 27.8 16.3 303.3 36.2
L F1 48.8 15.7 28.1 131.0 42.8
F2 46.3 18.8 19.8 151.6 40.6
N8 R F1 86.1 44.2 34.5 434.5 72.0
F2 76.3 26.2 40.1 250.8 66.2
L F1 64.7 19.7 38.7 180.8 57.2
F2 53.2 22.6 22.5 199.3 44.2
N9 R F1 66.2 21.7 33.9 280.7 61.6
F2 61.1 29.2 22.8 367.7 51.5
L F1 61.7 40.8 18.2 272.8 46.6
F2 62.7 46.3 18.2 588.9 46.7
N10 R F1 65.5 34.4 22.9 488.8 56.5
F2 60.4 23.2 26.1 412.4 55.5
L F1 59.2 35.1 23.3 259.2 46.8
F2 54.7 22.1 26.6 199.2 48.2
Nil R F1 80.0 31.8 45.5 352.8 68.8
F2 69.4 28.3 37.0 316.8 58.8
L F1 73.2 35.7 37.1 484.3 62.6
F2 70.1 41.4 30.5 585.1 55.4
N12 R F1 55.0 28.1 13.8 172.8 50.9
F2 48.6 27.5 19.8 204.5 37.6
L F1 47.0 19.5 21.9 168.2 41.1
F2 40.2 19.5 19.4 157.1 33.4
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Doppler Results - 6 Weeks (W)
Case Probe Mean Std Min Max Median
W1 R F1 59.1 38.7 14.0 314.2 49.3
F2 55.5 40.4 13.8 382.1 39.8
L F1 44.3 30.2 13.8 455.6 33.7
F2 41.2 43.9 5.3 721.3 26.6
W2 R F1 98.6 36.1 36.0 360.7 90.1
F2 91.0 35.4 33.5 324.2 79.6
L F1 86.0 45.6 35.5 504.7 70.3
F2 81.5 37.2 33.5 485.6 69.4
W3 R F1 71.8 47.7 16.4 532.4 52.2
F2 67.1 47.1 16.3 504.5 49.0
L F1 50.9 19.5 28.7 243.8 44.4
F2 46.0 23.0 19.0 331.5 38.2
W4 R F1 87.0 50.4 31.2 280.6 62.0
F2 74.8 35.7 32.5 224.6 57.4
L F1 80.5 37.7 36.6 219.8 61.6
F2 67.2 36.1 20.7 206.5 48.6
W5 R F1 88.2 45.0 26.9 270.1 74.1
F2 73.6 36.9 23.2 236.4 59.8
L F1 71.8 40.9 0.0 219.9 52.2
F2 68.1 34.6 0.0 211.8 54.6
W6 R F1 81.9 25.9 21.1 468.7 62.2
F2 56.0 25.9 21.1 100.0 47.4
L F1 44.1 27.2 7.9 247.7 36.5
F2 37.9 31.2 3.5 365.1 27.5
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Flexor Tendon Healing
Doppler Results - 6 Weeks
Case Probe Mean Std Min Max Median
W7 R F1 76.8 29.7 0.0 233.7 68.5
F2 57.1 23.7 0.0 192.2 47.4
L F1 53.9 24.0 23.0 167.4 44.4
F2 45.4 17.6 10.6 129.7 39.3
W8 R F1 53.2 52.9 0.0 523.6 31.0
F2 52.7 39.4 0.0 420.4 34.8
L F1 53.0 20.6 24.8 212.8 44.8
F2 43.0 16.3 19.6 125.7 37.0
W9 R F1 61.6 33.6 16.8 333.1 49.2
F2 60.2 25.6 15.5 236.2 54.0
L F1 54.5 23.0 21.0 148.8 45.8
F2 52.4 10.5 17.9 136.7 42.9
W10 R F1 73.1 26.0 25.3 187.5 65.2
F2 54.7 27.8 22.5 230.7 43.6
L F1 49.0 19.1 27.4 147.2 42.9
F2 48.9 28.5 17.5 203.6 38.8
Wll R F1 83.4 31.6 31.7 208.6 82.2
F2 56.8 25.5 13.9 157.2 50.6
L F1 42.3 26.6 12.9 166.5 32.8
F2 38.5 19.2 11.3 127.4 32.4
W12 R F1 84.0 21.0 48.6 180.7 79.8
F2 73.3 28.7 32.8 284.8 65.6
L F1 53.0 29.4 12.0 200.1 43.5
F2 43.6 25.2 10.0 158.9 34.3
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Flexor Tendon Healing
Doppler Results - 6 Weeks (S)
Case Probe Mean Std Min Max Median
SI R F1 75.9 29.3 36.4 280.7 66.4
F2 61.5 30.2 22.1 200.5 49.3
L F1 64.3 31.5 23.2 224.2 52.0
F2 57.4 21.5 26.3 163.6 49.8
S2 R F1 84.1 27.5 40.8 287.4 76.7
F2 57.9 33.1 16.4 260.5 44.6
L F1 71.7 31.4 31.7 190.8 58.3
F2 70.7 35.2 28.4 224.7 55.1
S3 R F1 83.4 31.0 41.8 204.7 73.6
F2 72.8 44.1 18.0 217.6 55.8
L F1 57.8 38.6 14.6 218.6 38.2
F2 51.6 28.7 15.1 176.1 37.6
S4 R F1 64.0 31.6 22.9 176.8 49.7
F2 52.5 21.6 21.0 146.0 43.8
L F1 56.2 25.6 21.2 311.8 48.3
F2 49.0 18.8 16.6 188.7 43.9
S5 R F1 68.1 34.4 0.0 252.8 56.8
F2 51.9 35.0 0.0 304.0 50.1
L F1 53.5 24.9 12.4 152.0 45.3
F2 52.2 25.1 16.4 154.8 44.4
S6 R F1 60.9 27.8 18.5 220.4 53.1
F2 47.1 29.8 6.8 462.4 38.9
L F1 56.4 24.1 16.9 148.2 47.4
F2 55.0 22.9 20.5 135.8 47.3
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Doppler Results - 6 Weeks
Case Probe Mean Std Min Max Median
S7 R F1 39.7 33.1 0.0 138.5 26.4
F2 36.1 30.6 0.0 149.2 143.5
L F1 33.4 23.8 4.2 186.4 26.5
F2 27.3 18.0 4.6 142.4 22.7
S8 R F1 97.2 54.6 24.9 412.2 87.7
F2 83.3 38.0 19.2 265.9 80.9
L F1 73.8 34.6 22.2 200.0 62.5
F2 62.0 21.7 23.9 166.6 56.0
S9 R F1 79.5 24.2 38.1 163.7 77.2
F2 75.8 25.9 29.7 168.0 76.2
L F1 56.4 27.3 20.5 306.7 46.7
F2 49.0 35.8 15.3 457.0 36.8
S10 R F1 64.7 17.2 27.2 151.5 62.3
F2 63.5 21.1 31.7 159.2 57.9
L F1 53.0 33.8 17.0 204.7 41.4
F2 50.7 27.6 16.5 162.9 39.2
Sll R F1 82.5 16.2 56.6 176.1 77.9
F2 76.4 10.5 55.7 180.1 74.0
L F1 64.6 23.2 31.8 206.5 56.9
F2 64.4 22.7 25.2 178.3 100.5
S12 R F1 86.3 57.1 21.1 445.5 81.3
F2 85.8 44.4 29.3 406.8 79.5
L F1 76.9 9.6 56.6 121.3 74.3
F2 72.2 15.9 47.6 172.9 67.1
20 Appendix 7 - Doppler Blood Flow Data
Flexor Tendon Healing
Doppler Results - 6 Weeks (T)
Case Probe Mean Std Min Max Median








T3 R F1 82.1 29.8 38.6 181.2 69.1
F2 44.6 30.3 12.7 161.2 30.0
L F1 59.0 10.7 27.8 85.4 58.8
F2 54.5 19.4 19.3 317.5 50.4
T4 R F1 88.5 16.9 46.5 169.0 87.1
F2 34.8 15.7 10.3 109.9 87.1
L F1 43.4 16.2 19.4 171.9 30.9
F2 40.8 16.4 18.8 191.6 36.2
T5 R F1 116.8 49.6 26.9 375.0 100.9
F2 45.1 25.2 9.7 907.0 36.6
L F1 35.5 13.7 15.8 145.0 31.9
F2 34.0 9.0 19.8 95.5 31.9
T6 R F1 125.1 18.7 95.6 658.3 122.0
F2 34.7 17.1 13.2 459.1 31.2
L F1 23.4 12.5 9.0 186.2 18.9
F2 22.2 15.0 8.4 222.5 16.3
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Doppler Results - 6 Weeks
Case Probe Mean Std Min Max Median
T7 R F1 80.8 40.5 42.7 583.2 69.5
F2 60.3 37.2 15.1 627.8 52.8
L F1 32.5 24.8 9.3 368.1 21.2
F2 32.5 33.0 8.2 473.7 22.2
T8 R F1 81.2 64.0 34.0 536.5 63.6
F2 31.3 74.6 1.9 726.9 9.9
L F1 26.9 25.5 7.0 453.5 21.5
F2 23.3 28.9 5.5 436.4 16.1
T9 R F1 66.8 24.7 41.3 573.9 60.9
F2 34.5 41.3 9.2 873.6 24.0
L F1 20.6 12.5 8.1 199.3 17.5
F2 17.8 11.4 6.3 188.3 14.4
T10 R F1 75.8 18.4 26.5 248.0 72.5
F2 24.2 11.3 9.3 150.9 20.4
L F1 14.3 13.6 9.0 186.2 19.3
F2 23.4 16.6 7.3 222.5 16.5
Til R F1 112.3 76.9 15.6 609.8 84.7
F2 85.0 42.3 26.3 573.7 75.0
L F1 32.6 15.8 12.2 122.3 26.8
F2 28.0 14.0 10.4 121.5 22.8
T12 R F1 132.4 26.1 38.5 232.5 132.5
F2 74.9 21.9 35.4 205.6 67.0
L F1 46.9 33.4 11.6 183.4 31.6
F2 36.5 26.6 8.3 157.0 23.1
22 Appendix 7 - Doppler Blood Flow Data
Flexor Tendon Healing
APPENDIX 8
PicoResults - 6 Months
mm mms'
s s
Case D max D '/2 rel V max V zero V min
time time Tt time time time tOAccel
A1 R 5.34 2.67 0.82 127.04 0.00 -15.68
0.09 0.38 0.71 0.009 0.13 0.36 0.3585
L 5.87 2.93 0.71 135.27 0.79 -19.02
0.08 0.37 0.76 0.01 0.11 0.37 0.3699
A2 R 4.76 2.38 0.88 117.79 1.32 -12.57
0.10 0.44 0.79 0.009 0.11 0.39 0.1424
L 4.86 2.43 0.55 130.12 0.11 -13.79
0.15 0.39 0.80 0.009 0.13 0.33 0.3304
A3 R 4.91 2.46 1.12 111.45 0.34 -12.52
0.32 0.55 0.90 0.009 0.10 0.48 0.1324
L 5.01 2.56 0.35 125.34 -2.06 -11.83
0.09 0.32 0.77 0.009 0.09 0.14 0.1509
A4 R Died
L
A5 R 3.63 1.82 0.21 63.09 0.58 -10.23
0.19 0.47 1.10 0.016 0.45 0.46 0.4716
L 3.63 1.82 0.13 72.72 0.50 -8.38
0.09 0.43 0.90 0.014 0.13 0.43 0.4412
A6 R 3.50 1.75 0.36 112.76 0.47 -12.85
0.15 0.38 0.79 0.009 0.08 0.34 0.0996
L 4.55 2.28 0.78 114.24 0.48 -15.47
0.18 0.35 0.78 0.009 0.15 0.30 0.3043
1 Appendix 8 - Pico data
Flexor Tendon Healing
Pico Results - 6 Months
mm mms
s s
Case D max D XA rel V max V zero Vmin
time time Tt time time time tOAccel
A7 R 3.07 1.53 0.56 80.63 0.88 -10.88
0.33 0.49 0.72 0.007 0.11 0.44 0.1544
L 3.12 1.56 0.51 71.10 0.27 -11.80
0.26 0.46 0.60 0.006 0.10 0.43 0.1281
A8 R 3.83 1.92 0.45 126.16 0.57 -16.90
0.16 0.31 0.50 0.005 0.14 0.30 0.3039
L 4.70 2.35 0.02 143.76 -0.93 -18.45
0.09 0.29 0.69 0.008 0.09 0.29 0.2814
A9 R 3.13 1.57 0.13 96.02 0.32 -13.79
0.23 0.36 0.79 0.009 0.09 0.34 0.1018
L 3.14 1.57 0.17 105.10 0.53 -9.80
0.08 0.28 0.61 0.008 0.07 0.31 0.1117
A10 R 3.57 1.79 0.45 76.18 0.46 -10.49
0.39 0.61 0.95 0.009 0.19 0.58 0.2143
L 3.88 1.94 0.54 80.20 -0.46 -7.26
0.16 0.61 0.93 0.009 0.14 0.61 0.2189
All R 4.21 2.15 0.79 57.7 0.98 -10.6
0.37 0.62 0.89 0.009 0.14 0.58 0.1711
L 2.77 1.39 0.33 61.89 0.004 -6.03
0.24 0.48 0.89 0.009 0.22 0.41 0.4099
A12 R 3.00 1.50 0.51 62.73 0.06 -11.3
0.27 0.42 0.84 0.009 0.24 0.39 0.1312
L 4.05 2.03 0.40 100.91 0.29 -11.07
0.19 0.43 0.86 0.009 0.17 0.38 0.3663
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PicoResults - 6 Months
mm mms
s s
Case D max D y2 rel V max V zero Vmin
time time Tt time time time tOAccel
B1 R 5.23 2.62 0.59 121.47 0.37 -12.46
0.12 0.37 0.86 0.009 0.09 0.16 0.1693
L 3.35 1.77 0.19 88.39 0.29 -6.52
0.09 0.42 0.96 0.009 0.09 0.14 0.1386
B2 R 1.61 0.81 -0.99 33.7 0.24 -8.5
0.25 0.39 0.92 0.009 0.10 0.40 0.1164
L 2.34 1.17 -0.69 55.7 -0.82 -8.06
0.08 0.33 0.80 0.009 0.09 0.35 0.1369
B3 R 3.86 1.93 0.45 104.98 0.11 -8.95
0.22 0.46 0.88 0.009 0.09 0.39 0.1082
L 3.49 1.75 0.29 79.48 0.17 -13.34
0.02 0.25 0.72 0.009 0.04 0.07 0.0722
B4 R 3.83 1.92 0.35 101.6 0.13 -10.07
0.17 0.40 0.89 0.009 0.19 0.35 0.1394
L 3.27 1.64 0.12 88.3 -0.91 -9.7
0.01 0.36 0.81 0.009 0.09 0.36 0.1195
B5 R 5.17 2.59 1.57 67.22 0.25 -14.63
0.13 0.59 0.99 0.019 0.12 0.18 0.1796
L 4.31 2.16 0.75 94.79 1.02 -9.69
0.10 0.35 0.61 0.009 0.09 0.36 0.1793
B6 R 3.08 1.54 0.20 83.09 1.30 -8.68
0.09 0.29 0.73 0.009 0.08 0.28 0.1689
L 4.76 2.38 0.31 104.5 0.67 -9.58
0.12 0.39 0.86 0.009 0.11 0.41 0.1892
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Pico Results - 6 Months
mm mms"1"
s s
Case D max D y2 rel V max V zero Vmin
time time Tt time time time tOAccel
B7 R 3.64 1.82 0.38 88.89 0.12 -10.96
0.13 0.36 0.88 0.01 0.13 0.35 0.3507
L 3.86 1.93 0.09 101.44 -1.00 -11.25
0.09 0.29 0.74 0.01 0.10 0.28 0.2705
B8 R 4.10 2.05 0.42 98.24 0.70 -12.96
0.16 0.42 0.84 0.009 0.13 0.41 0.1452
L 4.65 2.33 0.31 122.43 0.65 -21.24
0.09 0.34 0.74 0.008 0.09 0.34 0.1306
B9 R 3.83 1.92 0.19 93.80 0.30 -14.8
0.17 0.32 0.69 0.009 0.12 0.31 0.3098
L 4.50 2.75 0.20 108.08 0.70 -19.27
0.10 0.21 0.61 0.008 0.09 0.18 0.1835
BIO R 3.62 1.81 0.22 95.17 0.05 -11.6
0.14 0.38 0.82 0.009 0.16 0.35 0.3506
L 3.50 1.75 0.17 69.33 0.37 -15.24
0.14 0.36 0.67 0.008 0.18 0.34 0.3275
Bll R 4.09 2.05 0.59 96.68 0.63 -13.64
0.19 0.40 0.78 0.008 0.14 0.36 0.3648
L 4.44 2.22 0.32 121.38 0.02 -15.6
0.09 0.42 0.85 0.009 0.11 0.39 0.1439
B12 R 1.95 0.98 0.09 54.29 0.02 -8.32
0.23 0.36 0.72 0.008 0.18 0.33 0.1236
L 2.51 1.26 0.22 31.6 0.13 -8.20
0.16 0.43 0.78 0.004 0.16 0.40 0.0417
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Pico Results - 6 Months
mm mms"1"
s s
Case D max D !4 rel V max V zero V min
time time Tt time time time tOAccel
CI R 2.95 1.48 0.03 42.71 0.25 -8.67
0.22 0.46 1.19 0.02 0.20 0.44 0.4357
L 3.11 1.56 0.13 30.75 0.14 -5.86
0.04 0.63 1.40 0.02 0.28 0.57 0.5730
C2 R 3.02 1.51 0.15 32.20 0.20 -8.33
0.23 0.42 1.33 0.02 0.19 0.34 0.3397
L 4.09 2.05 0.32 36.93 0.40 -12.61
0.19 0.39 0.86 0.03 0.19 0.31 0.1187
C3 R 3.02 1.56 0.12 40.85 0.40 -8.2
0.19 0.41 1.12 0.02 0.17 0.32 0.3201
L 4.16 2.08 0.15 66.39 0.25 -10.72
0.14 0.36 0.90 0.02 0.13 0.32 0.2843
C4 R 2.66 1.33 0.42 39.24 0.22 -5.14
0.30 0.55 1.37 0.02 0.22 0.50 0.4978
L 2.76 1.38 0.03 40.77 0.31 -8.55
0.25 0.44 1.20 0.02 0.18 0.41 0.4255
C5 R Died
L
C6 R 2.63 1.32 0.10 39.09 0.15 -5.89
0.34 0.62 1.42 0.02 0.32 0.54 0.3389
L 2.84 1.42 0.16 36.39 0.42 -7.16
0.22 0.53 1.19 0.02 0.23 0.48 0.1582
5 Appendix 8 - Pico data
Flexor Tendon Healing




Case D max D Vi rel V max V zero Vmin
time time Tt time time time tOAccel
C7 R 3.53 1.77 0.51 72.93 0.17 -13.46
0.25 0.38 0.74 0.007 0.23 0.36 0.1800
L 3.26 1.63 0.30 83.61 0.34 -12.62
0.19 0.56 0.68 0.009 0.16 0.35 0.1203
C8 R 4.28 2.14 0.52 74.22 0.70 -17.49
0.13 0.36 0.68 0.008 0,12 0.35 0.5714
L 3.25 1.63 0.10 68.78 0.43 -17.72
0.08 0.22 0.47 0.008 0.09 0.18 0.1579
C9 R 3.85 1.93 0.10 75.30 0.37 -16.31
0.28 0.49 0.77 0.009 0.13 0.47 0.4622
L 4.92 2.46 1.28 84.47 0.20 -13.50
0.20 0.64 0.81 0.008 0.88 0.14 0.1496
CIO R 5.02 2.15 0.13 11.37 0.80 -15.02
0.15 0.21 0.39 0.007 0.12 0.20 0.2046
L 3.76 1.88 0.26 86.01 0.10 -13.67
0.09 0.27 0.68 0.008 0.88 0.14 0.1408
Cll R 4.09 2.05 0.75 77.59 0.80 -15.02
0.18 0.45 0.63 0.006 0.45 0.41 0.1621
L 4.26 2.13 0.84 93.11 0.20 -8.05
0.09 0.60 0.94 0.009 0.13 0.50 0.1734
C12 R 3.34 1.67 0.29 77.96 0.30 -7.80
0.18 0.52 0.96 0.009 0.12 0.46 0.1689
L 3.99 2.00 0.38 96.78 0.36 -12.63
0.09 0.27 0.55 0.007 0.09 0.14 0.1389
6 Appendix 8 - Pico data
Flexor Tendon Healing
Pico Results - 6 Months
mm mms"1"
s s
Case D max D y2 rel V max V zero V min
time time Tt time time time tOAccel
D1 R 2.12 1.06 0.32 35.96 0.05 -3.79
0.13 0.56 1.60 0.02 0.14 0.51 0.5244
L 3.05 1.53 0.12 46.83 0.60 -6.9
0.02 0.54 1.07 0.02 0.19 0.49 0.5097
D2 R 2.98 1.49 0.14 80.06 0.01 -14.22
0.23 0.35 0.69 0.009 0.10 0.35 0.1069
L 3.39 1.70 0.57 81.31 0.30 -7.89
0.29 0.56 0.90 0.009 0.12 0.49 0.1295
D3 R 3.12 1.56 0.01 32.43 0.22 -11.23
0.18 0.36 0.73 0.02 0.18 0.32 0.2985
L 4.88 2.44 0.47 72.49 0.10 -8.59
0.14 0.51 1.05 0.02 0.12 0.52 0.2412
D4 R 3.34 1.67 0.13 56.29 0.50 -9.19
0.08 0.36 0.77 0.02 0.11 0.22 0.2242
L 4.17 2.09 0.21 67.06 0.50 -9.06
0.12 0.43 0.97 0.02 0.15 0.28 0.3038
D5 R 3.53 1.77 0.74 44.41 0.13 -6.45
0.36 0.61 0.14 0.02 0.24 0.55 0.5741
L 3.76 1.88 0.19 44.66 0.16 -11.78
0.27 0.44 0.79 0.02 0.22 0.43 0.4268
D6 R 4.86 2.43 0.25 79.47 0.97 -11.71
0.19 0.43 0.89 0.02 0.15 0.37 0.3682
L 4.38 2.19 0.59 71.59 0.35 -9.80
0.12 0.41 0.88 0.02 0.12 0.22 0.2230
7 Appendix 8 - Pico data
Flexor Tendon Healing




Case D max D '/2 rel V max V zero V min
time time Tt time time time tOAccel
D7 R 4.37 2.18 0.29 117.5 0.40 -15.56
0.15 0.33 0.76 0.009 0.13 0.32 0.3178
L 4.38 2.19 0.56 114.67 0.15 -12.10
0.11 0.41 0.71 0.007 0.10 0.35 0.3439
D8 R 3.71 1.86 0.41 70.71 0.11 -14.75
0.23 0.38 0.76 0.009 0.14 0.37 0.3677
L 3.67 1.84 0.29 104.86 0.05 -14.48
0.09 0.33 0.82 0.009 0.13 0.29 0.2841
D9 R 3.93 1.97 0.18 59.71 0.23 -12.52
0.11 0.37 0.77 0.02 0.12 0.39 0.1622
L 4.16 2.18 0.58 58.87 0.50 -12.66
0.11 0.38 0.69 0.02 0.13 0.36 0.3588
D10 R 3.44 1.72 0.36 73.97 0.50 -11.86
0.25 0.44 0.80 0.009 0.12 0.41 0.1467
L 3.39 1.70 0.65 90.62 0.02 -10.09
0.09 0.37 0.72 0.009 0.37 0.72 0.3075
Dll R 3.80 1.90 0.58 75.94 0.08 -7.42
0.20 0.60 0.94 0.009 0.13 0.50 0.1519
L 3.28 1.64 0.27 62.10 0.49 -11.90
0.16 0.49 0.76 0.009 0.18 0.46 0.1965
D12 R 3.74 1.87 0.67 74.71 0.04 -8.31
0.22 0.65 0.97 0.009 0.15 0.60 0.1897
L 4.06 2.03 1.30 58.44 0.30 -7.54
0.21 0.66 0.84 0.02 0.15 0.62 0.1654
8 Appendix 8 - Pico data
Flexor Tendon Healing
Pico Results - 6 Weeks
mm mms^
s s
Case D max D rel V max V zero Vmin
time time Tt time time time tOAccel
AG R 3.45 1.73 0.06 75.76 0.38 -16.43
0.23 0.39 0.71 0.008 0.12 0.37 0.1332
L 3.37 1.69 0.32 78.65 0.88 -10.90
0.09 0.44 0.69 0.007 0.09 0.37 0.1347
Ah R 3.39 1.70 0.34 85.31 0.10 -11.28
0.23 0.47 0.79 0.009 0.24 0.45 0.1480
L 3.70 1.85 0.25 89.62 0.48 -11.76
0.07 0.44 0.83 0.009 0.12 0.42 0.1597
Aj R 3.22 1.61 0.67 85.88 0.36 -10.14
0.40 0.58 0.89 0.009 0.10 0.52 0.1287
L 4.39 2.19 0.29 107.41 0.41 -16.58
0.14 0.45 0.83 0.01 0.11 0.42 0.1308
Ak R 4.26 2.13 0.17 117.85 0.18 -19.79
0.16 0.37 0.66 0.009 0.10 0.36 0.1206
L 4.25 2.13 0.28 115.34 0.95 -12.13
0.07 0.43 0.77 0.008 0.10 0.38 0.1357
Al R 4.64 2.32 0.24 122.57 0.15 -17.52
0.14 0.36 0.64 0.008 0.93 0.35 0.1339
L 6.04 3.02 0.47 152.59 0.94 -17.48
0.09 0.32 0.80 0.009 0.09 0.15 0.1461
Am R 3.58 1.79 0.25 73.21 0.19 -16.81
0.14 0.38 0.61 0.008 0.22 0.35 0.1309
L 3.61 1.81 0.13 76.85 0.45 -17.02
0.19 0.37 0.68 0.009 0.20 0.35 0.1549
9 Appendix 8 - Pico data
Flexor Tendon Healing
Pico Results - 6 Weeks
mm mms
s s
Case D max D l/2 rel V max V zero V min
time time Tt time time time tOAccel
Bg R 4.51 2.26 0.49 117.88 0.61 -21.13
0.22 0.37 0.60 0.007 0.09 0.34 0.1099
L 3.85 1.93 0.45 100.02 0.10 -13.40
0.10 0.41 0.72 0.008 0.11 0.38 0.1335
Bh R 3.19 1.60 0.02 47.99 0.73 -15.80
0.19 0.43 0.68 0.004 0.11 0.40 0.1651
L 4.59 2.29 0.78 71.64 0.17 -12.64
0.12 0.51 0.79 0.003 0.13 0.43 0.1654
Bj R 2.83 1.42 0.17 84.42 0.07 -11.28
0.09 0.41 0.64 0.008 0.09 0.38 0.1166
L 3.51 1.76 0.79 100.33 0.84 -7.77
0.07 0.36 0.79 0.009 0.09 0.31 0.1548
Bk R 6.35 3.18 0.33 140.22 1.20 -21.76
0.09 0.34 0.70 0.009 0.11 0.36 0.1364
L 6.39 3.19 0.39 179.29 1.10 -18.29
0.09 0.36 0.68 0.008 0.09 0.36 0.1335
Bl r 3.15 1.58 0.54 83.10 0.42 -11.74
0.27 0.45 0.67 0.007 0.10 0.42 0.1291
L 3.53 1.77 0.29 98.24 0.59 -18.42
0.30 0.43 0.71 0.008 0.12 0.42 0.1356
Bm R 3.05 1.53 0.26 91.71 0.14 -10.26
0.38 0.57 0.80 0.008 0.09 0.54 0.1179
L 3.58 1.79 0.29 94.79 0.58 -17.15
0.29 0.43 0.63 0.008 0.10 0.43 0.1335
10 Appendix 8 - Pico data
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Case D max D Vz rel V max V zero V min
time time Tt time time time tOAccel
Ca r 3.77 1.89 -0.03 36.93 0.90 -9.94
0.35 0.51 1.19 0.02 0.24 0.48 0.4800
L 3.67 1.84 0.07 54.35 0.80 -10.17
0.09 0.41 0.92 0.02 0.17 0.32 0.3055
CB r 3.79 1.90 -0.02 41.98 0.39 -9.82
0.33 0.49 1.18 0.02 0.22 0.47 0.4552
L 3.64 1.82 0.77 73.61 0.05 -8.96
0.38 0.57 1.19 0.02 0.15 0.48 0.1495
Cc r 2.48 1.24 0.26 41.29 0.25 -5.99
0.29 0.49 0.95 0.02 0.25 0.46 0.4947
L 3.92 1.96 0.74 56.63 0.35 -8.96
0.18 0.61 1.07 0.02 0.29 0.55 0.5526
CD r 2.26 1.13 0.13 34.31 0.45 -5.16
0.38 0.61 1.16 0.17 0.21 0.56 0.2108
L 3.21 1.61 0.64 51.33 0.01 -8.10
0.98 0.56 0.89 0.01 0.19 0.50 0.2378
Ce r 4.46 2.23 0.86 88.51 0.46 -11.09
0.27 0.49 0.95 0.01 0.22 0.42 0.4105
L 4.15 2.75 0.61 79.34 0.53 -10.76
0.33 0.49 1.14 0.02 0.15 0.50 0.1777
Cf r 1.36 0.68 0.06 22.74 0.18 -4.14
0.41 0.58 0.92 0.01 0.14 0.56 0.1837
L 2.08 1.04 0.15 37.64 0.04 -4.83
0.28 0.54 1.09 0.02 0.11 0.48 0.1616
11 Appendix 8 - Pico data
Flexor Tendon Healing
PicoResults - 6 Weeks
mm mms
s s
Case D max D !/2 rel V max V zero V min
time time Tt time time time tOAccel
Cg r 3.03 1.52 0.15 46.67 0.73 -15.67
0.37 0.46 0.69 0.03 0.09 0.42 0.2665
l 5.50 2.75 0.64 67.42 0.50 -18.44
0.20 0.36 0.68 0.02 0.10 0.31 0.3601
Ch r 4.63 2.32 0.23 94.08 0.12 -20.83
0.26 0.42 0.74 0.009 0.12 0.41 0.1458
l 3.60 1.80 0.16 99.33 0.009 -10.52
0.09 0.43 0.77 0.009 0.11 0.40 0.1437
Cj r 3.51 1.76 0.26 89.79 -0.73 l H—* oo
0.16 0.26 0.56 0.009 0.14 0.25 0.2567
l 4.15 2.08 0.78 111.23 0.42 -14.41
0.17 0.35 0.68 0.009 0.15 0.30 0.2999
Ck r 3.42 1.71 0.07 81.59 0.65 -17.81
0.12 0.25 0.61 0.009 0.11 0.24 0.2395
l 3.17 1.59 0.32 65.14 0.12 -11.01
0.10 0.34 0.65 0.009 0.15 0.36 0.3047
Cl r 2.93 1.47 0.45 65.27 0.24 -8.60
0.31 0.49 0.84 0.009 0.10 0.44 0.1333
l 4.01 2.01 0.20 84.10 0.59 -15.81
0.09 0.37 0.65 0.009 0.15 0.36 0.3617
Cm r 2.54 1.27 0.01 63.54 0.78 -11.59
0.13 0.26 0.60 0.009 0.11 0.31 0.2327
l 3.12 1.56 0.19 79.76 0.60 -14.72
0.17 0.30 0.64 0.009 0.16 0.28 0.2843
12 Appendix 8 - Pico data
Flexor Tendon Healing
Pico Results - 6 Weeks
mm mms"1"
s s
Case D max D V2 rel V max V zero Vmin
time time Tt time time time tOAccel
Da R 2.74 1.37 0.22 37.03 0.42 -6.44
0.25 0.47 0.77 0.02 0.19 0.43 0.4491
L 3.14 1.57 0.09 40.34 0.09 -8.08
0.18 0.46 0.83 0.02 0.18 0.46 0.4400
Db R 2.41 1.21 0.17 39.38 0.14 -6.68
0.31 0.50 0.99 0.02 0.20 0.46 0.4609
L 2.71 1.36 0.19 51.99 0.18 -7.57
0.28 0.48 0.99 0.02 0.15 0.44 0.1830
DC R 2.21 1.11 0.32 23.46 0.18 -4.73
0.49 0.77 1.03 0.02 0.23 0.66 0.2416
L 3.40 1.70 0.47 65.36 0.12 -9.68
0.30 0.52 0.99 0.01 0.13 0.47 0.1484
Dd R 3.09 1.55 0.22 51.64 0.03 -10.09
0.31 0.47 0.74 0.02 0.26 0.45 0.4360
L 3.98 1.99 0.61 69.43 0.33 -7.21
0.30 0.67 1.08 0.02 0.29 0.52 0.1995
De R 3.08 1.54 1.09 51.44 0.16 -5.40
0.31 0.69 0.93 0.01 0.24 0.51 0.5196
L 3.09 1.05 0.46 49.88 0.01 -5.84
0.18 0.80 1.12 0.01 0.18 0.64 0.2241
Df r 3.38 1.69 0.80 48.24 0.46 -7.26
0.28 0.47 0.88 0.02 0.17 0.42 0.4200
L 3.58 1.79 0.33 67.63 0.24 -7.60
0.19 0.46 1.02 0.02 0.14 0.38 0.3706
13 Appendix 8 - Pico data
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Case D max D Vi rel V max V zero Vmin
time time Tt time time time tOAccel
Dg R 3.44 1.72 0.16 103.80 0.35 -15.89
0.20 0.32 0.75 0.009 0.17 0.30 0.1000
L 5.15 2.58 0.52 121.82 -1.20 -12.97
0.09 0.39 0.76 0.008 0.97 0.39 0.1377
Dh R 4.42 2.21 0.26 107.93 1.00 -19.48
0.31 0.44 0.82 0.009 0.09 0.42 0.1322
L 4.57 2.29 0.65 104.17 0.60 -20.16
0.19 0.31 0.54 0.009 0.16 0.29 0.2856
Dj R 3.67 1.83 0.15 59.02 0.86 -11.66
0.19 0.44 0.78 0.009 0.13 0.43 0.1893
L 4.75 2.38 0.33 124.05 0.65 -21.58
0.09 0.35 0.64 0.008 0.09 0.35 0.1271
Dk r 4.48 2.24 0.22 129.22 0.22 -16.77
0.11 0.35 0.66 0.009 0.09 0.35 0.1394
L 4.70 2.35 0.20 138.76 0.50 -15.14
0.16 0.39 0.77 0.01 0.09 0.35 0.1308
Dl R 2.67 1.34 0.13 50.98 0.35 -12.09
0.18 0.32 0.60 0.007 0.14 0.31 0.2997
L 2.68 1.34 0.20 77.47 0.33 -10.90
0.08 0.37 0.63 0.009 0.13 0.34 0.1306
Divi R 2.83 1.42 0.26 72.38 0.008 -11.93
0.29 0.41 0.75 0.008 0.09 0.39 0.2997
L 4.31 2.16 0.12 87.04 0.42 -20.64
0.17 0.28 0.69 0.009 0.15 0.28 0.2661
14 Appendix 8 - Pico data
Flexor Tendon Healing
Pico Results - 6 Weeks
mm mms
s s
Case D max D !/2 rel V max V zero V min
time time Tt time time time tOAccel
N1 R 3.15 1.58 0.26 63.00 0.64 -11.41
0.11 0.33 0.66 0.009 0.13 0.31 0.3117
L 4.07 2.04 1.26 89.89 0.37 -12.03
0.13 0.42 0.67 0.009 0.45 0.36 0.3510
N2 R 3.12 1.56 0.68 79.71 0.13 -9.65
0.15 0.38 0.76 0.009 0.17 0.31 0.3050
L 3.24 1.62 0.23 66.88 0.71 -15.44
0.15 0.26 0.57 0.009 0.13 0.24 0.2337
N3 R 2.83 1.42 0.69 69.19 0.22 -8.64
0.22 0.50 0.79 0.009 0.10 0.43 0.1230
L 3.32 1.66 0.73 68.32 0.59 -10.29
0.35 0.55 0.82 0.009 0.15 0.49 0.1850
N4 R 2.40 1.20 0.06 74.26 0.52 -9.10
0.07 0.31 0.46 0.009 0.07 0.35 0.1150
L 2.89 1.45 0.62 79.69 0.70 -8.97
0.22 0.42 0.77 0.01 0.10 0.37 0.1100
N5 R 3.77 1.89 0.18 121.37 0.22 -11.69
0.07 0.31 0.65 0.009 0.08 0.32 0.1221
L 3.73 1.87 0.22 113.47 0.51 -11.42
0.82 0.32 0.72 0.009 0.91 0.34 0.1372
N6 R 3.03 1.52 0.11 104.48 0.55 -14.41
0.11 0.23 0.57 0.006 0.09 0.21 0.2102
L 2.95 1.48 0.30 77.44 0.51 -11.30
0.18 0.36 0.78 0.01 0.19 0.32 0.1003
15 Appendix 8 - Pico data
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Case D max D rel V max V zero Vmin
time time Tt time time time tOAccel
N7 R 3.54 1.78 0.20 105.55 0.29 -9.48
0.80 0.35 0.76 0.009 0.08 0.34 0.1289
L 4.11 2.06 0.84 118.68 0.80 -8.04
0.84 0.39 0.76 0.009 0.08 0.13 0.1204
N8 R 3.37 1.69 0.32 81.65 0.49 -12.01
0.19 0.38 0.78 0.009 0.13 0.37 0.1587
L 3.19 1.96 0.27 81.81 0.20 -13.44
0.59 0.39 0.75 0.009 0.12 0.37 0.1812
N9 R 4.21 2.11 0.74 81.06 0.50 -22.99
0.11 0.21 0.43 0.009 0.09 0.16 0.1680
L 3.33 1.12 0.13 58.48 0.95 -11.29
0.09 0.32 0.55 0.007 0.08 0.25 0.2559
N10 R 3.08 1.54 0.41 95.46 0.38 -7.79
0.21 0.44 0.72 0.008 0.20 0.36 0.0929
L 2.77 1.39 0.39 84.20 0.05 -8.70
0.02 0.41 0.69 0.01 0.10 0.36 0.1208
Nil R 4.47 2.24 0.71 128.45 0.15 -11.66
0.86 0.51 0.78 0.009 0.10 0.46 0.1282
L 3.76 1.88 0.27 97.22 0.98 -10.72
0.30 0.51 0.87 0.009 0.10 0.48 0.1424
N12 R 3.33 1.67 0.18 95.32 0.02 -12.01
0.17 0.36 0.68 0.01 0.10 0.34 0.1410
L 4.14 2.07 0.33 134.96 0.30 -15.51
0.13 0.33 0.57 0.007 0.11 0.29 0.2837
16 Appendix 8 - Pico data
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Case D max D y2 rel V max V zero V min
time time Tt time time time tOAccel
W1 R 2.38 1.19 0.34 59.03 0.46 -9.42
0.28 0.39 0.65 0.008 0.11 0.37 0.1212
L 3.29 1.65 0.16 98.54 0.26 -13.27
0.17 0.34 0.66 0.008 0.11 0.33 0.1273
W2 R 3.02 1.51 0.22 77.95 0.78 -9.25
0.08 0.43 0.75 0.009 0.10 0.42 0.1326
L 3.82 1.91 0.56 95.20 0.08 -9.01
0.10 0.49 0.83 0.009 0.11 0.44 0.1471
W3 R 3.50 1.75 0.26 101.34 0.63 -12.98
0.17 0.42 0.74 0.009 0.09 0.38 0.1093
L 4.79 2.40 1.15 122.86 0.46 -7.60
0.13 0.49 0.81 0.009 0.12 0.34 0.3372
W4 R 3.11 1.51 0.51 84.38 0.22 -8.67
0.29 0.56 0.87 0.009 0.12 0.50 0.1358
L 4.79 2.40 1.15 122.86 0.46 -7.60
0.13 0.49 0.84 0.009 0.12 0.34 0.3103
W5 R 3.95 1.98 0.23 121.19 0.57 -12.04
0.18 0.40 0.76 0.009 0.09 0.34 0.1129
L 4.225 2.13 0.45 107.53 0.08 -15.69
0.19 0.39 0.71 0.009 0.19 0.36 0.1287
W6 R 3.15 1.76 0.28 102.68 0.61 -11.16
0.16 0.36 0.71 0.008 0.15 0.29 0.1233
L 4.02 2.01 0.31 125.10 0.60 -12.43
0.09 0.35 0.64 0.007 0.09 0.31 0.1266
17 Appendix 8 - Pico data
Flexor Tendon Healing
Pico Results - 6 Weeks
mm mms"
s s
Case D max D y2 rel V max V zero Vmin
time time Tt time time time tOAccel
W7 R 4.02 2.01 0.31 130.51 0.07 -12.18
0.09 3.50 0.64 0.007 0.08 0.30 0.1332
L 5.10 2.55 0.16 139.46 0.73 -19.17
0.18 0.35 0.76 0.009 0.12 0.35 0.3359
W8 R 3.79 1.89 0.38 103.75 0.51 -10.19
0.11 0.44 0.82 0.009 0.10 0.42 0.1373
L 3.85 1.98 0.73 99.13 0.28 -9.95
0.19 0.44 0.67 0.007 0.20 0.34 0.1167
W9 R 3.48 1.74 0.19 111.45 0.09 -13.52
0.17 0.34 0.70 0.008 0.18 0.30 0.1142
L 3.64 1.82 0.41 108.41 0.15 -12.06
0.13 0.35 0.78 0.009 0.15 0.30 0.1116
W10 R 3.21 1.61 0.17 78.84 0.60 -9.26
0.17 0.39 0.78 0.009 0.12 0.37 0.3593
L 3.42 1.71 0.23 110.17 0.50 -11.89
0.13 0.31 0.60 0.009 0.09 0.29 0.1329
Wll R 2.66 1.33 0.13 79.24 0.29 -9.49
0.08 0.35 0.73 0.008 0.12 0.31 0.3020
L 4.01 2.01 0.28 69.81 0.39 -14.57
0.10 0.32 0.74 0.008 0.12 0.26 0.2726
W12 R 2.48 1.24 0.04 68.52 0.07 -12.59
0.78 0.26 0.37 0.009 0.98 0.25 0.2558
L 3.41 1.71 0.31 87.23 0.19 -9.69
0.11 0.39 0.75 0.009 0.11 0.36 0.1626
18 Appendix 8 - Pico data
Flexor Tendon Healing
Pico Results - 6 Weeks
mm mms"
s s
Case D max D y2 rel V max V zero V min
time time Tt time time time tOAccel
SI R 2.54 1.27 0.23 79.25 0.87 -8.70
0.07 0.44 0.82 0.009 0.07 0.38 0.1093
L 3.61 1.81 0.35 105.29 0.49 -10.79
0.10 0.36 0.61 0.009 0.09 0.33 0.1455
S2 R 4.05 2.03 0.21 93.95 0.06 -13.71
0.29 0.46 0.83 0.01 0.10 0.43 0.1310
L 4.39 2.19 0.48 117.59 0.49 -12.53
0.12 0.39 0.69 0.007 0.09 0.35 0.1441
S3 R 3.55 1.78 0.30 102.97 0.001 -10.69
0.09 0.39 0.82 0.009 0.11 0.35 0.3461
L 3.93 1.72 0.23 112.83 0.39 -10.90
0.15 0.41 0.86 0.009 0.09 0.34 0.1482
S4 R 3.58 1.79 0.20 87.37 0.58 -11.34
0.18 0.41 0.78 0.009 0.15 0.39 0.3617
L 3.82 1.91 0.26 113.03 0.08 -13.19
0.22 0.41 0.81 0.009 0.09 0.37 0.1071
S5 R 4.62 2.31 0.25 101.86 0.63 -15.28
0.08 0.33 0.69 0.008 0.11 0.32 0.3310
L 4.69 2.35 0.22 115.42 0.22 -14.75
0.12 0.39 0.80 0.009 0.14 0.36 0.3506
S6 R 3.44 1.72 0.12 91.11 0.08 -13.09
0.17 0.35 0.67 0.009 0.17 0.33 0.3167
L 3.82 1.96 0.20 137.78 0.87 -11.59
0.07 0.30 0.61 0.007 0.07 0.28 0.1420
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Case D max D !4 rel V max V zero Vmin
time time Tt time time time tOAccel
S7 R 3.59 1.80 0.31 47.51 0.45 -15.54
0.22 0.38 0.65 0.01 0.14 0.33 0.3467
L 3.73 1.81 0.41 59.44 0.68 -14.73
0.02 0.37 0.73 0.008 0.17 0.34 0.3427
S8 R 3.63 1.82 0.23 106.52 0.70 -8.42
0.11 0.37 0.74 0.008 0.98 0.35 0.1710
L 3.89 1.95 0.44 94.51 0.48 -9.12
0.12 0.39 0.79 0.009 0.11 0.35 0.1638
S9 R 3.35 1.68 0.25 84.13 0.09 -10.87
0.17 0.38 0.74 0.009 0.14 0.35 0.3514
L 3.77 1.89 0.32 85.46 0.42 -12.49
0.15 0.35 0.70 0.009 0.16 0.30 0.2948
S10 R 3.45 1.73 0.20 88.67 0.94 -9.59
0.11 0.37 0.73 0.008 0.11 0.31 0.2106
L 4.22 2.11 0.52 90.03 0.60 -11.43
0.15 3.56 0.70 0.009 0.13 0.33 0.3214
Sll R 4.11 2.06 0.36 119.06 0.36 -11.95
0.15 0.37 0.73 0.008 0.11 0.31 0.3054
L 4.54 2.27 0.41 118.81 0.61 -13.67
0.16 0.39 0.79 0.01 0.12 0.35 0.1408
S12 R 3.33 1.67 0.03 64.71 0.86 -13.98
0.13 0.28 0.60 0.008 0.11 0.29 0.2870
L 4.28 2.14 0.18 102.87 0.44 -17.30
0.11 0.28 0.58 0.008 0.11 0.25 0.2519
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Pico Results - 6 Weeks
mm mms
s s
Case D max D Vi rel V max V zero V min





T3 R 3.44 1.72 0.38 78.41 0.24 -9.56
0.16 0.38 0.82 0.009 0.15 0.32 0.3260
L 4.14 2.07 0.25 104.31 0.45 -18.93
0.19 0.31 0.62 0.009 0.15 0.29 0.2806
T4 R 4.80 2.40 0.83 112.65 0.15 -16.58
0.19 0.38 0.77 0.009 0.18 0.34 0.3304
L 5.40 2.70 0.26 129.69 0.67 -19.73
0.22 0.42 0.76 0.009 0.22 0.39 0.1442
T5 R 4.32 2.16 0.23 79.95 0.33 -22.41
0.17 0.32 0.60 0.01 0.07 0.27 0.1298
L 5.31 2.66 0.52 159.42 0.28 -16.19
0.09 0.38 0.68 0.008 0.09 0.34 0.1299
T6 R 5.38 2.69 0.26 129.69 0.68 -19.63
0.22 0.42 0.76 0.009 0.21 0.40 0.1731
L 5.53 2.77 0.36 136.79 0.59 -19.38
0.17 0.41 0.69 0.009 0.13 0.39 0.1662
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Pico Results - 6 Weeks
mm mms
s s
Case D max D y2 rel V max V zero Vmin
time time Tt time time time tOAccel
T7 R 4.22 2.11 0.32 53.94 0.74 -20.48
0.17 0.32 0.57 0.01 0.15 0.32 0.3167
L 4.36 2.18 0.49 136.49 0.24 -16.82
0.13 0.31 0.62 0.008 0.12 0.27 0.1165
T8 R 4.53 2.27 0.39 136.00 0.77 -16.31
0.08 0.39 0.65 0.009 0.08 0.33 0.1665
L 5.11 2.56 0.38 127.25 0.98 -16.46
0.10 0.32 0.57 0.009 0.09 0.35 0.1445
T9 R 3.49 1.75 0.25 92.34 0.41 -12.04
0.27 0.44 0.80 0.009 0.09 0.39 0.1357
L 3.71 1.86 0.23 78.84 0.67 -18.54
0.17 0.39 0.66 0.009 0.13 0.38 0.1294
T10 R 4.18 2.09 0.28 104.89 0.28 -20.79
0.21 0.34 0.60 0.009 0.19 0.33 0.1233
L 4.56 2.29 0.51 124.99 0.56 -14.37
0.21 0.42 0.70 0.007 0.09 0.34 0.1164
Til R 3.40 1.70 0.43 87.41 0.64 -10.67
0.24 0.46 0.85 0.009 0.96 0.41 0.2659
L 4.04 2.02 0.20 78.47 0.23 -17.87
0.15 0.29 0.51 0.009 0.15 0.28 0.1245
T12 R 3.60 1.80 0.22 62.89 0.93 -15.13
0.28 0.42 0.71 0.009 0.13 0.41 0.3183
L 4.29 2.15 0.27 103.51 0.28 -16.80
0.19 0.34 0.66 0.009 0.16 0.32 0.1506
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APPENDIX 9
Instron Results - 6 Months (A)
kgf mm
Case Force (UTS) Displacement
A1 R 24.60 15.56
L 19.12 13.17
A2 R 19.61 9.62
L 18.74 14.22
A3 R 22.95 9.75
L 17.44 11.46
A6 R 16.91 10.85
L 15.30 4.02
A10 R 29.96 12.29
L 11.47 7.61
A12 R 23.48 9.69
L 16.9 14.98
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Flexor Tendon Healing
Instron Results - 6 Months (B)
kgf mm
Case Force (UTS) Displacement
B2 R 17.77 10.91
L 16.09 9.27
B5 R 13.34 15.89
L 11.27 17.43
B6 R 21.61 18.46
L 17.42 11.86
B7 R 16.00 12.05
L 11.04 10.47
Bll R 38.98 12.65
L 26.90 7.82
B12 R 36.22 11.65
L 32.79 11.15
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Instron Results - 6 Months (C)
kgf mm
Case Force (UTS) Displacement
CI R 29.69 12.11
L 26.02 12.57
C4 R 19.85 13.56
L 16.81 15.11
C6 R 21.58 16.79
L 18.69 8.15
CIO R 43.82 6.63
L 19.06 10.65
Cll R 35.44 13.35
L 30.69 6.65
C12 R 40.58 8.49
L 18.15 13.17
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Instron Results - 6 Months (D)
kgf mm
Case Force (UTS) Displacement
D1 R 18.22 10.93
L 17.97 16.09
D2 R 20.93 10.99
L 18.91 15.42
D6 R 22.33 14.69
L 20.94 16.01
D10 R 35.44 11.50
L 33.57 6.23
Dll R 27.23 8.93
L 29.46 12.35
D12 R 38.27 9.32
L 36.10 7.13
4 Appendix 9 - Instron data
Flexor Tendon Healing
Instron Results - 6 Weeks (A)
kgf mm
Case Force (UTS) Displacement
AG R 6.25 11.43
L 38.42 7.52
AH R 12.84 13.21
L 29.89 7.39
AJ R 5.27 8.62
L 26.86 7.20
AK R 7.01 13.66
L 16.28 7.66
AL R 4.94 8.33
L 13.47 4.80
AM R 5.46 6.22
L 12.46 14.04
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Instron Results - 6 Weeks (B)
kgf mm
Case Force (UTS) Displacement
BG R 12.42 13.99
L 31.30 11.19
BH R 4.99 6.74
L 30.81 8.76
BJ R 9.95 6.80
L 31.98 8.46
BK R 17.39 12.18
L 27.80 6.65
BL R 8.13 9.97
L 21.87 7.01
BM R 5.44 17.06
L 27.40 9.36
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Instron Results - 6 Weeks (C)
kgf mm
Case Force (UTS) Displacement
CB R 11.56 3.88
L 22.98 5.30
CC R 13.34 3.61
L 18.97 6.57
CD R 6.77 6.64
L 19.38 7.37
CG R 17.52 9.15
L 37.81 9.97
CH R 6.65 6.72
L 31.22 9.79
CJ R 6.38 13.67
L 33.65 7.36
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Instron Results - 6 Weeks (D)
kgf mm
Case Force (UTS) Displacement
DB R 7.94 10.42
L 26.91 5.66
DC R 5.58 6.58
L 25.46 10.43
DF R 5.94 5.32
L 23.13 13.63
DG R 7.15 7.85
L 26.74 5.98
DH R 9.84 7.35
L 25.09 8.59
DJ R 11.05 9.19
L 23.38 4.04
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Instron Results - 6 Weeks (N)
kgf mm
Case Force (UTS) Displacement
N4 R 12.56 4.72
L 12.59 5.12
N6 R 25.94 8.11
L 31.13 7.49
N7 R 24.65 8.21
L 25.41 9.32
N8 R 14.85 7.04
L 15.09 4.79
N9 R 28.63 8.56
L 26.00 9.53
N10 R 28.12 5.99
L 27.07 5.89
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Instron Results - 6 Weeks (S)
kgf mm
Case Force (UTS) Displacement
SI R 43.26 10.19
L 31.47 10.23
S2 R 45.01 9.16
L 37.20 8.09
S3 R 27.35 9.54
L 34.15 14.47
S4 R 45.28 9.19
L 34.38 9.88
S5 R 39.55 12.26
L 36.30 7.81
S6 R 44.92 8.79
L 38.66 9.56
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Instron Results - 6 Weeks (W)
kgf mm
Case Force (UTS) Displacement
W4 R 20.36 8.11
L 18.62 6.70
W5 R 44.66 10.97
L 34.48 9.79
W6 R 24.10 8.78
L 23.30 7.42
W7 R 27.99 8.65
L 24.57 9.26
W8 R 29.77 7.70
L 34.14 12.04
W9 R 31.70 15.28
L 24.07 6.32
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Instron Results - 6 Weeks (T)
kgf mm
Case Force (UTS) Displacement
T1 R Died
L
T3 R 7.03 12.18
L 37.30 7.28
T4 R 20.85 12.23
L 39.36 8.66
T6 R 6.74 8.78
L 34.43 8.68
T7 R 3.41 8.15
L 57.99 11.38
T8 R 13.05 15.43
L 35.05 7.17
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A5 L 178.82 0.485 3.218 7.673 3.276 1.886 2.903 0.687
R 183.88 0.553 11.529 15.862 6.450 3.771 5.890 0.576
A7 L 183.80 0.513 6.333 10.608 4.395 3.326 3.475 0.707
R 182.50 0.532 19.263 18.589 7.764 5.191 6.038 0.701
A8 L 184.79 0.445 5.180 8.915 3.459 2.924 2.564 0.819
R 181.56 0.481 15.754 16.914 6.912 4.068 6.038 0.692
A9 L 173.68 0.449 3.675 8.027 3.326 1.674 3.178 0.717
R 182.46 0.524 18.142 20.028 7.746 5.911 5.466 0.568
All L 179.76 0.538 4.790 9.067 3.692 3.072 2.669 0.732



















B1 L 175.97 0.550 7.720 11.637 4.662 2.606 4.470 0.716
R 184.64 0.513 18.549 19.633 6.878 5.148 5.424 0.605
B3 L 183.81 0.487 4.637 8.793 3.549 3.136 2.373 0.754
R 182.63 0.505 26.630 23.757 7.967 7.119 6.038 0.593
B4 L 174.66 0.523 5.800 9.359 3.647 3.263 2.373 0.832
R 183.71 0.483 11.890 15.363 5.856 3.220 5.720 0.633
B8 L 176.67 0.494 3.350 7.094 2.850 2.246 2.119 0.836
R 180.39 0.570 20.575 18.958 7.090 5.911 5.890 0.719
B9 L 189.00 0.447 4.249 8.020 3.103 2.564 2.352 0.830
R 181.33 0.464 20.756 19.454 7.625 4.936 6.038 0.689
B10 L 179.91 0.495 8.991 11.767 4.556 4.004 3.369 0.816
R 182.19 0.535 11.515 16.480 5,654 4.025 5.487 0.533
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C2 L 183.04 0.459 2.468 7.538 2.892 2.881 1.589 0.767
R 190.11 0.485 10.560 22.032 7.717 5.975 6.038 0.532
C3 L 177.46 0.457 5.788 11.181 4.367 2.203 4.216 0.582
R 191.88 0.593 18.004 17.790 7.045 4.809 5.975 0.715
C5 L Died
R
C7 L 171.09 0.585 2.418 6.187 2.198 2.013 1.864 0.794
R 179.78 0.503 19.334 17.093 6.439 4.936 5.911 0.832
C8 L 175.74 0.482 4.938 8.560 3.200 2.839 2.485 0.847
R 184.47 0.495 9.032 13.257 4.744 4.216 3.559 0.646
C9 L 178.25 0.486 6.880 9.899 3.492 2.966 3.008 0.882



















D3 L 179.72 0.473 5.231 8.514 2.910 2.627 2.733 0.907
R 183.10 0.461 20.253 20.300 7.735 7.331 5.148 0.618
D4 L 181.91 0.507 3.778 8.776 3.337 2.754 2.458 0.616
R 184.04 0.478 28.789 25.323 9.866 9.301 5.996 0.564
D5 L 178.20 0.445 3.372 8.625 3.294 2.436 2.606 0.570
R 185.87 0.533 8.655 14.259 5.040 3.157 4.597 0.535
D7 L 178.33 0.537 4.538 8.625 3.371 2.818 2.627 0.767
R 182.81 0.535 8.655 14.259 5.040 3.157 4.597 0.535
D8 L 185.13 0.454 5.049 10.451 3.998 2.013 3.983 0.581
R 180.54 0.530 8.965 12.463 5.065 3.305 4.640 0.725
D9 L 171.51 0.507 4.668 8.618 3.427 2.521 2.860 0.790
R 182.83 0.556 6.091 14.477 5.061 3.602 4.492 0.365
2 Appendix 10 - AIS data
Flexor Tendon Healing




















AA L 193.21 0.440 5.152 9.248 3.739 2.924 2.754 0.757
R 198.71 0.509 24.130 20.263 7.353 5.784 5.614 0.739
AB L 178.52 0.502 3.106 7.805 2.934 2.479 1.949 0.641
R 194.68 0.547 32.215 27.054 9.642 8.305 6.038 0.553
AC L 176.23 0.494 3.675 9.547 4.197 2.797 3.411 0.507
R 187.01 0.545 22.443 18.652 7.129 4.936 5.551 0.811
AD L 182.65 0.505 4.084 8.218 3.090 2.585 2.458 0.760
R 183.39 0.511 27.603 21.902 8.273 5.763 6.038 0.723
AE L 175.97 0.511 4.803 9.306 3.379 3.199 2.288 0.697
R 185.58 0.553 26.660 21.809 8.132 7.394 5.212 0.704
AF L 175.09 0.516 4.813 9.217 3.542 3.072 2.585 0.712



















BA L 174.85 0.568 2.950 6.873 2.482 2.373 1.970 0.785
R 182.76 0.598 9.535 12.905 5.093 4.068 3.941 0.719
BB L 180.15 0.521 3.689 8.445 3.674 3.347 2.055 0.650
R 197.63 0.505 18.366 10.063 6.432 5.720 5.254 0.537
BC L 181.47 0.470 3.911 8.863 3.470 2.987 2.691 0.626
R 205.24 0.568 26.096 22.831 7.290 6.716 6.038 0.629
BD L 176.55 0.562 3.806 8.208 3.239 3.199 1.589 0.710
R 195.42 0.496 32.579 26.936 8.269 7.394 6.038 0.564
BE L 178.22 0.567 4.538 9.053 3.802 3.072 2.712 0.696
R 199.26 0.421 33.764 26.402 8.165 8.093 6.038 0.609
BF L 181.23 0.498 3.671 8.231 3.387 2.267 2.966 0.681
R 200.31 0.532 34.019 22.076 7.230 7.203 6.038 0.877
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CA L 183.73 0.399 4.307 8.330 3.319 2.818 2.479 0.780
R 193.03 0.495 18.983 18.543 7.137 4.216 6.038 0.694
CE L 179.27 0.517 3.360 7.340 2.830 2.436 2.097 0.792
R 202.79 0.454 31.070 23.841 8.758 8.093 5.953 0.687
CF L 185.48 0.423 7.581 13.545 4.899 4.025 3.898 0.519
R 189.98 0.477 25.855 21.330 7.616 5.614 6.038 0.714
CK L 178.85 0.463 5.184 8.624 3.243 2.775 2.585 0.876
R 188.58 0.604 15.576 17.082 6.870 3.983 6.038 0.671
CL L 178.75 0.510 6.911 9.761 3.454 3.157 2.966 0.911
R 184.20 0.479 14.991 16.138 6.251 5.784 3.729 0.723
CM L 180.33 0.473 5.622 8.792 3.230 2.797 2.648 0.914



















DA L 176.22 0.584 5.070 8.641 3.210 2.797 2.691 0.853
R 209.56 0.553 29.236 23.455 7.521 5.869 6.038 0.668
DD L 189.39 0.423 9.790 13.613 5.512 3.898 4.809 0.664
R 193.93 0.503 31.302 21.765 7.868 7.500 4.894 0.830
DE L 195.24 0.536 4.596 10.492 3.918 3.750 2.288 0.525
R 185.58 0.538 15.316 15.241 5.740 3.941 5.455 0.829
DK L 165.41 0.549 3.414 8.012 3.345 2.839 2.267 0.688
R 191.22 0.539 19.610 16.848 5.719 5.678 5.106 0.868
DL L 177.61 0.512 4.299 7.725 2.997 2.648 2.034 0.890
R 189.86 0.591 15.830 17.394 7.041 4.809 6.038 0.657
DM L 175.04 0.549 4.393 8.059 3.179 2.775 2.228 0.850
R 172.82 0.600 4.676 8.490 3.217 2.924 2.225 0.815
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N1 L 180.49 0.547 4.591 8.118 2.919 2.754 2.479 0.875
R 178.88 0.519 5.050 8.607 3.237 2.140 3.199 0.857
N2 L 179.65 0.505 5.740 9.188 3.400 3.136 2.797 0.855
R 177.76 0.474 5.330 9.446 3.912 3.157 2.966 0.751
N3 L 182.61 0.605 5.024 8.674 3.323 2.797 2.606 0.839
R 182.10 0.544 5.346 9.152 3.501 3.305 2.311 0.802
N5 L 179.55 0.568 3.578 8.488 3.598 2.246 3.136 0.624
R 177.38 0.498 4.648 8.105 3.075 3.051 2.076 0.889
Nil L 174.12 0.589 3.215 7.900 3.270 2.203 2.903 0.647
R 174.83 0.554 2.391 6.142 2.517 2.288 1.631 0.796
N12 L 175.60 0.545 6.554 10.500 4.246 4.131 2.267 0.747



















W1 L 181.67 0.536 2.439 6.934 2.893 2.436 1.907 0.637
R 185.72 0.545 7.981 12.757 4.699 4.025 3.305 0.616
W2 L 174.21 0.585 2.612 7.867 3.568 2.331 2.797 0.530
R 183.65 0.559 15.992 17.533 6.167 5.9111 4.301 0.654
W3 L 177.41 0.517 3.455 7.614 2.997 2.903 1.716 0.749
R 187.87 0.513 29.007 22.329 7.619 6.843 5.593 0.731
W10 L 174.18 0.492 2.674 6.296 2.396 2.288 1.610 0.848
R 184.21 0.538 10.610 15.075 6.231 4.261 5.508 0.587
Wll L 180.02 0.513 3.607 7.963 3.312 3.136 1.653 0.715
R 193.24 0.535 27.210 19.803 6.665 6.525 5.614 0.872
W12 L 188.88 0.565 6.190 11.583 4.570 3.729 3.157 0.580
R 186.21 0.545 23.437 19.278 7.122 6.356 5.911 0.792
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S7 L 176.35 0.525 2.856 6.750 2.736 2.331 2.055 0.788
R 181.82 0.463 6.860 10.142 3.769 2.987 3.538 0.838
S8 L 180.86 0.475 7.123 10.113 3.683 3.644 2.585 0.875
R 178.25 0.484 6.176 10.816 3.990 2.606 3.835 0.663
S9 L 181.35 0.477 5.095 8.607 3.206 3.244 2.076 0.864
R 176.39 0.548 5.969 9.757 3.902 3.623 2.521 0.788
S10 L 177.57 0.494 3.613 7.398 2.637 2.648 1.780 0.830
R 184.23 0.439 11.240 13.108 5.136 5.042 2.733 0.822
Sll L 180.33 0.437 7.149 10.857 4.315 3.665 3.136 0.762
R 179.04 0.475 8.254 10.813 3.933 3.877 2.585 0.887
S12 L 181.88 0.555 6.333 10.857 4.379 3.157 3.390 0.726





















T8 L 162.24 0.537 3.390 7.188 2.799 2.309 2.225 0.824
R 208.72 0.445 29.812 22.380 7.942 6.292 7.436 0.748
T9 L 172.59 0.471 5.764 9.611 3.944 3.093 2.775 0.784
R 203.96 0.375 20.137 20.927 6.475 5.212 6.038 0.578
4.832T10 L 169.93 0.552 8.350 2.946 2.627 2.691 0.871
R 200.67 0.518 16.887 15.979 6.049 3.877 5.847 0.831
Til L 172.89 0.510 2.527 6.103 2.335 2.309 1.377 0.852
R 232.16 0.451 15.671 15.930 5.957 3.453 5.636 0.776
T12 L 151.37 0.592 6.374 9.493 3.440 2.542 3.199 0.889
R 239.14 0.464 20.066 17.027 5.811 5.763 5.021 0.870
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APPENDIX 11
Morphometric Analysis - % Composition 6 Months
Case Tendon Bv's Suture Other
A4 L Died
R
A5 L 100 0 0 0
R 85 11 0 4
A7 L 96 4 0 0
R 88 9 0 3
A8 L 95 5 0 0
R 90 6 0 4
A9 L 100 0 0 0
R 95 5 0 0
All L 97 3 0 0
R 77 7 16 0
Case Tendon BV's Suture Other
B1 L 100 0 0 0
R 87 11 7 5
B3 L 98 2 2 0
R 93 7 7 0
B4 L 94 6 6 0
R 80 5 5 4
B8 L 95 5 5 0
R 74 9 9 3
B9 L 89 11 11 0
R 73 11 11 3
B10 L 91 9 9 0
R 82 10 10 8
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Morphometric Analysis - % Composition
Case Tendon Bv's Suture Other
C2 L 98 0 0 0
R 91 0 0 0
C3 L 100 0 0 0
R 76 5 5 3
C5 L Died
R
C7 L 100 0 0 0
R 95 5 0 0
C8 L 96 4 0 0
R 78 9 13 0
C9 L 100 0 0 0
R 88 9 0 3
Case Tendon Bv's Suture Other
D3 L 100 0 0 0
R 89 6 5 0
D4 L 98 0 0 0
R 92 8 0 0
D5 L 94 6 0 0
R 89 11 0 0
D7 L 97 3 0 0
R 83 13 4 0
D8 L 100 0 0 0
R 87 10 3 0
D9 L 100 0 0 0
R 93 7 0 0
2 Appendix 11 - Percent composition data
Flexor Tendon Healing
Morphometry Analysis - % Composition 6 Weeks
Case Tendon Bv's Suture Other
AA L 96 4 0 0
R 64 2 17 7
AB L 100 0 0 0
R 72 12 3 13
AC L 100 0 0 0
R 56 8 12 24
AD L 100 0 0 0
R 52 6 30 12
AE L 89 11 0 0
R 49 15 3 3
AF L 88 12 0 0
R 64 14 14 8
Case Tendon Bv's Suture Other
BA L 100 0 0 0
R 64 27 0 9
BB L 100 0 0 0
R 64 17 12 7
BC L 94 6 0 0
R 68 17 4 11
BD L 98 0 0 2
R 50 16 30 4
BE L 100 0 0 0
R 49 28 15 8
BF L 96 4 0 0
R 51 20 24 8
3 Appendix 11 - Percent composition data
Flexor Tendon Healing
Morphometric Analysis - % Composition
Case Tendon Bv's Suture Other
CA L 100 0 0 0
R 70 14 16 0
CE L 89 11 0 0
R 68 28 4 0
CF L 96 4 0 0
R 84 16 0 0
CK L 96 4 0 0
R 68 9 23 0
CL L 100 0 0 0
R 77 11 12 0
CM L 100 0 0 0
R 63 28 0 9
Case Tendon Bv's Suture Other
DA L 100 0 0 0
R 73 19 8 0
DD L 93 7 0 0
R 76 15 9 0
DE L 100 0 0 0
R 58 15 27 0
DK L 97 3 0 0
R 77 23 0 0
DL L 96 4 0 0
R 62 23 15 0
DM L 100 0 0 0
R 72 12 16 0
4 Appendix 11 - Percent composition data
Flexor Tendon Healing
Morphometry Analysis - % Composition
Case Tendon bv's Suture Other
N1 L 99 1 - 0
R 98 2 - 0
N2 L 100 0 - 0
R 99 1 - 0
N3 L 98 2 - 0
R 97 3 - 0
N5 L 100 0 - 0
R 96 4 - 0
Nil L 99 0 - 1
R 99 1 - 0
N12 L 99 1 - 0
R 97 3 - 0
Case Tendon Bv'S Suture Other
S7 L 100 0 - 0
R 99 1 - 0
S8 L 97 3 - 0
R 96 4 - 0
S9 L 100 0 - 0
R 97 0 - 3
S10 L 100 0 - 0
R 99 0 - 1
Sll L 100 0 - 0
R 100 0 - 0
S12 L 100 0 - 0
R 100 0 - 0
5 Appendix 11 - Percent composition data
Flexor Tendon Healing
Morphometric Analysis - % Composition
Case Tendon BV's Suture Other
W1 L 100 0 - 0
R 93 5 - 2
W2 L 97 3 - 0
R 94 6 - 0
W3 L 98 2 - 0
R 92 5 - 3
W10 L 98 2 - 0
R 92 6 - 2
Wll L 96 4 - 0
R 93 5 - 2
W12 L 94 6 - 1
R 88 8 - 4
Case Tendon Bv's Suture Other
T2 L Died
R
T8 L 99 0 0 1
R 53 33 4 10
T9 L 100 0 0 0
R 83 19 0 8
T10 L 100 0 0 0
R 63 25 0 12
Til L 100 0 0 0
R 47 23 0 30
T12 L 98 0 0 2
R 52 36 0 12
6 Appendix 11 - Percent composition data
